{
  "metadata": {
    "project": "Clinical Trial Eligibility Questionnaire",
    "version": "2.0_improved",
    "created_date": "2026-01-10",
    "last_updated": "2026-01-12",
    "total_criteria": 740,
    "total_clusters": 10,
    "clusters": [
      {
        "code": "AAO",
        "name": "Affected Area and Organs",
        "count": 66,
        "primary_question": "How much of your body is affected?"
      },
      {
        "code": "AGE",
        "name": "Age-Based Eligibility",
        "count": 71,
        "primary_question": "How old are you?"
      },
      {
        "code": "AIC",
        "name": "Active Infection History Criteria",
        "count": 84,
        "primary_question": "Were you diagnosed with any infectious diseases?"
      },
      {
        "code": "BIO",
        "name": "Biomarkers",
        "count": 4,
        "primary_question": "Do you have biomarker test results?"
      },
      {
        "code": "BMI",
        "name": "Weight and Body Mass Index",
        "count": 34,
        "primary_question": "What is your weight and height?"
      },
      {
        "code": "CMB",
        "name": "Comorbid Conditions and Risk Factors",
        "count": 271,
        "primary_question": "Do you have any other diseases?"
      },
      {
        "code": "CPD",
        "name": "Chronic Plaque Psoriasis Duration Criteria",
        "count": 49,
        "primary_question": "How long have you had psoriasis or psoriatic arthritis?"
      },
      {
        "code": "FLR",
        "name": "Flare History",
        "count": 52,
        "primary_question": "Have you experienced disease flares?"
      },
      {
        "code": "NPV",
        "name": "Non-Plaque Psoriasis Variants",
        "count": 61,
        "primary_question": "What form of psoriasis do you have?"
      },
      {
        "code": "SEV",
        "name": "Severity Scores",
        "count": 48,
        "primary_question": "Do you have illness severity scores in your medical records?"
      }
    ]
  },
  "CLUSTER_AGE": {
    "cluster_name": "Age-Based Eligibility",
    "cluster_code": "AGE",
    "total_criteria": 71,
    "primary_question": "How old are you?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "AGE_2447",
        "nct_id": "NCT06170840",
        "raw_text": "When signing the informed consent, age ≤ 18 years old ≤ 75 years old, gender is not limited.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2414",
        "nct_id": "NCT06643260",
        "raw_text": "Male or female, 18 years and above;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2413",
        "nct_id": "NCT06643260",
        "raw_text": "Male or female, 18 years and above;",
        "AGE_MIN": null,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2379",
        "nct_id": "NCT06380153",
        "raw_text": "adults of both sexes aged 18-70 years old (both ends, whichever is based on written informed consent)",
        "AGE_MIN": 18,
        "AGE_MAX": 70,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2365",
        "nct_id": "NCT03997786",
        "raw_text": "Subject must be 6 to < 18 years of age, of either sex, of any race/ ethnicity, must weight greater than or equal to 15Kg.",
        "AGE_MIN": 6,
        "AGE_MAX": 17,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2332",
        "nct_id": "NCT06610890",
        "raw_text": "Male and female subjects aged from 18 to 65 years old (including 18 and 65 years old), the ratio of male to female was 1:1;",
        "AGE_MIN": 18,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2320",
        "nct_id": "NCT07219420",
        "raw_text": "At least 18 years of age inclusive, at the time of signing the informed consent form (ICF)",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2311",
        "nct_id": "NCT07033234",
        "raw_text": "Male or female participants aged 18-65 years (inclusive) at the time of signing the informed consent form;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2307",
        "nct_id": "NCT07033234",
        "raw_text": "Healthy adults aged 18-45 years (inclusive) at the time of signing the informed consent form;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2293",
        "nct_id": "NCT06477237",
        "raw_text": "Male or female subjects aged 18-75 years (inclusive)",
        "AGE_MIN": 18,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2278",
        "nct_id": "NCT06648772",
        "raw_text": "PHQ-8 (adults) or modified PHQ-A (aged 12-17 years) ≥ 10 points, for children aged 6-11 years, investigators assessed the presence or risk of depression after communicating with their parents/guardians at baseline or screening.",
        "AGE_MIN": 12,
        "AGE_MAX": 17,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AGE_2255",
        "nct_id": "NCT06648772",
        "raw_text": "Aged ≥ 6 years at the time of signing the ICF, male or female.",
        "AGE_MIN": 6,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2216",
        "nct_id": "NCT07013201",
        "raw_text": "Age 18 years or above at the time of informed consent signing.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2176",
        "nct_id": "NCT06628206",
        "raw_text": "≥ 18 years old, irrespective of their race and ethnicity.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2136",
        "nct_id": "NCT07038720",
        "raw_text": "Men and women aged 18-55 at the time of screening visit;",
        "AGE_MIN": null,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2135",
        "nct_id": "NCT07038720",
        "raw_text": "Men and women aged 18-55 at the time of screening visit;",
        "AGE_MIN": null,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2119",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 2. Male or female subjects between the ages of 18 and 75 (including the threshold) at the time of signing the ICF.",
        "AGE_MIN": 18,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2103",
        "nct_id": "NCT06672393",
        "raw_text": "Male or female subjects aged 18 years and older",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2081",
        "nct_id": "NCT06926582",
        "raw_text": "Male or female subjects between the ages of 18-70 years",
        "AGE_MIN": 18,
        "AGE_MAX": 70,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2070",
        "nct_id": "NCT07078695",
        "raw_text": "Male aged between 18 to 55 years of age (inclusive)",
        "AGE_MIN": 18,
        "AGE_MAX": 55,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2068",
        "nct_id": "NCT07078695",
        "raw_text": "Healthy white participants.",
        "AGE_MIN": null,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2061",
        "nct_id": "NCT06846541",
        "raw_text": "Males or females, age ≥18 years",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2038",
        "nct_id": "NCT06143371",
        "raw_text": "Male or female, aged 18 to 50 years of age (inclusive) at the time of signing informed consent.",
        "AGE_MIN": 18,
        "AGE_MAX": 50,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2033",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "AGE_MIN": 55,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_2013",
        "nct_id": "NCT06671496",
        "raw_text": "The participant is aged 18 years or older at the time of signing the informed consent form (ICF).",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1998",
        "nct_id": "NCT06833307",
        "raw_text": "between 6 and 18years of age at time of screening.",
        "AGE_MIN": 6,
        "AGE_MAX": 18,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1964",
        "nct_id": "NCT06641089",
        "raw_text": "Participants must be ≥18 years of age .",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1949",
        "nct_id": "NCT06077331",
        "raw_text": "Male or female subjects between the ages of 18-70 years",
        "AGE_MIN": 18,
        "AGE_MAX": 70,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1901",
        "nct_id": "NCT07102888",
        "raw_text": "Age ≥ 6 years old and < 18 years old at screening.",
        "AGE_MIN": null,
        "AGE_MAX": 6,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1855",
        "nct_id": "NCT06723171",
        "raw_text": "Inclusion Criteria: 1. At least 18 years of age",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1827",
        "nct_id": "NCT06620692",
        "raw_text": "Female or male patients are ≥ 20 years old.",
        "AGE_MIN": 20,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1782",
        "nct_id": "NCT07129382",
        "raw_text": "Age 18-70 years (inclusive) at consent, any gender",
        "AGE_MIN": 18,
        "AGE_MAX": 70,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1759",
        "nct_id": "NCT06058546",
        "raw_text": "Aged 18-65, male or female.",
        "AGE_MIN": 18,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1721",
        "nct_id": "NCT06376474",
        "raw_text": "Adults of both sexes aged from 18 to 70 years old (both ends, based on written informed consent).",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1690",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant must be 6 to <18 years of age, inclusive, at the time of signing the informed consent/assent according to local regulation",
        "AGE_MIN": null,
        "AGE_MAX": 6,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1681",
        "nct_id": "NCT07029516",
        "raw_text": "aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1649",
        "nct_id": "NCT06506916",
        "raw_text": "Control Cohort: Study participant must be ≥18 years of age at the time of signing the informed consent",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1641",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant must be at least 18 years of age inclusive at the time of signing the Informed Consent Form (ICF)",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1624",
        "nct_id": "NCT06945107",
        "raw_text": "Male or female, aged ≥18 years and ≤75 years.",
        "AGE_MIN": null,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1623",
        "nct_id": "NCT06945107",
        "raw_text": "Male or female, aged ≥18 years and ≤75 years.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1566",
        "nct_id": "NCT06562894",
        "raw_text": "Subjects aged ≥18 to ≤ 65 years;",
        "AGE_MIN": null,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1565",
        "nct_id": "NCT06562894",
        "raw_text": "Subjects aged ≥18 to ≤ 65 years;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1520",
        "nct_id": "NCT06943950",
        "raw_text": "Age ≥18 and ≤ 65 years old.",
        "AGE_MIN": null,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1519",
        "nct_id": "NCT06943950",
        "raw_text": "Age ≥18 and ≤ 65 years old.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1503",
        "nct_id": "NCT06592274",
        "raw_text": "Male or female subjects aged 18-75 years (inclusive)",
        "AGE_MIN": 18,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1497",
        "nct_id": "NCT06299982",
        "raw_text": "Age ≥18 years old, both male and female.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1462",
        "nct_id": "NCT06542614",
        "raw_text": "Be 18-70 years old (both 18 and 70 years old), regardless of gender；",
        "AGE_MIN": null,
        "AGE_MAX": 70,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1461",
        "nct_id": "NCT06542614",
        "raw_text": "Be 18-70 years old (both 18 and 70 years old), regardless of gender；",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1381",
        "nct_id": "NCT07090330",
        "raw_text": "Participants ≥ 18 years of age",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1360",
        "nct_id": "NCT06671483",
        "raw_text": "The participant is aged 18 years or older at the time of signing the informed consent form (ICF). In South Korea, the age requirement for adult participants is >=19 years of age.",
        "AGE_MIN": 19,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1359",
        "nct_id": "NCT06671483",
        "raw_text": "The participant is aged 18 years or older at the time of signing the informed consent form (ICF). In South Korea, the age requirement for adult participants is >=19 years of age.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1348",
        "nct_id": "NCT06176508",
        "raw_text": "Male or female subjects between the ages of 18-75 years.",
        "AGE_MIN": 18,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1330",
        "nct_id": "NCT07150988",
        "raw_text": "Age≥18 years, regardless of gender;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1322",
        "nct_id": "NCT07024602",
        "raw_text": "Male and female participants between 18 to 65 years of age inclusive, at the time of screening.",
        "AGE_MIN": 18,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1290",
        "nct_id": "NCT06918743",
        "raw_text": "The age of signing the informed consent must be ≥18 years old and ≤75 years old, male or female",
        "AGE_MIN": null,
        "AGE_MAX": 75,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1289",
        "nct_id": "NCT06918743",
        "raw_text": "The age of signing the informed consent must be ≥18 years old and ≤75 years old, male or female",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1273",
        "nct_id": "NCT06844799",
        "raw_text": "Adults aged 18 and above, male or female;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1251",
        "nct_id": "NCT06380907",
        "raw_text": "Adults ≥ 18 years of age.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1227",
        "nct_id": "NCT06641076",
        "raw_text": "Participants must be ≥18 years of age .",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1214",
        "nct_id": "NCT06888193",
        "raw_text": "Study participant must be at least 18 years of age at the time of signing the informed consent.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1188",
        "nct_id": "NCT05642182",
        "raw_text": "Subjects of both sexes ≥18 years of age with at least one skin plaque that is >5 cm2 due to known psoriasis considered clinically to be MILD to MODERATE or MODERATE to SEVERE during evaluation and diagnosis at least 1 year prior.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1168",
        "nct_id": "NCT04772079",
        "raw_text": "Males and females aged 4 to <12 years for Cohort 2.",
        "AGE_MIN": null,
        "AGE_MAX": 12,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1167",
        "nct_id": "NCT04772079",
        "raw_text": "Males and females aged 4 to <12 years for Cohort 2.",
        "AGE_MIN": 4,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1166",
        "nct_id": "NCT04772079",
        "raw_text": "Males and females aged 12 to <18 years for Cohort 1.",
        "AGE_MIN": null,
        "AGE_MAX": 18,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1165",
        "nct_id": "NCT04772079",
        "raw_text": "Males and females aged 12 to <18 years for Cohort 1.",
        "AGE_MIN": 12,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1160",
        "nct_id": "NCT06663332",
        "raw_text": "Participant is <18 years of age and resides in a county where 2 years have elapsed post marketing authorization for the respective pediatric indication",
        "AGE_MIN": null,
        "AGE_MAX": 18,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AGE_1159",
        "nct_id": "NCT06663332",
        "raw_text": "Participant is greater than or equal to (>=) 18 years of age and resides in a country where 2 years have elapsed post marketing authorization for the respective adult indication",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AGE_1132",
        "nct_id": "NCT06005532",
        "raw_text": "2. Male and female patients aged 18-65 years, body weight ≥ 50 kg and ≤ 120 kg.",
        "AGE_MIN": 18,
        "AGE_MAX": 65,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1122",
        "nct_id": "NCT06846710",
        "raw_text": "Male or female participants aged 18-65 years (inclusive) at the time of signing the informed consent form;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1118",
        "nct_id": "NCT06846710",
        "raw_text": "Healthy adults aged 18-45 years (inclusive) at the time of signing the informed consent form;",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AGE_1054",
        "nct_id": "NCT06550076",
        "raw_text": "Participant is aged 18 years or older at the time of consent.",
        "AGE_MIN": 18,
        "AGE_MAX": null,
        "AGE_UNIT": "years",
        "EXCLUSION_STRENGTH": "inclusion"
      }
    ]
  },
  "CLUSTER_BMI": {
    "cluster_name": "Weight and Body Mass Index",
    "cluster_code": "BMI",
    "total_criteria": 34,
    "primary_question": "What is your weight and height?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "BMI_2382",
        "nct_id": "NCT06380153",
        "raw_text": "Body mass index (BMI) : 19-32 kg/m2 (including cut-off value)",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2381",
        "nct_id": "NCT06380153",
        "raw_text": "The body weight of male subjects was not less than 50 kg and that of female subjects was not less than 45 kg.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2380",
        "nct_id": "NCT06380153",
        "raw_text": "The body weight of male subjects was not less than 50 kg and that of female subjects was not less than 45 kg.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2366",
        "nct_id": "NCT03997786",
        "raw_text": "Subject must be 6 to < 18 years of age, of either sex, of any race/ ethnicity, must weight greater than or equal to 15Kg.",
        "EXCLUSION_STRENGTH": "inclusion",
        "WEIGHT_MIN": 15,
        "WEIGHT_UNIT": "kg"
      },
      {
        "id": "BMI_2335",
        "nct_id": "NCT06610890",
        "raw_text": "Body weight: male ≥50.0kg, female ≥45.0kg, body mass index [BMI= weight (kg)/height 2 (m2)] between 19.0 kg/m2 and 26.0kg/m2 (including boundary values);",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2334",
        "nct_id": "NCT06610890",
        "raw_text": "Body weight: male ≥50.0kg, female ≥45.0kg, body mass index [BMI= weight (kg)/height 2 (m2)] between 19.0 kg/m2 and 26.0kg/m2 (including boundary values);",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2333",
        "nct_id": "NCT06610890",
        "raw_text": "Body weight: male ≥50.0kg, female ≥45.0kg, body mass index [BMI= weight (kg)/height 2 (m2)] between 19.0 kg/m2 and 26.0kg/m2 (including boundary values);",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2313",
        "nct_id": "NCT07033234",
        "raw_text": "Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2309",
        "nct_id": "NCT07033234",
        "raw_text": "body mass index (weight/square of height (kg/m2)) within the range of 18-28 kg/m2 (inclusive);",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2308",
        "nct_id": "NCT07033234",
        "raw_text": "Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2177",
        "nct_id": "NCT06628206",
        "raw_text": "Body Mass Index (BMI) 18.0-35.0 kg/m2, inclusive, at screening.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2139",
        "nct_id": "NCT07038720",
        "raw_text": "Body mass index (BMI) 18.5-28 kg/m2, inclusive, and total body weight ≥50 kg for male or ≥45 kg for female;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2138",
        "nct_id": "NCT07038720",
        "raw_text": "Body mass index (BMI) 18.5-28 kg/m2, inclusive, and total body weight ≥50 kg for male or ≥45 kg for female;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2137",
        "nct_id": "NCT07038720",
        "raw_text": "Body mass index (BMI) 18.5-28 kg/m2, inclusive, and total body weight ≥50 kg for male or ≥45 kg for female;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2073",
        "nct_id": "NCT07078695",
        "raw_text": "Women with body weight ≥ 45.0 kg, men with body weight ≥ 50.0 kg, body mass index (BMI) between 18.0 and 30.0 kg/m2 (inclusive) at screening.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2072",
        "nct_id": "NCT07078695",
        "raw_text": "Women with body weight ≥ 45.0 kg, men with body weight ≥ 50.0 kg, body mass index (BMI) between 18.0 and 30.0 kg/m2 (inclusive) at screening.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2071",
        "nct_id": "NCT07078695",
        "raw_text": "Women with body weight ≥ 45.0 kg, men with body weight ≥ 50.0 kg, body mass index (BMI) between 18.0 and 30.0 kg/m2 (inclusive) at screening.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2040",
        "nct_id": "NCT06143371",
        "raw_text": "Body mass index (BMI) 18 to 30 kg/m2 (inclusive) and a weight between 50 to 100 kg (inclusive) at the time of screening",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2039",
        "nct_id": "NCT06143371",
        "raw_text": "Body mass index (BMI) 18 to 30 kg/m2 (inclusive) and a weight between 50 to 100 kg (inclusive) at the time of screening",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_2032",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1916",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not weigh < 30.0 kg at Screening and Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "BMI_1724",
        "nct_id": "NCT06376474",
        "raw_text": "Body mass index (BMI) : 19-32 kg/m2 (including cut-off value).",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1723",
        "nct_id": "NCT06376474",
        "raw_text": "The body weight of male subjects should not be less than 50 kg and the body weight of female subjects should not be less than 45 kg.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1722",
        "nct_id": "NCT06376474",
        "raw_text": "The body weight of male subjects should not be less than 50 kg and the body weight of female subjects should not be less than 45 kg.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1696",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has body weight ≥15 kg and body mass index for age percentile of ≥5 at Screening",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1651",
        "nct_id": "NCT06506916",
        "raw_text": "Control Cohort: Study participant has body weight <120 kg",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1647",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has body weight <120 kg",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1291",
        "nct_id": "NCT06918743",
        "raw_text": "At screening, body mass index [BMI= weight (kg)/height 2 (m2)]≥18.0kg/m2",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1174",
        "nct_id": "NCT04772079",
        "raw_text": "Participants weighing ≤ 18.0 kg at screening for Cohort 2 (age 4 to < 12 years), Part A and Part B.",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "BMI_1173",
        "nct_id": "NCT04772079",
        "raw_text": "Participants weighing ≤ 30.0 kg at screening for Cohort 1 (age 12 to < 18 years), Part A and Part B.",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "BMI_1133",
        "nct_id": "NCT06005532",
        "raw_text": "2. Male and female patients aged 18-65 years, body weight ≥ 50 kg and ≤ 120 kg.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1123",
        "nct_id": "NCT06846710",
        "raw_text": "Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1120",
        "nct_id": "NCT06846710",
        "raw_text": "Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg; body mass index (weight/square of height (kg/m2)) within the range of 18-28 kg/m2 (inclusive);",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BMI_1119",
        "nct_id": "NCT06846710",
        "raw_text": "Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg; body mass index (weight/square of height (kg/m2)) within the range of 18-28 kg/m2 (inclusive);",
        "EXCLUSION_STRENGTH": "inclusion"
      }
    ]
  },
  "CLUSTER_NPV": {
    "cluster_name": "Non-Plaque Psoriasis Variants",
    "cluster_code": "NPV",
    "total_criteria": 61,
    "primary_question": "What form of psoriasis do you have?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "NPV_2453",
        "nct_id": "NCT06170840",
        "raw_text": "Other types of psoriasis were diagnosed during screening, such as guttate psoriasis, erythrodermic psoriasis, generalized pustular psoriasis, arthropathic psoriasis, drug-induced or drug-aggravated psoriasis.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2426",
        "nct_id": "NCT06643260",
        "raw_text": "Psoriasis limited to erythrodermic, guttate, palmar, plantar, or generalized pustular psoriasis in the absence of plaque psoriasis;",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2372",
        "nct_id": "NCT03997786",
        "raw_text": "Subject has predominantly non-plaque forms of psoriasis specifically erythrodermic psoriasis, predominantly pustular psoriasis, medication-induced or medication-exacerbated psoriasis, or new-onset guttate psoriasis",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2328",
        "nct_id": "NCT07219420",
        "raw_text": "Has drug-induced PSO (eg, first onset or current exacerbation due to beta blockers, calcium channel inhibitors, lithium, or tumor necrosis factor [TNF] inhibitor) or drug-induced pustular PSO (eg, acute generalized exanthematous pustulosis, acute localized exanthematous pustulosis)",
        "PSORIASIS_VARIANT": [
          "pustular",
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2327",
        "nct_id": "NCT07219420",
        "raw_text": "Has the following: palmoplantar PSO (plaque PSO on palms/soles), guttate PSO, erythrodermic PSO (EP), generalized pustular PSO (GPP), Acrodermatitis continua of Hallopeau (ACH), atopic dermatitis, dyshidrotic eczema or chronic hand eczema.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "palmoplantar"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2317",
        "nct_id": "NCT07033234",
        "raw_text": "Guttate psoriasis, pustular psoriasis, erythrodermic psoriasis, drug-induced psoriasis, or other diseases that affect the treatment results;",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2299",
        "nct_id": "NCT06477237",
        "raw_text": "Drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2298",
        "nct_id": "NCT06477237",
        "raw_text": "Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic and/or guttate psoriasis) at screening or baseline",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2263",
        "nct_id": "NCT06648772",
        "raw_text": "Non-plaque psoriasis (e.g., guttate psoriasis, pustular psoriasis, erythrodermic psoriasis, and arthropathic psoriasis) or drug-induced psoriasis.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2195",
        "nct_id": "NCT06628206",
        "raw_text": "Currently have non-plaque forms of psoriasis e.g. erythrodermic, guttate or pustular with the exception of nail psoriasis which is allowed.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "nail psoriasis",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2125",
        "nct_id": "NCT06842199",
        "raw_text": "Exclusion Criteria: 1. The diagnosis was non-plaque psoriasis.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2109",
        "nct_id": "NCT06672393",
        "raw_text": "Diagnosis of non-plaque psoriasis or drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2087",
        "nct_id": "NCT06926582",
        "raw_text": "Diagnosis of non-plaque psoriasis or drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2054",
        "nct_id": "NCT06143371",
        "raw_text": "Psoriasis other than a plaque variant.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2002",
        "nct_id": "NCT06833307",
        "raw_text": "Drug-induced psoriasis.",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_2001",
        "nct_id": "NCT06833307",
        "raw_text": "Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic and guttate psoriasis) at Screening or Baseline/randomization.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1993",
        "nct_id": "NCT07130604",
        "raw_text": "Erythrodermic psoriasis, pustular psoriasis, guttate psoriasis, reverse psoriasis, drug-induced psoriasis.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1955",
        "nct_id": "NCT06077331",
        "raw_text": "Diagnosis of non-plaque psoriasis or drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1917",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have non-plaque psoriasis (ie, guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis) or any skin condition other than plaque psoriasis that could interfere with assessments of treatment effect at Screening or Day 1.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1871",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 3. Has current drug-induced psoriasis (e.g., a new onset of psoriasis or an exacerbation of psoriasis from beta-blockers, calcium channel blockers, or lithium)",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1870",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 2. Has a non-plaque form of psoriasis (e.g., erythrodermic, guttate, or pustular) at Screening or at time of randomization",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1845",
        "nct_id": "NCT06620692",
        "raw_text": "Patients with the following subtype of psoriasis: New onset guttate psoriasis.",
        "PSORIASIS_VARIANT": [
          "guttate"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1844",
        "nct_id": "NCT06620692",
        "raw_text": "Patients with the following subtype of psoriasis: edication-induced or medication-exacerbated psoriasis.",
        "PSORIASIS_VARIANT": [
          "unspecified"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1843",
        "nct_id": "NCT06620692",
        "raw_text": "Patients with the following subtype of psoriasis: Generalized or localized pustular psoriasis.",
        "PSORIASIS_VARIANT": [
          "pustular"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1842",
        "nct_id": "NCT06620692",
        "raw_text": "Patients with the following subtype of psoriasis: Erythrodermic psoriasis",
        "PSORIASIS_VARIANT": [
          "erythrodermic"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1788",
        "nct_id": "NCT07129382",
        "raw_text": "Forms of psoriasis other than plaque-type (e.g., erythrodermic, pustular, guttate, or drug-induced psoriasis).",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1767",
        "nct_id": "NCT06058546",
        "raw_text": "Psoriasis caused by drug-induced factors; combined with non-plaque Psoriasis at screening (such as guttate,arthropathica, pustular, erythrodermic and other types of Psoriasis); The skin lesions are exclusively observed in subjects with specific areas such as the face, scalp, nails, skin folds, glans penis, mucous membranes, palms, and soles.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1766",
        "nct_id": "NCT06058546",
        "raw_text": "Psoriasis caused by drug-induced factors; combined with non-plaque Psoriasis at screening (such as guttate,arthropathica, pustular, erythrodermic and other types of Psoriasis); The skin lesions are exclusively observed in subjects with specific areas such as the face, scalp, nails, skin folds, glans penis, mucous membranes, palms, and soles.",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1698",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has a presence of guttate, inverse, pustular, or erythrodermic PSO or other dermatological condition that may impact the clinical assessment of PSO",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "inverse"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1688",
        "nct_id": "NCT07029516",
        "raw_text": "Patients with unrelated nail disorders: onychomycosis, nail psoriasis, genetically induced onychodystrophy.",
        "PSORIASIS_VARIANT": [
          "nail psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1653",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has a form of PSO other than plaque type (eg, pustular, erythrodermic and guttate PSO, or drug induced PSO)",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1633",
        "nct_id": "NCT06945107",
        "raw_text": "Previous diagnosis of drug-induced psoriasis (e.g., psoriasis induced by beta blockers, calcium channel inhibitors, etc.);",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1632",
        "nct_id": "NCT06945107",
        "raw_text": "Diagnosed with guttate psoriasis, pustular psoriasis, or erythrodermic psoriasis during screening or at baseline;",
        "PSORIASIS_VARIANT": [
          "erythrodermic"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1631",
        "nct_id": "NCT06945107",
        "raw_text": "Diagnosed with guttate psoriasis, pustular psoriasis, or erythrodermic psoriasis during screening or at baseline;",
        "PSORIASIS_VARIANT": [
          "pustular"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1630",
        "nct_id": "NCT06945107",
        "raw_text": "Diagnosed with guttate psoriasis, pustular psoriasis, or erythrodermic psoriasis during screening or at baseline;",
        "PSORIASIS_VARIANT": [
          "guttate"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1615",
        "nct_id": "NCT06640257",
        "raw_text": "Existence of any of the following medical history or comorbid diseases: drug-induced psoriasis; other active inflammatory diseases or autoimmune diseases; history of organ transplantation; history of lymphocytic proliferation; severe infections, etc.",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1606",
        "nct_id": "NCT04123795",
        "raw_text": "Study participant has guttate PSO without plaque PSO",
        "PSORIASIS_VARIANT": [
          "guttate",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1605",
        "nct_id": "NCT04123795",
        "raw_text": "Study participant has generalized pustular or erythrodermic psoriasis (PSO)",
        "PSORIASIS_VARIANT": [
          "erythrodermic",
          "pustular"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1602",
        "nct_id": "NCT04123795",
        "raw_text": "Study participants aged ≥12 years may alternatively have a diagnosis of moderate to severe mixed guttate/plaque PSO with >50 % to <80 % guttate lesions for ≥3 months, and must meet the same criteria listed above",
        "PSORIASIS_VARIANT": [
          "guttate",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "NPV_1529",
        "nct_id": "NCT06943950",
        "raw_text": "Forms of psoriasis other than plaque psoriasis (Guttate psoriasis、erythrodermic psoriasis、Pustular psoriasis、Drug-induced psoriasis).",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1510",
        "nct_id": "NCT06592274",
        "raw_text": "Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic and/or guttate psoriasis) at screening or baseline Drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1499",
        "nct_id": "NCT06299982",
        "raw_text": "Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic and/or guttate psoriasis).",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1471",
        "nct_id": "NCT06542614",
        "raw_text": "Have other forms of psoriasis other than plaque psoriasis (e.g., guttate psoriasis, generalized pustular psoriasis, erythrodermic psoriasis, arthropathic psoriasis);",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1396",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has evidence of nonplaque psoriasis (erythrodermic, pustular, predominantly guttate psoriasis, predominantly inverse, or drug-induced psoriasis). If a participant meets criteria for inclusion based on typical plaque psoriasis presentation, a limited amount of inverse psoriasis is not exclusionary.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "inverse",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1386",
        "nct_id": "NCT07090330",
        "raw_text": "Nonplaque forms of psoriasis (including guttate, erythrodermic, or pustular) or drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1355",
        "nct_id": "NCT06176508",
        "raw_text": "Non-plaque psoriasis (ie, guttate, inverse, pustular, erythrodermic or drug-induced psoriasis), with the exception of nail psoriasis, which is allowed.",
        "PSORIASIS_VARIANT": [
          "nail psoriasis",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1336",
        "nct_id": "NCT07150988",
        "raw_text": "Forms of psoriasis other than chronic plaque-type;",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1298",
        "nct_id": "NCT06918743",
        "raw_text": "Present with any of the following medical history or concomitant diseases: Diagnosis of other types of psoriasis other than plaque psoriasis during subject screening, Such as guttate psoriasis, pustular psoriasis, erythrodermic psoriasis, articular psoriasis, or drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1279",
        "nct_id": "NCT06844799",
        "raw_text": "Confirmation of other types of psoriasis, including but not limited to guttiform psoriasis, pustular psoriasis, erythrodermic psoriasis, drug-induced exacerbation of psoriasis from the screening period to the time before randomization;",
        "PSORIASIS_VARIANT": [
          "unspecified"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1257",
        "nct_id": "NCT06380907",
        "raw_text": "Other types of psoriasis dominant other than plaque psoriasis (e.g., psoriatic arthritis, pustular, erythrodermic, guttate, palmar, plantar, scalp or nail disease) or the lesion is not eligible for topical treatment only.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1248",
        "nct_id": "NCT06630559",
        "raw_text": "Patient diagnosed with forms of psoriasis other than chronic plaque-type or medication-induced psoriasis.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1195",
        "nct_id": "NCT05642182",
        "raw_text": "The forms of psoriasis other than chronic plaque psoriasis (such as drug-induced psoriasis or guttate, erythrodermic, or pustular psoriasis) or if the psoriasis does not meet the criterion of chronicity (defined as a clinically significant flare of psoriasis within 12 weeks before baseline).",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1185",
        "nct_id": "NCT06863493",
        "raw_text": "History of current drug-induced PsO or a drug-induced exacerbation of pre-existing psoriasis.",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1175",
        "nct_id": "NCT04772079",
        "raw_text": "Other forms of psoriasis.",
        "PSORIASIS_VARIANT": [
          "unspecified"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1143",
        "nct_id": "NCT06005532",
        "raw_text": "4. Drug-induced psoriasis.",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1142",
        "nct_id": "NCT06005532",
        "raw_text": "3. Other (other than plaque) forms of psoriasis.",
        "PSORIASIS_VARIANT": [
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1128",
        "nct_id": "NCT06846710",
        "raw_text": "Guttate psoriasis, pustular psoriasis, erythrodermic psoriasis, drug-induced psoriasis, or other diseases that affect the treatment results;",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1094",
        "nct_id": "NCT07158268",
        "raw_text": "Current drug-induced psoriasis",
        "PSORIASIS_VARIANT": [
          "drug-induced"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1093",
        "nct_id": "NCT07158268",
        "raw_text": "Non-plaque psoriasis (e.g., erythrodermic, guttate, or pustular psoriasis)",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1085",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has developed evidence of non-plaque psoriasis (erythrodermic, pustular, predominantly guttate psoriasis, predominantly inverse, or drug-induced psoriasis) since enrollment in the parent study or Part A.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "inverse",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "NPV_1061",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has evidence of non-plaque psoriasis (erythrodermic, pustular, predominantly guttate psoriasis, predominantly inverse, or drug-induced psoriasis). If a participant meets criteria for inclusion based on typical plaque psoriasis presentation, a limited amount of inverse psoriasis is not exclusionary.",
        "PSORIASIS_VARIANT": [
          "guttate",
          "erythrodermic",
          "pustular",
          "inverse",
          "drug-induced",
          "plaque psoriasis"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      }
    ]
  },
  "CLUSTER_CPD": {
    "cluster_name": "Chronic Plaque Psoriasis Duration Criteria",
    "cluster_code": "CPD",
    "total_criteria": 49,
    "primary_question": "How long have you had psoriasis or psoriatic arthritis?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "CPD_2448",
        "nct_id": "NCT06170840",
        "raw_text": "The patient meets the diagnosis of plaque psoriasis, has a history of plaque psoriasis for ≥ 6 months before randomization, and meets the following conditions.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2419",
        "nct_id": "NCT06643260",
        "raw_text": "Duration of psoriasis of at least 12 months;",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 12,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2367",
        "nct_id": "NCT03997786",
        "raw_text": "Diagnosis of predominantly plaque psoriasis for ≥6 months (as determined by subject interview and confirmation of diagnosis through physical examination by investigator).",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2321",
        "nct_id": "NCT07219420",
        "raw_text": "Have a palmoplantar pustulosis (PPP) diagnosis for at least 24 weeks prior to the Screening Visit",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 24,
          "unit": "weeks",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2312",
        "nct_id": "NCT07033234",
        "raw_text": "Chronic plaque psoriasis for at least 6 months with or without psoriatic arthritis;",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2294",
        "nct_id": "NCT06477237",
        "raw_text": "Chronic plaque psoriasis (PSO) for at least 6 months prior to the Randomization.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2256",
        "nct_id": "NCT06648772",
        "raw_text": "Clinical diagnosis of plaque psoriasis before the first dose in this study, with a disease duration of ≥ 6 months (for those aged ≥ 12 years) or ≥ 3 months (for those aged 6-11 years) and stable for the last 4 weeks.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2220",
        "nct_id": "NCT07013201",
        "raw_text": "Mild to severe PPP current condition defined by: Disease duration of PPP of >6 months before randomisation.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2182",
        "nct_id": "NCT06628206",
        "raw_text": "PsA diagnosis of at least 3 months duration prior to the date of first screening with Classification of Psoriatic Arthritis (CASPAR) confirmed diagnosis at Screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2179",
        "nct_id": "NCT06628206",
        "raw_text": "Diagnosis of RA and meeting the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for RA at least 3 months prior to screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2120",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 3. History of plaque psoriasis ≥6 months at baseline.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2104",
        "nct_id": "NCT06672393",
        "raw_text": "Diagnosis of plaque psoriasis for at least 6 months",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_2082",
        "nct_id": "NCT06926582",
        "raw_text": "Diagnosis of plaque psoriasis for at least 6 months",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1999",
        "nct_id": "NCT06833307",
        "raw_text": "Chronic plaque-type psoriasis present for at least 6 months and diagnosed before randomization.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1965",
        "nct_id": "NCT06641089",
        "raw_text": "Participants have a confirmed diagnosis of psoriatic arthritis (PsA) per the 2006 Classification for Psoriatic Arthritis (CASPAR) criteria with symptoms for ≥6 months before the Screening Visit.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1950",
        "nct_id": "NCT06077331",
        "raw_text": "Diagnosis of plaque psoriasis for at least 6 months",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1941",
        "nct_id": "NCT06865105",
        "raw_text": "Participant has a documented clinical diagnosis of PsA with symptom onset at least 6 months prior to the Screening Visit and fulfillment of the Classification Criteria for Psoriatic Arthritis (CASPAR) at Screening Visit.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1908",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must have stable plaque psoriasis for 6 months or more prior to Screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1902",
        "nct_id": "NCT07102888",
        "raw_text": "History of plaque psoriasis ≥ 3 months.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1856",
        "nct_id": "NCT06723171",
        "raw_text": "Inclusion Criteria: 2. Have a diagnosis of plaque psoriasis (with or without psoriatic arthritis) for at least 6 months before the first administration of study treatment",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1830",
        "nct_id": "NCT06620692",
        "raw_text": "Patients who have well diagnosed chronic plaque psoriasis for at least 6 months before the Screening Visit (according to Am Fam Physician. 2013 May 1;87(9):626-633).",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1822",
        "nct_id": "NCT06100744",
        "raw_text": "Diagnosis of juvenile psoriatic arthritis (jPsA) according to International League of Associations for Rheumatology criteria for at least 6 months prior to screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1784",
        "nct_id": "NCT07129382",
        "raw_text": "Stable plaque psoriasis at screening, defined as no significant flare-ups or morphological changes during the 6 months prior to screening (investigator-assessed).",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1783",
        "nct_id": "NCT07129382",
        "raw_text": "Clinically diagnosed with chronic plaque psoriasis, defined as disease duration ≥ 6 months at screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1709",
        "nct_id": "NCT06807424",
        "raw_text": "Have a diagnosis of psoriatic arthritis (PsA) for at least 3 months before the first administration of study intervention and meet classification criteria for Psoriatic Arthritis (CASPAR) at screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1691",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has had a diagnosis of moderate to severe plaque psoriasis (PSO) for at least 3 months prior to the Screening Visit",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1643",
        "nct_id": "NCT06506916",
        "raw_text": "Cohort B only: In addition to the criteria specified above, study participant has a documented diagnosis of adult-onset psoriatic arthritis (PsA) and meets the CASPAR classification criteria for at least 6 months prior to Screening for active PsA and must have ≥1 tender joint count (TJC) out of 68 and ≥1 swollen joint count (SJC) out of 66 at Screening or up to 3 months before Screening (documented evidence)",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1642",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant must have: Cohort A and Cohort B: Plaque psoriasis (PSO) diagnosed for at least 6 months prior to the Screening Visit",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1625",
        "nct_id": "NCT06945107",
        "raw_text": "Diagnosed with plaque psoriasis for ≥6 months, with or without psoriatic arthritis.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1593",
        "nct_id": "NCT04123795",
        "raw_text": "Study participant must have a diagnosis of moderate to severe plaque psoriasis (PSO) for ≥3 months and:",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1553",
        "nct_id": "NCT06878404",
        "raw_text": "Have a diagnosis of psoriatic arthritis (PsA) for at least 3 months before the first administration of study intervention and meet classification criteria for psoriatic arthritis (CASPAR) at screening",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 3,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1521",
        "nct_id": "NCT06943950",
        "raw_text": "Subjects with a clinical diagnosis of stable moderate-to-severe plaque psoriasis with a history ≥6 months before randomization.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1504",
        "nct_id": "NCT06592274",
        "raw_text": "Chronic plaque psoriasis (PSO) for at least 6 months prior to the randomization.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1463",
        "nct_id": "NCT06542614",
        "raw_text": "Clinically diagnosed with stable moderate to severe plaque psoriasis with a history ≥ 6 months (from randomization), and no morphological changes in skin lesions or significant disease outbreaks as assessed by the investigator;",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1392",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has stable plaque psoriasis, defined as no significant flare or change in morphology (as assessed by the investigator) in psoriasis, for 6 months before screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1391",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a diagnosis of chronic plaque psoriasis for 6 months prior to the screening visit.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1382",
        "nct_id": "NCT07090330",
        "raw_text": "Have a diagnosis of plaque psoriasis for > 6 months",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1349",
        "nct_id": "NCT06176508",
        "raw_text": "Has a history of psoriatic arthritis (PsA) for at least 6 months, and meets the Classification Criteria for Psoriatic Arthritis (CASPAR) at screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1292",
        "nct_id": "NCT06918743",
        "raw_text": "A history of plaque psoriasis ≥6 months prior to randomization",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1274",
        "nct_id": "NCT06844799",
        "raw_text": "Diagnosed plaque psoriasis for at least 6 months before randomization, with or without psoriatic arthritis;",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1253",
        "nct_id": "NCT06380907",
        "raw_text": "Clinical diagnosis of psoriasis vulgaris of at least 6 months duration as determined by Investigator via medical records or in medical history obtained from the patient, is currently eligible for topical treatment and meets all the following criteria at screening and baseline.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1247",
        "nct_id": "NCT06630559",
        "raw_text": "Patient has had a diagnosis of chronic plaque psoriasis for at least 24 weeks.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 24,
          "unit": "weeks",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1228",
        "nct_id": "NCT06641076",
        "raw_text": "Participants have a confirmed diagnosis of psoriatic arthritis (PsA) per the 2006 Classification for Psoriatic Arthritis (CASPAR) criteria with symptoms for ≥6 months before the Screening Visit.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1169",
        "nct_id": "NCT04772079",
        "raw_text": "Plaque psoriasis for at least 6 months.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1134",
        "nct_id": "NCT06005532",
        "raw_text": "3. Established clinical diagnosis plaque psoriasis, lasting at least 6 months before the screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1124",
        "nct_id": "NCT06846710",
        "raw_text": "Chronic plaque psoriasis for at least 6 months with or without psoriatic arthritis;",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1088",
        "nct_id": "NCT07158268",
        "raw_text": "Confirmed diagnosis of plaque psoriasis with a disease duration of at least 26 weeks before the first administration of the study intervention",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 26,
          "unit": "weeks",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1056",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has stable plaque psoriasis defined as no significant flare or change in morphology (as assessed by the investigator) in psoriasis for >=6 months before screening.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      },
      {
        "id": "CPD_1055",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has a diagnosis of chronic plaque psoriasis for >=6 months prior to the screening visit.",
        "CONDITION_TYPE": [
          "chronic plaque psoriasis",
          "psoriatic arthritis"
        ],
        "EXCLUSION_STRENGTH": "inclusion",
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 6,
          "unit": "months",
          "reference": "diagnosis"
        }
      }
    ]
  },
  "CLUSTER_SEV": {
    "cluster_name": "Severity Scores",
    "cluster_code": "SEV",
    "total_criteria": 48,
    "primary_question": "Do you have illness severity scores in your medical records?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "SEV_2450",
        "nct_id": "NCT06170840",
        "raw_text": "Physician overall assessment (PGA) ≥ 2 at baseline.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2441",
        "nct_id": "NCT06643260",
        "raw_text": "PHQ-9 score ˃ 4 at baseline;",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "SEV_2417",
        "nct_id": "NCT06643260",
        "raw_text": "Static PGA ≥3 at the Screening and Baseline visits;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2416",
        "nct_id": "NCT06643260",
        "raw_text": "PASI score ≥12 at the Screening and Baseline visits;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2323",
        "nct_id": "NCT07219420",
        "raw_text": "Have PPP-IGA ≥3 at the Screening Visit and Baseline Visit",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2322",
        "nct_id": "NCT07219420",
        "raw_text": "Have PPPASI ≥12 at the Screening Visit and Baseline Visit",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2258",
        "nct_id": "NCT06648772",
        "raw_text": "IGA score of ≥ 2 points;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2222",
        "nct_id": "NCT07013201",
        "raw_text": "Mild to severe PPP current condition defined by: PPPASI ≥8 at screening and baseline.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2124",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 5. The following three criteria were met: a) psoriasis Area and Severity index (PASI) score ≥12; b) Psoriasis affected body surface area (BSA) ≥10%; c) Static physician overall assessment (sPGA) ≥3 scores",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2122",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 5. The following three criteria were met: a) psoriasis Area and Severity index (PASI) score ≥12; b) Psoriasis affected body surface area (BSA) ≥10%; c) Static physician overall assessment (sPGA) ≥3 scores",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2108",
        "nct_id": "NCT06672393",
        "raw_text": "PASI ≥ 12, sPGA ≥3",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2107",
        "nct_id": "NCT06672393",
        "raw_text": "PASI ≥ 12, sPGA ≥3",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2085",
        "nct_id": "NCT06926582",
        "raw_text": "sPGA score of 2-3, BSA 2-15%, PASI score 2-15",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2083",
        "nct_id": "NCT06926582",
        "raw_text": "sPGA score of 2-3, BSA 2-15%, PASI score 2-15",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_2044",
        "nct_id": "NCT06143371",
        "raw_text": "A diagnosis of plaque psoriasis with Psoriasis Area Severity Index (PASI) score ≥3 to ≤15 and Physician Global Assessment (PGA) score ≥2 (mild) to <4 (moderate).",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1987",
        "nct_id": "NCT05669833",
        "raw_text": "Already meets the primary endpoint at Baseline; [cDAPSA low disease activity ≤ 14; IGA of psoriasis 0/1] In patients with psoriasis, cDAPSA can be 10-14 IF the Investigator Global Assessment of Psoriasis ≥ 2.",
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "SEV_1980",
        "nct_id": "NCT05669833",
        "raw_text": "cDAPSA score ≥ 10; See also Exclusion #4 - cDAPSA must be > 14 in patients without psoriasis.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1954",
        "nct_id": "NCT06077331",
        "raw_text": "PASI ≥ 12, sPGA ≥3",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1953",
        "nct_id": "NCT06077331",
        "raw_text": "PASI ≥ 12, sPGA ≥3",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1910",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must have moderate to severe psoriasis defined by: ii) Static Physician's Global Assessment (sPGA) ≥ 3, at screening visit and Day 1.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1909",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must have moderate to severe psoriasis defined by: i) Psoriasis Area and Severity Index (PASI) ≥ 12, at screening visit and Day 1.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1764",
        "nct_id": "NCT06058546",
        "raw_text": "At screening period: 3 ≤PASI≤ 20, 3%≤BSA≤ 10% and sPGA≥2.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1762",
        "nct_id": "NCT06058546",
        "raw_text": "At screening period: 3 ≤PASI≤ 20, 3%≤BSA≤ 10% and sPGA≥2.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1693",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant meets the following at both the Screening and Baseline Visits: Investigator's Global Assessment (IGA) score ≥3 (on a scale from 0 to 4)",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1627",
        "nct_id": "NCT06945107",
        "raw_text": "At both screening and baseline, meet the criteria of sPGA (Static Physician's Global Assessment) ≥2 and body surface area (BSA) involvement ≥3%, along with the investigator's assessment of inadequate response to the original IL-17 monoclonal antibody therapy, warranting a switch to biologic treatment.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1597",
        "nct_id": "NCT04123795",
        "raw_text": "PASI score is ≥10 and <12 with at least one of the following: >Clinically relevant facial or scalp involvement",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1596",
        "nct_id": "NCT04123795",
        "raw_text": "Psoriasis Area and Severity Index (PASI) score is ≥12 or",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1595",
        "nct_id": "NCT04123795",
        "raw_text": "Physician's Global Assessment (PGA) score ≥3 (on a scale from 0 to 4)",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1537",
        "nct_id": "NCT06231381",
        "raw_text": "Patients must be experiencing an acute GPP flare of moderate-to-severe intensity at baseline, defined as: New appearance or worsening of existing pustules, and a GPPGA pustulation subscore of ≥ 2;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1536",
        "nct_id": "NCT06231381",
        "raw_text": "Patients must be experiencing an acute GPP flare of moderate-to-severe intensity at baseline, defined as: A Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score of ≥ 3;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1525",
        "nct_id": "NCT06943950",
        "raw_text": "PASI score of ≥10 and Static Physician's Global Assessment (sPGA) score ≥3 at screening and baseline.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1507",
        "nct_id": "NCT06592274",
        "raw_text": "Psoriasis Area Severity Index (PASI) >=12 and body surface area (BSA) affected by PSO >=10% and Static Physician Global Assessment (sPGA) score >=3.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1505",
        "nct_id": "NCT06592274",
        "raw_text": "Psoriasis Area Severity Index (PASI) >=12 and body surface area (BSA) affected by PSO >=10% and Static Physician Global Assessment (sPGA) score >=3.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1467",
        "nct_id": "NCT06542614",
        "raw_text": "At screening and baseline, the PASI score was ≥ 12 points, the BSA ≥ 10%, and the sPGA ≥ 3 points ;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1465",
        "nct_id": "NCT06542614",
        "raw_text": "At screening and baseline, the PASI score was ≥ 12 points, the BSA ≥ 10%, and the sPGA ≥ 3 points ;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1393",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has moderate-to-severe plaque psoriasis, as defined by a PASI score 12 and an sPGA score 3, at screening and Day 1.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1383",
        "nct_id": "NCT07090330",
        "raw_text": "Have moderate-to-severe chronic plaque psoriasis defined as: BSA ≥ 10%, and PASI ≥ 12, and IGA score of ≥ 3 on a 5-point scale",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1295",
        "nct_id": "NCT06918743",
        "raw_text": "At screening and baseline, the BSA of the affected area was 2%-20% (including both ends), PASI score ≥2, PGA score ≥2.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1294",
        "nct_id": "NCT06918743",
        "raw_text": "At screening and baseline, the BSA of the affected area was 2%-20% (including both ends), PASI score ≥2, PGA score ≥2.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1254",
        "nct_id": "NCT06380907",
        "raw_text": "Clinical diagnosis of psoriasis vulgaris of at least 6 months duration as determined by Investigator via medical records or in medical history obtained from the patient, is currently eligible for topical treatment and meets all the following criteria at screening and baseline: IGA ≥ 2 (5 score system).",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1190",
        "nct_id": "NCT05642182",
        "raw_text": "Subjects of both sexes ≥18 years of age with at least one skin plaque that is >5 cm2 due to known psoriasis considered clinically to be MILD to MODERATE or MODERATE to SEVERE during evaluation and diagnosis at least 1 year prior.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1183",
        "nct_id": "NCT06863493",
        "raw_text": "Body Surface Area (BSA) >= 10% and <= 15%; and Psoriasis Area and Severity Index (PASI) >= 12; and Static Physician Global Assessment (sPGA) = 3 (moderate) based on a 5-point scale (0 to 4) -",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1182",
        "nct_id": "NCT06863493",
        "raw_text": "Body Surface Area (BSA) >= 10% and <= 15%; and Psoriasis Area and Severity Index (PASI) >= 12; and Static Physician Global Assessment (sPGA) = 3 (moderate) based on a 5-point scale (0 to 4) -",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1138",
        "nct_id": "NCT06005532",
        "raw_text": "4. sPGA ≥ 3 points.",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1136",
        "nct_id": "NCT06005532",
        "raw_text": "4. PASI ≥ 12 points;",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1091",
        "nct_id": "NCT07158268",
        "raw_text": "Investigator Global Assessment (IGA) for plaque psoriasis total score ≥ 3 (moderate or severe disease) at both screening and baseline visits",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1090",
        "nct_id": "NCT07158268",
        "raw_text": "Psoriasis Area and Severity Index (PASI) total score ≥ 12 at both screening and baseline visits",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "SEV_1057",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has moderate-to-severe plaque psoriasis as defined by a PASI score >=12 and a sPGA score >=3 at screening and Day 1.",
        "EXCLUSION_STRENGTH": "inclusion"
      }
    ]
  },
  "CLUSTER_AAO": {
    "cluster_name": "Affected Area and Organs",
    "cluster_code": "AAO",
    "total_criteria": 66,
    "primary_question": "How much of your body is affected?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "AAO_2449",
        "nct_id": "NCT06170840",
        "raw_text": "At baseline, plaque psoriasis covered 2% to 20% of BSA (including both ends) (scalp, palms, and soles were not counted as BSA).",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2415",
        "nct_id": "NCT06643260",
        "raw_text": "Diagnosis of moderate-to-severe chronic plaque-type psoriasis with BSA involvement ≥10%;",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2368",
        "nct_id": "NCT03997786",
        "raw_text": "Moderate to severe psoriasis at baseline defined as: at least 10% Body Surface Area (BSA) involvement, PGA score ≥ 3, and PASI score ≥ 12",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2324",
        "nct_id": "NCT07219420",
        "raw_text": "Have pustules on the palms of the hands and/or soles of the feet at the Screening Visit and Baseline Visit, defined as pustule severity ≥2 and having more than 5 active pustules",
        "ANATOMICAL_LOCATION": [
          "hands",
          "feet",
          "palms",
          "soles"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2295",
        "nct_id": "NCT06477237",
        "raw_text": "Psoriasis Area Severity Index (PASI) >=12 and body surface area (BSA) affected by PSO >=10% and Static Physician Global Assessment (sPGA) score >=3.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2259",
        "nct_id": "NCT06648772",
        "raw_text": "PASI score of ≥ 2 points (excluding the scalp, palms, and soles).",
        "ANATOMICAL_LOCATION": [
          "scalp",
          "palms",
          "soles"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2257",
        "nct_id": "NCT06648772",
        "raw_text": "Patients are required to meet the following requirements at screening and baseline: Psoriasis involving 2%-20% BSA (excluding the scalp, palms, and soles);",
        "ANATOMICAL_LOCATION": [
          "scalp",
          "face",
          "palms",
          "soles"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2247",
        "nct_id": "NCT07013201",
        "raw_text": "Cutaneously applied treatments in regions other than the palms or soles, which could interfere with clinical trial evaluations or pose a safety concern (excluding treatments for psoriasis patches or other non-exclusionary skin conditions, if needed) within 1 week prior to baseline.",
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_2230",
        "nct_id": "NCT07013201",
        "raw_text": "Concurrent plaque psoriasis covering >5% of body surface area.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_2223",
        "nct_id": "NCT07013201",
        "raw_text": "Presence of ≥5 well-demarcated fresh pustules (white or yellow pustules) in total across all affected areas at screening and baseline.",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2218",
        "nct_id": "NCT07013201",
        "raw_text": "Diagnosis of PPP in accordance with the consensus diagnostic criteria established by European Rare and Severe Psoriasis Expert Network: primary, persistent, sterile, macroscopically visible pustules on the palms and/or soles, with or without plaque psoriasis elsewhere on the body.",
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2194",
        "nct_id": "NCT06628206",
        "raw_text": "Significant systemic involvement secondary to RA/PsA (active vasculitis, pulmonary fibrosis, or Felty's syndrome).",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_2184",
        "nct_id": "NCT06628206",
        "raw_text": "Active disease defined by ≥ 3 tender out of 68 joints and ≥ 3 swollen out of 66 swollen joint count at both screening and Day 1.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2180",
        "nct_id": "NCT06628206",
        "raw_text": "Active disease defined by ≥ 6 tender out of 68 joints and ≥ 6 swollen out of 66 swollen joint count at both screening and Day 1.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2123",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 5. The following three criteria were met: a) psoriasis Area and Severity index (PASI) score ≥12; b) Psoriasis affected body surface area (BSA) ≥10%; c) Static physician overall assessment (sPGA) ≥3 scores",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2106",
        "nct_id": "NCT06672393",
        "raw_text": "Plaque covering ≥ 10% of BSA",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2098",
        "nct_id": "NCT05442190",
        "raw_text": "Have lesions involving 2-30% of the body (trunk and/or limbs). For subjects with scalp psoriasis included in the treatment area, the total treatment area on body and scalp must not exceed 30%.",
        "ANATOMICAL_LOCATION": [
          "scalp",
          "trunk"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2097",
        "nct_id": "NCT05442190",
        "raw_text": "Have a static Investigator Global Assessment (IGA)/Psoriasis Area and Severity Index (PASI) of disease severity of mild or moderate on the body (trunk and/or limbs).",
        "ANATOMICAL_LOCATION": [
          "trunk"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2096",
        "nct_id": "NCT05442190",
        "raw_text": "Have a clinical diagnosis of plaque psoriasis (psoriasis vulgaris) of at least 6-months duration that involves the body (trunk and/or limbs) that is amenable to topical treatment and opaque coverage after application.",
        "ANATOMICAL_LOCATION": [
          "trunk"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2084",
        "nct_id": "NCT06926582",
        "raw_text": "sPGA score of 2-3, BSA 2-15%, PASI score 2-15",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2017",
        "nct_id": "NCT06671496",
        "raw_text": "The participant has active arthritis as shown by a minimum of >=3 tender joints in TJC68 and >=3 swollen joints in SJC66 at the screening and baseline (Day 1) visits.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_2000",
        "nct_id": "NCT06833307",
        "raw_text": "Moderate to severe psoriasis as defined at Baseline/ randomization by: PASI score of 12 or greater, and sPGA score of 3 or greater (based on a static scale of 0 - 5), and Body Surface Area (BSA) affected by plaque psoriasis of 10% or greater.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1991",
        "nct_id": "NCT07130604",
        "raw_text": "During the screening period and before taking the investigational drug for the first time, psoriatic surface area (BSA) ≥10%, PGA score ≥ 3, PASI score ≥ 12.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1979",
        "nct_id": "NCT05669833",
        "raw_text": "Active psoriatic arthritis defined by at least 1 swollen joint;",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1966",
        "nct_id": "NCT06641089",
        "raw_text": "Participants have moderate to severe active disease (defined by a 68 tender joint count [TJC68] of ≥3 and a 66 swollen joint count [SJC66] of ≥3).",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1952",
        "nct_id": "NCT06077331",
        "raw_text": "Plaque covering ≥ 10% of BSA",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1942",
        "nct_id": "NCT06865105",
        "raw_text": "Participant has active disease defined as greater than or equal to 3 tender joints (based on 68 joint count) and greater than or equal to 3 swollen joints (based on 66 joint count) at both the Screening Visit and Baseline.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1911",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must have moderate to severe psoriasis defined by: iii) Body Surface Area (BSA) ≥ 10% involvement, at screening visit and Day 1.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1869",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 1. Has more than 15% of total body surface area affected by psoriasis plaques",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_1858",
        "nct_id": "NCT06723171",
        "raw_text": "Inclusion Criteria: 3. Excludes participants with scalp only plaques",
        "ANATOMICAL_LOCATION": [
          "scalp"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1857",
        "nct_id": "NCT06723171",
        "raw_text": "Inclusion Criteria: 3. Meet the following disease severity criteria for moderate to severe plaque psoriasis at Screening and Baseline visits: IGA Score of 3 or 4 AND Total affected body surface area of >3 to 10% for moderate and 10% to 15% for severe psoriasis",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1823",
        "nct_id": "NCT06100744",
        "raw_text": "Active Disease in >= 3 joints at screening and at Baseline (swelling not due to deformity, or limitation of motion with pain, tenderness, or both) are eligible for inclusion in the study.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1785",
        "nct_id": "NCT07129382",
        "raw_text": "Moderate-to-severe disease at screening/randomization: PASI≥12, sPGA≥3, and BSA≥10%;",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1768",
        "nct_id": "NCT06058546",
        "raw_text": "Psoriasis caused by drug-induced factors; combined with non-plaque Psoriasis at screening (such as guttate,arthropathica, pustular, erythrodermic and other types of Psoriasis); The skin lesions are exclusively observed in subjects with specific areas such as the face, scalp, nails, skin folds, glans penis, mucous membranes, palms, and soles.",
        "ANATOMICAL_LOCATION": [
          "scalp",
          "face",
          "nails",
          "palms",
          "soles",
          "skin"
        ],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_1763",
        "nct_id": "NCT06058546",
        "raw_text": "At screening period: 3 ≤PASI≤ 20, 3%≤BSA≤ 10% and sPGA≥2.",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1710",
        "nct_id": "NCT06807424",
        "raw_text": "Have active PsA as defined by: (a) At least 3 swollen joints and at least 3 tender joints at screening and at baseline.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1694",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant meets the following at both the Screening and Baseline Visits: Psoriasis Area and Severity Index (PASI) score ≥12 OR PASI score ≥10 plus at least 1 of the following: clinically relevant facial involvement, clinically relevant genital involvement, clinically relevant hand and foot involvement",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1692",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant meets the following at both the Screening and Baseline Visits: Body surface area (BSA) affected by PSO ≥10%",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1683",
        "nct_id": "NCT07029516",
        "raw_text": "Patients that have proximal subungual onychomycosis, if their distal subungual onychomycosis is extended into the proximal portion of the nail or if it affects >75% of the nail.",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "mandatory_exclude"
      },
      {
        "id": "AAO_1644",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant must have Psoriasis Area and Severity Index (PASI) score ≥12 and body surface area (BSA) affected by PSO ≥10% and Investigator's Global Assessment (IGA) score ≥3 on a 5 point scale",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1628",
        "nct_id": "NCT06945107",
        "raw_text": "At both screening and baseline, meet the criteria of sPGA (Static Physician's Global Assessment) ≥2 and body surface area (BSA) involvement ≥3%, along with the investigator's assessment of inadequate response to the original IL-17 monoclonal antibody therapy, warranting a switch to biologic treatment.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1601",
        "nct_id": "NCT04123795",
        "raw_text": "PASI score is ≥10 and <12 with at least one of the following: >Clinically relevant axillary involvement",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1600",
        "nct_id": "NCT04123795",
        "raw_text": "PASI score is ≥10 and <12 with at least one of the following: >Clinically relevant palm and sole involvement",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1599",
        "nct_id": "NCT04123795",
        "raw_text": "PASI score is ≥10 and <12 with at least one of the following: >Clinically relevant genital involvement",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1598",
        "nct_id": "NCT04123795",
        "raw_text": "PASI score is ≥10 and <12 with at least one of the following: >Clinically relevant facial or scalp involvement",
        "ANATOMICAL_LOCATION": [
          "scalp"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1594",
        "nct_id": "NCT04123795",
        "raw_text": "Body Surface Area (BSA) affected by psoriasis ≥10 %",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1556",
        "nct_id": "NCT06878404",
        "raw_text": "Have at least 1 of the PsA subsets: distal interphalangeal joint involvement, polyarticular arthritis with absence of rheumatoid nodules, arthritis mutilans, asymmetric peripheral arthritis, or spondylitis with peripheral arthritis",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1554",
        "nct_id": "NCT06878404",
        "raw_text": "Have active PsA as defined by: (a) At least 3 swollen joints and at least 3 tender joints at screening and at baseline (b) C-reactive protein greater than or equal to 0.1 milligrams per deciliter at screening from the central laboratory",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1538",
        "nct_id": "NCT06231381",
        "raw_text": "Patients must be experiencing an acute GPP flare of moderate-to-severe intensity at baseline, defined as: ≥ 5% Body Surface Area (BSA) covered with pustules.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1524",
        "nct_id": "NCT06943950",
        "raw_text": "Body Surface Area (BSA) affected by plaque-type psoriasis ≥10% at screening and baseline.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1506",
        "nct_id": "NCT06592274",
        "raw_text": "Psoriasis Area Severity Index (PASI) >=12 and body surface area (BSA) affected by PSO >=10% and Static Physician Global Assessment (sPGA) score >=3.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1466",
        "nct_id": "NCT06542614",
        "raw_text": "At screening and baseline, the PASI score was ≥ 12 points, the BSA ≥ 10%, and the sPGA ≥ 3 points ;",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1394",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has plaque psoriasis covering 10 percent (%) of his or her total body surface area (BSA) at screening and Day 1.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1364",
        "nct_id": "NCT06671483",
        "raw_text": "The participant has active arthritis as shown by a minimum of >=3 tender joints in TJC68 and >=3 swollen joints in SJC66 at the screening and baseline (Day 1) visits.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1351",
        "nct_id": "NCT06176508",
        "raw_text": "Active arthritis as shown ≥ 3 swollen joints (66 joints) and ≥ 3 tender joints (68 joints) at both screening and baseline.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1293",
        "nct_id": "NCT06918743",
        "raw_text": "At screening and baseline, the BSA of the affected area was 2%-20% (including both ends), PASI score ≥2, PGA score ≥2.",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1255",
        "nct_id": "NCT06380907",
        "raw_text": "Clinical diagnosis of psoriasis vulgaris of at least 6 months duration as determined by Investigator via medical records or in medical history obtained from the patient, is currently eligible for topical treatment and meets all the following criteria at screening and baseline: Affected BSA 3%-15% (excluding head).",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1229",
        "nct_id": "NCT06641076",
        "raw_text": "Participants have moderate to severe active disease (defined by a 68 tender joint count [TJC68] of ≥3 and a 66 swollen joint count [SJC66] of ≥3).",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1181",
        "nct_id": "NCT06863493",
        "raw_text": "Body Surface Area (BSA) >= 10% and <= 15%; and Psoriasis Area and Severity Index (PASI) >= 12; and Static Physician Global Assessment (sPGA) = 3 (moderate) based on a 5-point scale (0 to 4) -",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1137",
        "nct_id": "NCT06005532",
        "raw_text": "4. BSA ≥ 10 %;",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1111",
        "nct_id": "NCT07148414",
        "raw_text": "For psoriatic arthritis: Day 1 TJC ≥3 out of 68 and SJC ≥3 out of 66 (dactylitis counts as 1 joint each).",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1110",
        "nct_id": "NCT07148414",
        "raw_text": "For psoriatic arthritis: Day 1 TJC ≥3 out of 68 and SJC ≥3 out of 66 (dactylitis counts as 1 joint each).",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1102",
        "nct_id": "NCT07148414",
        "raw_text": "Documentation of ≥1 of the following: Positive test results for rheumatoid factor or anti-citrullinated peptide antibodies at Screening, OR Previous radiographs with bony erosions in hands or feet consistent with RA.",
        "ANATOMICAL_LOCATION": [
          "hands",
          "feet"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1099",
        "nct_id": "NCT07148414",
        "raw_text": "For rheumatoid arthritis: Moderate-to-severely active RA as defined by the presence of ≥4 swollen joints (based on 28 joint count) and ≥4 tender joints (based on 28 joint count) at Screening and Day 1.",
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1089",
        "nct_id": "NCT07158268",
        "raw_text": "Total Body Surface Area (BSA) involvement ≥ 10% at both screening and baseline visits",
        "ANATOMICAL_LOCATION": [
          "face"
        ],
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "AAO_1058",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has plaque psoriasis covering >=10% of his or her total BSA at screening and Day 1.",
        "ANATOMICAL_LOCATION": [],
        "EXCLUSION_STRENGTH": "inclusion"
      }
    ]
  },
  "CLUSTER_AIC": {
    "cluster_name": "Active Infection History Criteria",
    "cluster_code": "AIC",
    "total_criteria": 84,
    "primary_question": "Were you diagnosed with any infectious diseases?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "AIC_2461",
        "nct_id": "NCT06170840",
        "raw_text": "Any history of infection or recurrent infection requiring systemic antibiotic treatment within 2 weeks prior to first dosing, or serious infection requiring hospitalization or intravenous antibiotic treatment within 8 weeks prior to first dosing.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "recurrent infection",
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "recurrent",
          "requiring systemic antibiotic treatment",
          "requiring hospitalization",
          "requiring intravenous antibiotic treatment"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 2,
            "unit": "weeks",
            "reference": "first dosing"
          },
          {
            "relation": "within",
            "amount": 8,
            "unit": "weeks",
            "reference": "first dosing"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic antibiotic treatment",
          "hospitalization",
          "intravenous antibiotic treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on recent infection requiring treatment or hospitalization"
        ]
      },
      {
        "id": "AIC_2376",
        "nct_id": "NCT03997786",
        "raw_text": "Subject with presence of any infection or history of recurrent infection requiring treatment with systemic antibiotics within 2 weeks prior to Screening, or severe infection (e.g. pneumonia, cellulitis, bone or joint infections) requiring hospitalization or treatment with IV antibiotics within 8 weeks prior to Screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "recurrent infection",
          "severe infection",
          "pneumonia",
          "cellulitis",
          "bone infections",
          "joint infections"
        ],
        "CONDITION_PATTERN": [
          "presence",
          "history of recurrent infection",
          "requiring treatment with systemic antibiotics",
          "requiring hospitalization",
          "requiring treatment with IV antibiotics"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "bone",
          "joint"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 2,
            "unit": "weeks",
            "reference": "Screening"
          },
          {
            "relation": "within",
            "amount": 8,
            "unit": "weeks",
            "reference": "Screening"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic antibiotics",
          "hospitalization",
          "IV antibiotics"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on recent or active infection requiring treatment or hospitalization"
        ]
      },
      {
        "id": "AIC_2319",
        "nct_id": "NCT07033234",
        "raw_text": "Known history of recurrent or chronic infections, or prior history of chronic or recurrent infections, including but not limited to: chronic renal infection, chronic chest infection (e.g., bronchiectasis), symptomatic urinary tract infection, and open, draining, or infected skin wounds; history of serious infections (e.g., sepsis, pneumonia, and pyelonephritis), or hospitalization or treatment with intravenous antibiotics for infections within 2 months before screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "recurrent infections",
          "chronic infections",
          "chronic renal infection",
          "chronic chest infection",
          "bronchiectasis",
          "symptomatic urinary tract infection",
          "open skin wounds",
          "draining skin wounds",
          "infected skin wounds",
          "serious infections",
          "sepsis",
          "pneumonia",
          "pyelonephritis"
        ],
        "CONDITION_PATTERN": [
          "known history",
          "prior history",
          "hospitalization",
          "treatment with intravenous antibiotics"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "renal",
          "chest",
          "urinary tract",
          "skin"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antibiotics"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on history of chronic or serious infections or recent hospitalization or IV antibiotic treatment"
        ]
      },
      {
        "id": "AIC_2302",
        "nct_id": "NCT06477237",
        "raw_text": "Serious infection defined as requiring hospitalization or iv anti-infective(s) within 1 month prior to randomization",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "requiring hospitalization",
          "requiring intravenous anti-infective treatment"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "month",
          "reference": "prior to randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous anti-infective treatment"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion based on recent serious infection requiring hospitalization and IV treatment"
        ]
      },
      {
        "id": "AIC_2301",
        "nct_id": "NCT06477237",
        "raw_text": "Any active infection (other than common cold) within 14 days",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 14,
          "unit": "days",
          "reference": "current"
        },
        "IMPACT": [
          "exclusion based on any active infection within 14 days"
        ]
      },
      {
        "id": "AIC_2283",
        "nct_id": "NCT06648772",
        "raw_text": "Prior active infection requiring the use of oral or intravenous antibiotics, antifungal or antiviral agents within 7 days before the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection"
        ],
        "CONDITION_PATTERN": [
          "prior active infection",
          "requiring use of antibiotics or antifungal or antiviral agents"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 7,
          "unit": "days",
          "reference": "before first dose"
        },
        "TREATMENT_REQUIREMENT": [
          "oral antibiotics",
          "intravenous antibiotics",
          "antifungal agents",
          "antiviral agents"
        ],
        "IMPACT": [
          "exclusion based on recent active infection requiring antimicrobial treatment"
        ]
      },
      {
        "id": "AIC_2264",
        "nct_id": "NCT06648772",
        "raw_text": "Skin disorders or other conditions that, in the judgment of the investigator, may interfere with the assessment of endpoints relevant to this study, including but not limited to: viral lesions, fungal and bacterial skin infections, parasitic infections, syphilis or tuberculosis-related skin manifestations, etc.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "skin disorders",
          "viral lesions",
          "fungal skin infections",
          "bacterial skin infections",
          "parasitic infections",
          "syphilis",
          "tuberculosis-related skin manifestations"
        ],
        "CONDITION_PATTERN": [
          "conditions that may interfere with assessment"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion based on skin conditions interfering with endpoint assessment"
        ]
      },
      {
        "id": "AIC_2232",
        "nct_id": "NCT07013201",
        "raw_text": "History of any known primary immunodeficiency disorder, including a positive human immunodeficiency virus test at screening, or the participant taking antiretroviral medications as determined by medical history and/or the participant's verbal report.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "primary immunodeficiency disorder",
          "human immunodeficiency virus infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "positive test",
          "taking antiretroviral medications"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": 0,
          "unit": "time",
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "antiretroviral medications"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on immunodeficiency or HIV infection"
        ]
      },
      {
        "id": "AIC_2231",
        "nct_id": "NCT07013201",
        "raw_text": "Clinically significant infection within 4 weeks prior to baseline, which, in the opinion of the investigator, may compromise the safety of the participant in the trial, interfere with evaluation of the IMP, or reduce the participant's ability to participate in the trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant infection"
        ],
        "CONDITION_PATTERN": [
          "within 4 weeks prior to baseline"
        ],
        "SEVERITY": "clinically significant",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "baseline"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion based on infection compromising safety or evaluation or participation"
        ]
      },
      {
        "id": "AIC_2229",
        "nct_id": "NCT07013201",
        "raw_text": "Clinically significant infection on the palms or soles.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "IMPACT": [
          "exclusion based on infection on palms or soles"
        ]
      },
      {
        "id": "AIC_2213",
        "nct_id": "NCT06628206",
        "raw_text": "History of infection 1) requiring hospitalization or parenteral antimicrobial therapy within 3 months prior to Day 1 or 2) treated with oral antimicrobial therapy within 2 weeks prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "requiring hospitalization",
          "requiring parenteral antimicrobial therapy",
          "treated with oral antimicrobial therapy"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 3,
            "unit": "months",
            "reference": "Day 1"
          },
          {
            "relation": "within",
            "amount": 2,
            "unit": "weeks",
            "reference": "Day 1"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "parenteral antimicrobial therapy",
          "oral antimicrobial therapy"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on recent infection requiring hospitalization or antimicrobial therapy"
        ]
      },
      {
        "id": "AIC_2205",
        "nct_id": "NCT06628206",
        "raw_text": "Any active or recurrent infection within the past 4 weeks prior to screening requiring IV or oral antibiotics.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "recurrent infection"
        ],
        "CONDITION_PATTERN": [
          "within past 4 weeks prior to screening",
          "requiring IV or oral antibiotics"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "IV antibiotics",
          "oral antibiotics"
        ],
        "IMPACT": [
          "exclusion based on recent active or recurrent infection requiring antibiotics"
        ]
      },
      {
        "id": "AIC_2202",
        "nct_id": "NCT06628206",
        "raw_text": "The subject has COVID-19 positive status (confirmed by clinical signs and symptoms and a positive SARS-CoV-2 NAAT or rapid antigen COVID test) at any time during the screening period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "COVID-19 infection"
        ],
        "CONDITION_PATTERN": [
          "positive status confirmed by clinical signs and positive test"
        ],
        "TIMEFRAME": {
          "relation": "at any time",
          "amount": 0,
          "unit": "time",
          "reference": "screening period"
        },
        "TREATMENT_REQUIREMENT": [
          "positive SARS-CoV-2 NAAT or rapid antigen COVID test"
        ],
        "IMPACT": [
          "exclusion based on COVID-19 positive status during screening"
        ]
      },
      {
        "id": "AIC_2153",
        "nct_id": "NCT07038720",
        "raw_text": "Subject with any acute infection, or any symptoms or signs of infection;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute infection",
          "symptoms or signs of infection"
        ],
        "CONDITION_PATTERN": [
          "any"
        ],
        "SEVERITY": "acute",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on any acute infection or infection symptoms/signs"
        ]
      },
      {
        "id": "AIC_2151",
        "nct_id": "NCT07038720",
        "raw_text": "Has serious bone or joint infection within 6 months before screening, serious infection (e.g., hospitalization for infection or parenteral antibiotic treatment for infection), or herpes zoster virus infection within 3 months before screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bone infection",
          "joint infection",
          "serious infection",
          "herpes zoster virus infection"
        ],
        "CONDITION_PATTERN": [
          "within 6 months before screening",
          "within 3 months before screening",
          "hospitalization for infection",
          "parenteral antibiotic treatment for infection"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "bone",
          "joint"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 6,
            "unit": "months",
            "reference": "before screening"
          },
          {
            "relation": "within",
            "amount": 3,
            "unit": "months",
            "reference": "before screening"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "parenteral antibiotic treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on recent serious bone/joint or herpes zoster infections"
        ]
      },
      {
        "id": "AIC_2149",
        "nct_id": "NCT07038720",
        "raw_text": "History of chronic or recurrent infectious diseases, or systemic infection caused by fungal, parasitic or mycotic pathogens, or other opportunistic infections;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic infectious diseases",
          "recurrent infectious diseases",
          "systemic infection caused by fungal pathogens",
          "systemic infection caused by parasitic pathogens",
          "systemic infection caused by mycotic pathogens",
          "opportunistic infections"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on history of chronic, recurrent, systemic, or opportunistic infections"
        ]
      },
      {
        "id": "AIC_2127",
        "nct_id": "NCT06842199",
        "raw_text": "Exclusion Criteria: 3. Presence of infection or immune-related disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "immune-related disease"
        ],
        "CONDITION_PATTERN": [
          "presence"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion based on presence of infection or immune-related disease"
        ]
      },
      {
        "id": "AIC_2110",
        "nct_id": "NCT06672393",
        "raw_text": "Recent history of infection, history or risk of serious infection",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "recent history",
          "history or risk"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "recent",
          "amount": 0,
          "unit": "time",
          "reference": "current"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion based on recent or risk of serious infection"
        ]
      },
      {
        "id": "AIC_2088",
        "nct_id": "NCT06926582",
        "raw_text": "Recent history of infection, history or risk of serious infection",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "recent history",
          "history or risk"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "recent",
          "amount": 0,
          "unit": "time",
          "reference": "current"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion based on recent or risk of serious infection"
        ]
      },
      {
        "id": "AIC_2055",
        "nct_id": "NCT06143371",
        "raw_text": "Any sign of infection of any of the psoriatic lesions.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection"
        ],
        "CONDITION_PATTERN": [
          "sign of infection"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriatic lesions"
        ],
        "IMPACT": [
          "exclusion based on any sign of infection on psoriatic lesions"
        ]
      },
      {
        "id": "AIC_2052",
        "nct_id": "NCT06143371",
        "raw_text": "Ongoing opportunistic or systemic infections.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "opportunistic infections",
          "systemic infections"
        ],
        "CONDITION_PATTERN": [
          "ongoing"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_2008",
        "nct_id": "NCT06833307",
        "raw_text": "Active systemic infections (other than common cold) during the 4 weeks before randomization (e.g., hepatitis), or serious infections requiring hospitalization and/or intravenous injection of antibiotic treatment within eight weeks prior to randomization.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic infections",
          "hepatitis",
          "serious infections"
        ],
        "CONDITION_PATTERN": [
          "active",
          "requiring hospitalization"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "before",
          "amount": 4,
          "unit": "weeks",
          "reference": "randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "intravenous injection of antibiotic treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1995",
        "nct_id": "NCT07130604",
        "raw_text": "History of herpes zoster/herpes simplex, or presence of herpes zoster/herpes simplex infection during the screening period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster",
          "herpes simplex"
        ],
        "CONDITION_PATTERN": [
          "history",
          "presence during screening"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "screening period"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1956",
        "nct_id": "NCT06077331",
        "raw_text": "Recent history of infection, history or risk of serious infection",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "recent history",
          "history",
          "risk"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "recent",
          "amount": null,
          "unit": null,
          "reference": null
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1920",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have any ongoing evidence of chronic bacterial infection (eg, chronic pyelonephritis, chronic osteomyelitis, chronic bronchiectasis).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic bacterial infection",
          "chronic pyelonephritis",
          "chronic osteomyelitis",
          "chronic bronchiectasis"
        ],
        "CONDITION_PATTERN": [
          "ongoing evidence"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1919",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have any untreated bacterial infection within 60 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection"
        ],
        "CONDITION_PATTERN": [
          "untreated"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "prior to Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "untreated"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1918",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have a history of serious bacterial, fungal, or viral infection requiring hospitalization and intravenous (IV) antimicrobial treatment within 60 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious bacterial infection",
          "serious fungal infection",
          "serious viral infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "prior to Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antimicrobial treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1895",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 27. Is infected with human immunodeficiency virus (HIV)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "human immunodeficiency virus (HIV) infection"
        ],
        "CONDITION_PATTERN": [
          "infected"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1891",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 23. Has had herpes zoster (shingles) within 2 months prior to Screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster (shingles)"
        ],
        "CONDITION_PATTERN": [
          "had"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "prior to Screening"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1890",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 22. Has had a serious infection (e.g., sepsis, pneumonia, pyelonephritis) requiring hospitalization within the 2 months before Screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious infection",
          "sepsis",
          "pneumonia",
          "pyelonephritis"
        ],
        "CONDITION_PATTERN": [
          "had"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "before Screening"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1888",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 20. Has a history of chronic or recurrent infectious disease including but not limited to chronic renal infection, recurrent urinary tract infection (UTI), chronic respiratory infections (e.g., tuberculosis), skin infections, or fungal infections",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic infectious disease",
          "recurrent infectious disease",
          "chronic renal infection",
          "recurrent urinary tract infection (UTI)",
          "chronic respiratory infections",
          "tuberculosis",
          "skin infections",
          "fungal infections"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1847",
        "nct_id": "NCT06620692",
        "raw_text": "Patients who have systemic infection during the last 2 weeks prior to Screening Visit or active infection on the psoriasis lesion.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic infection",
          "active infection on psoriasis lesion"
        ],
        "CONDITION_PATTERN": [
          "systemic infection during last 2 weeks prior to Screening Visit",
          "active infection"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriasis lesion"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to Screening Visit"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1805",
        "nct_id": "NCT07129382",
        "raw_text": "Evidence of active infection and/or febrile illness requiring systemic anti-infective therapy within 2 weeks before randomization.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "febrile illness"
        ],
        "CONDITION_PATTERN": [
          "evidence"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "before randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "systemic anti-infective therapy"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1803",
        "nct_id": "NCT07129382",
        "raw_text": "History of severe bacterial, fungal, or viral infection requiring hospitalization for IV antibiotic or antiviral administration within 2 months before randomization.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "severe bacterial infection",
          "severe fungal infection",
          "severe viral infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "before randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "IV antibiotic or antiviral administration"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1802",
        "nct_id": "NCT07129382",
        "raw_text": "b) History of severe herpes (disseminated disease, multidermatomal HSV, encephalitis, ophthalmic herpes, or recurrent zoster [≥2 episodes in 2 years]).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "severe herpes",
          "disseminated disease",
          "multidermatomal HSV",
          "encephalitis",
          "ophthalmic herpes",
          "recurrent zoster"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "years",
          "reference": "prior 2 years for recurrent zoster episodes"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1801",
        "nct_id": "NCT07129382",
        "raw_text": "Herpes infection:a) Active herpes zoster/simplex (HSV-1/2) at screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster",
          "herpes simplex (HSV-1/2)"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1799",
        "nct_id": "NCT07129382",
        "raw_text": "History of opportunistic infections (e.g., PJP, histoplasmosis, coccidioidomycosis).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "opportunistic infections",
          "PJP",
          "histoplasmosis",
          "coccidioidomycosis"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1798",
        "nct_id": "NCT07129382",
        "raw_text": "Prosthetic joint infection (unless prosthesis removed/replaced ≥2 months before randomization).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "prosthetic joint infection"
        ],
        "CONDITION_PATTERN": [
          "active unless prosthesis removed/replaced"
        ],
        "ANATOMICAL_LOCATION": [
          "prosthetic joint"
        ],
        "TIMEFRAME": {
          "relation": "removed/replaced at least",
          "amount": 2,
          "unit": "months",
          "reference": "before randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "prosthesis removed or replaced"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1701",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has an active infection or history of infections (such as serious infection, chronic infections, opportunistic infections, unusually severe infections)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "history of infections",
          "serious infection",
          "chronic infections",
          "opportunistic infections",
          "unusually severe infections"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "AIC_1682",
        "nct_id": "NCT07029516",
        "raw_text": "aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Fragility Nails Distal Subungual Onychomycosis",
          "Nail Psoriasis"
        ],
        "CONDITION_PATTERN": [
          "affecting"
        ],
        "ANATOMICAL_LOCATION": [
          "nail bed"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true
      },
      {
        "id": "AIC_1679",
        "nct_id": "NCT06522035",
        "raw_text": "Any evidence of clinically significant active infection.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "clinically significant",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to active infection"
        ]
      },
      {
        "id": "AIC_1676",
        "nct_id": "NCT06522035",
        "raw_text": "Evidence of active local infection in the target joint.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "local infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "target joint"
        ],
        "IMPACT": [
          "exclusion due to active local infection"
        ]
      },
      {
        "id": "AIC_1656",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has an active infection or history of infection(s) as follows: A history of opportunistic, recurrent, or chronic infections that, in the opinion of the investigator, might cause this study to be detrimental to the study participant",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "opportunistic infection",
          "recurrent infection",
          "chronic infection"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to infections detrimental to participant"
        ]
      },
      {
        "id": "AIC_1655",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has an active infection or history of infection(s) as follows: A serious infection, defined as requiring hospitalization or intravenous anti-infective(s) within 2 months prior to the Baseline Visit",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "Baseline Visit"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous anti-infective"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion due to recent serious infection"
        ]
      },
      {
        "id": "AIC_1654",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has an active infection or history of infection(s) as follows: Any active systemic infection within 14 days prior to Baseline",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 14,
          "unit": "days",
          "reference": "Baseline"
        },
        "IMPACT": [
          "exclusion due to recent active systemic infection"
        ]
      },
      {
        "id": "AIC_1582",
        "nct_id": "NCT06562894",
        "raw_text": "Human immunodeficiency virus antibody positive or treponema pallidum antibody positive;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "HIV antibody positive",
          "treponema pallidum antibody positive"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to positive antibody status"
        ]
      },
      {
        "id": "AIC_1579",
        "nct_id": "NCT06562894",
        "raw_text": "History of severe herpes zoster or sever herpes simplex infection;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster infection",
          "herpes simplex infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of severe herpes infection"
        ]
      },
      {
        "id": "AIC_1577",
        "nct_id": "NCT06562894",
        "raw_text": "Have any chronic infection that requires systemic anti-infective therapy;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic infection"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic anti-infective therapy"
        ],
        "IMPACT": [
          "exclusion due to chronic infection requiring therapy"
        ]
      },
      {
        "id": "AIC_1576",
        "nct_id": "NCT06562894",
        "raw_text": "Bacterial, fungal, or viral infection requiring hospitalization/intravenous treatment within 4 weeks before the first dose of study drug or requiring oral treatment within 2 weeks before the first dose of study drug;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection",
          "fungal infection",
          "viral infection"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "first dose of study drug"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent infection requiring hospitalization or intravenous treatment"
        ]
      },
      {
        "id": "AIC_1532",
        "nct_id": "NCT06943950",
        "raw_text": "Active bacterial, viral, fungal, or other infection that requires medical intervention.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection",
          "viral infection",
          "fungal infection",
          "other infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TREATMENT_REQUIREMENT": [
          "medical intervention"
        ],
        "IMPACT": [
          "exclusion due to active infection requiring intervention"
        ]
      },
      {
        "id": "AIC_1513",
        "nct_id": "NCT06592274",
        "raw_text": "Serious infection defined as requiring hospitalization or iv anti-infective(s) within 1 month prior to randomization",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "month",
          "reference": "randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous anti-infective"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion due to recent serious infection"
        ]
      },
      {
        "id": "AIC_1512",
        "nct_id": "NCT06592274",
        "raw_text": "Any active infection (other than common cold) within 14 days",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 14,
          "unit": "days",
          "reference": null
        },
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent active infection"
        ]
      },
      {
        "id": "AIC_1479",
        "nct_id": "NCT06542614",
        "raw_text": "Clinically significant infection, including but not limited to upper respiratory tract infection, lower respiratory tract infection, herpes simplex, herpes zoster, during the screening period, and requiring antibiotic or antiviral medication treatment;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "upper respiratory tract infection",
          "lower respiratory tract infection",
          "herpes simplex",
          "herpes zoster"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "clinically significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "screening period",
          "reference": null
        },
        "TREATMENT_REQUIREMENT": [
          "antibiotic medication",
          "antiviral medication"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to infection requiring treatment during screening"
        ]
      },
      {
        "id": "AIC_1477",
        "nct_id": "NCT06542614",
        "raw_text": "History of severe bacterial, fungal or viral infection within 2 months prior to randomization, requiring hospitalization for intravenous antibiotics or antiviral drug treatment;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection",
          "fungal infection",
          "viral infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antibiotics",
          "antiviral drug treatment"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion due to recent severe infection"
        ]
      },
      {
        "id": "AIC_1476",
        "nct_id": "NCT06542614",
        "raw_text": "Has a history of severe herpes zoster or herpes simplex infection, including but not limited to herpetic encephalitis, disseminated herpes simplex, generalized herpes zoster;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster infection",
          "herpes simplex infection",
          "herpetic encephalitis",
          "disseminated herpes simplex",
          "generalized herpes zoster"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of severe herpes infection"
        ]
      },
      {
        "id": "AIC_1473",
        "nct_id": "NCT06542614",
        "raw_text": "Presence of serovirological abnormalities during the screening period:",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serovirological abnormalities"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "screening period",
          "reference": null
        },
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to serovirological abnormalities"
        ]
      },
      {
        "id": "AIC_1415",
        "nct_id": "NCT06973291",
        "raw_text": "Participant had a bacterial infection within 60 days prior to Day 1 for which he or she did not receive treatment.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "no treatment received"
        ],
        "IMPACT": [
          "exclusion due to untreated recent bacterial infection"
        ]
      },
      {
        "id": "AIC_1414",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of opportunistic infections (for example, Pneumocystis jirovecii pneumonia, histoplasmosis, coccidiomycosis).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "opportunistic infections"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "IMPACT": [
          "exclusion due to history of opportunistic infections"
        ]
      },
      {
        "id": "AIC_1413",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of an infected joint prosthesis, unless that prosthesis has been removed or replaced at least 60 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infected joint prosthesis"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "joint prosthesis"
        ],
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 60,
          "unit": "days",
          "reference": "Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "prosthesis removed or replaced"
        ],
        "IMPACT": [
          "exclusion due to infected joint prosthesis unless removed/replaced"
        ]
      },
      {
        "id": "AIC_1412",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of chronic or recurrent bacterial disease, including but not limited to chronic pyelonephritis or cystitis, chronic bronchitis/pneumonitis, osteomyelitis, or chronic skin ulcerations/infections or fungal infections (except superficial onychomycosis).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic bacterial disease",
          "chronic fungal infections"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "urinary tract",
          "bronchus/lung",
          "bone",
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of chronic or recurrent infections"
        ]
      },
      {
        "id": "AIC_1411",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has history of bacterial, viral, or fungal infection that required hospitalization or treatment with intravenous antimicrobial therapy within 8 weeks prior to Day 1 or oral antimicrobial therapy within 30 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection",
          "viral infection",
          "fungal infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "prior to",
          "amount": 8,
          "unit": "weeks",
          "reference": "Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antimicrobial therapy",
          "oral antimicrobial therapy"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent serious infection requiring treatment"
        ]
      },
      {
        "id": "AIC_1410",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has history of symptoms suggestive of systemic or invasive infection within 30 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic infection",
          "invasive infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "suggestive symptoms"
        ],
        "TIMEFRAME": {
          "relation": "prior to",
          "amount": 30,
          "unit": "days",
          "reference": "Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent symptoms suggestive of infection"
        ]
      },
      {
        "id": "AIC_1409",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of active infection or febrile illness within 7 days prior to Day 1, as assessed by the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "febrile illness"
        ],
        "CONDITION_PATTERN": [
          "history",
          "active"
        ],
        "TIMEFRAME": {
          "relation": "prior to",
          "amount": 7,
          "unit": "days",
          "reference": "Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to recent active infection or febrile illness"
        ]
      },
      {
        "id": "AIC_1408",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has positive results for Human Immunodeficiency Virus (HIV) by serology, regardless of viral load.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Human Immunodeficiency Virus (HIV) infection"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "IMPACT": [
          "exclusion due to positive HIV serology"
        ]
      },
      {
        "id": "AIC_1405",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has history of serious herpetic infection that includes any episode of disseminated disease, multidermatomal herpes zoster, herpes encephalitis, ophthalmic herpes, or recurrent herpes zoster (defined as 2 episodes within 2 years).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpetic infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "serious"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "disseminated disease",
          "multidermatomal herpes zoster",
          "herpes encephalitis",
          "ophthalmic herpes",
          "recurrent herpes zoster"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "years",
          "reference": "prior"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to serious herpetic infection history"
        ]
      },
      {
        "id": "AIC_1404",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has active herpes virus infection, including herpes zoster or herpes simplex 1 and 2 (demonstrated on physical examination and/or medical history) at screening or Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes virus infection",
          "herpes zoster",
          "herpes simplex 1",
          "herpes simplex 2"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening or Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "demonstrated on physical examination and/or medical history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to active herpes virus infection at screening or Day 1"
        ]
      },
      {
        "id": "AIC_1377",
        "nct_id": "NCT05092269",
        "raw_text": "Have had any of (a) confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2 [COVID-19]) infection (test positive), or (b) suspected SARS-CoV-2 infection (clinical features without documented test results), or (c) close contact with a person with known or suspected SARS-CoV-2 infection.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "SARS-CoV-2 (COVID-19) infection",
          "close contact with SARS-CoV-2 infected person"
        ],
        "CONDITION_PATTERN": [
          "confirmed",
          "suspected",
          "exposure"
        ],
        "SEVERITY": "severe (confirmed)",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to confirmed or suspected COVID-19 infection or close contact"
        ]
      },
      {
        "id": "AIC_1358",
        "nct_id": "NCT06176508",
        "raw_text": "Recent history of active infection, chronic infection history or risk of serious infection.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "chronic infection",
          "risk of serious infection"
        ],
        "CONDITION_PATTERN": [
          "recent history",
          "chronic",
          "risk"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "recent",
          "amount": null,
          "unit": null,
          "reference": null
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent or chronic infection or risk of serious infection"
        ]
      },
      {
        "id": "AIC_1338",
        "nct_id": "NCT07150988",
        "raw_text": "Presence of active infection requiring systemic therapy;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TREATMENT_REQUIREMENT": [
          "requiring systemic therapy"
        ],
        "IMPACT": [
          "exclusion due to active infection requiring systemic therapy"
        ]
      },
      {
        "id": "AIC_1303",
        "nct_id": "NCT06918743",
        "raw_text": "Active infection within 2 weeks prior to baseline requiring systemic anti-infective therapy, or severe infection or systemic infection within 4 weeks prior to baseline requiring intravenous anti-infective therapy or hospitalization due to infection, or other chronic, recurrent, or active infections deemed by the investigator not suitable for participation in the study;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "severe infection",
          "systemic infection",
          "chronic infection",
          "recurrent infection"
        ],
        "CONDITION_PATTERN": [
          "active",
          "severe",
          "systemic",
          "chronic",
          "recurrent"
        ],
        "SEVERITY": "severe (some infections)",
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 2,
            "unit": "weeks",
            "reference": "baseline"
          },
          {
            "relation": "within",
            "amount": 4,
            "unit": "weeks",
            "reference": "baseline"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic anti-infective therapy",
          "intravenous anti-infective therapy",
          "hospitalization"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent active or severe infections requiring treatment or hospitalization",
          "exclusion due to investigator judgment on infection suitability"
        ]
      },
      {
        "id": "AIC_1288",
        "nct_id": "NCT06844799",
        "raw_text": "A history of chronic recurrent infection, or opportunistic infection in the 6 months prior to screening, or hospitalization for a serious infectious disease or intravenous antibiotic use in the 2 months prior to randomization, with a confirmed or suspected illness in the 1 week prior to randomization.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic recurrent infection",
          "opportunistic infection",
          "serious infectious disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 6,
            "unit": "months",
            "reference": "prior to screening"
          },
          {
            "relation": "within",
            "amount": 2,
            "unit": "months",
            "reference": "prior to randomization"
          },
          {
            "relation": "within",
            "amount": 1,
            "unit": "week",
            "reference": "prior to randomization"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antibiotic use"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent history of chronic, recurrent, or serious infections requiring hospitalization or IV antibiotics"
        ]
      },
      {
        "id": "AIC_1262",
        "nct_id": "NCT06380907",
        "raw_text": "Positive for any of the following tests at screening: Human immunodeficiency virus (HIV): HIV antibody.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Human immunodeficiency virus (HIV) infection"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "positive HIV antibody test"
        ],
        "IMPACT": [
          "exclusion due to positive HIV antibody test at screening"
        ]
      },
      {
        "id": "AIC_1207",
        "nct_id": "NCT05642182",
        "raw_text": "Evidence of active infection during screening, or serious infection within the past month.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active infection",
          "serious infection"
        ],
        "CONDITION_PATTERN": [
          "active",
          "serious"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": [
          {
            "relation": "during",
            "amount": null,
            "unit": null,
            "reference": "screening"
          },
          {
            "relation": "within",
            "amount": 1,
            "unit": "month",
            "reference": "past"
          }
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to active infection during screening or serious infection within past month"
        ]
      },
      {
        "id": "AIC_1176",
        "nct_id": "NCT04772079",
        "raw_text": "History of recent infection.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection"
        ],
        "CONDITION_PATTERN": [
          "history",
          "recent"
        ],
        "TIMEFRAME": {
          "relation": "recent",
          "amount": null,
          "unit": null,
          "reference": null
        },
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent infection history"
        ]
      },
      {
        "id": "AIC_1150",
        "nct_id": "NCT06005532",
        "raw_text": "11. Confirmed coronavirus infection caused by COVID-19 within 8 weeks prior to the screening period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "coronavirus infection caused by COVID-19"
        ],
        "CONDITION_PATTERN": [
          "confirmed"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 8,
          "unit": "weeks",
          "reference": "screening period"
        },
        "IMPACT": [
          "exclusion due to confirmed COVID-19 infection within 8 weeks prior to screening"
        ]
      },
      {
        "id": "AIC_1130",
        "nct_id": "NCT06846710",
        "raw_text": "Known history of recurrent or chronic infections, or prior history of chronic or recurrent infections, including but not limited to: chronic renal infection, chronic chest infection (e.g., bronchiectasis), symptomatic urinary tract infection, and open, draining, or infected skin wounds; history of serious infections (e.g., sepsis, pneumonia, and pyelonephritis), or hospitalization or treatment with intravenous antibiotics for infections within 2 months before screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "recurrent infections",
          "chronic infections",
          "chronic renal infection",
          "chronic chest infection",
          "symptomatic urinary tract infection",
          "open skin wounds",
          "draining skin wounds",
          "infected skin wounds",
          "serious infections",
          "sepsis",
          "pneumonia",
          "pyelonephritis"
        ],
        "CONDITION_PATTERN": [
          "known history",
          "prior history"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "renal",
          "chest",
          "urinary tract",
          "skin"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "before screening"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "treatment with intravenous antibiotics"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of recurrent or chronic infections or serious infections requiring hospitalization or IV antibiotics"
        ]
      },
      {
        "id": "AIC_1016",
        "nct_id": "NCT07204639",
        "raw_text": "Positive for human immunodeficiency virus by antibody testing (HIV-1 and -2 Ab) at screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "human immunodeficiency virus (HIV) infection"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "positive antibody testing (HIV-1 and -2 Ab)"
        ],
        "IMPACT": [
          "exclusion due to positive HIV antibody test at screening"
        ]
      },
      {
        "id": "AIC_1013",
        "nct_id": "NCT07204639",
        "raw_text": "History of serious herpes zoster or serious herpes simplex infection, which includes, but is not limited to, any episode of disseminated herpes simplex, multidermatomal herpes zoster, herpes encephalitis, ophthalmic herpes, or recurrent herpes zoster (recurrent is defined as 2 episodes within 2 years)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster infection",
          "herpes simplex infection",
          "disseminated herpes simplex",
          "multidermatomal herpes zoster",
          "herpes encephalitis",
          "ophthalmic herpes",
          "recurrent herpes zoster"
        ],
        "CONDITION_PATTERN": [
          "history",
          "serious"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "years",
          "reference": "prior"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of serious herpes infections"
        ]
      },
      {
        "id": "AIC_1012",
        "nct_id": "NCT07204639",
        "raw_text": "Presence of herpes zoster lesions at screening or Day 1",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "herpes zoster infection"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening or Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "presence of lesions"
        ],
        "IMPACT": [
          "exclusion due to active herpes zoster lesions at screening or Day 1"
        ]
      },
      {
        "id": "AIC_1010",
        "nct_id": "NCT07204639",
        "raw_text": "Any history of proven infection of a joint prosthesis in which the prosthesis was not removed or replaced, or received antibiotics for suspected infection of a joint prosthesis in which the prosthesis was not removed or replaced",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection of joint prosthesis"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "joint prosthesis"
        ],
        "TREATMENT_REQUIREMENT": [
          "received antibiotics for suspected infection without prosthesis removal or replacement"
        ],
        "IMPACT": [
          "exclusion due to history of joint prosthesis infection without removal or replacement"
        ]
      },
      {
        "id": "AIC_1009",
        "nct_id": "NCT07204639",
        "raw_text": "Any ongoing evidence of chronic bacterial infection (eg, chronic pyelonephritis, chronic osteomyelitis, chronic bronchiectasis)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic bacterial infection",
          "chronic pyelonephritis",
          "chronic osteomyelitis",
          "chronic bronchiectasis"
        ],
        "CONDITION_PATTERN": [
          "ongoing",
          "active"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "AIC_1008",
        "nct_id": "NCT07204639",
        "raw_text": "Any untreated bacterial infection within 60 days prior to Day 1",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "bacterial infection"
        ],
        "CONDITION_PATTERN": [
          "untreated"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "untreated"
        ]
      },
      {
        "id": "AIC_1007",
        "nct_id": "NCT07204639",
        "raw_text": "History of serious bacterial, fungal, or viral infection requiring hospitalization and intravenous antimicrobial treatment within 60 days prior to Day 1",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious bacterial infection",
          "serious fungal infection",
          "serious viral infection"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "hospitalization",
          "intravenous antimicrobial treatment"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "AIC_1006",
        "nct_id": "NCT07204639",
        "raw_text": "History or evidence of outpatient active infection and/or febrile illness within 7 days prior to Day 1",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "infection",
          "febrile illness"
        ],
        "CONDITION_PATTERN": [
          "history",
          "active",
          "outpatient"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 7,
          "unit": "days",
          "reference": "Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true
      }
    ]
  },
  "CLUSTER_CMB": {
    "cluster_name": "Comorbid Conditions and Risk Factors",
    "cluster_code": "CMB",
    "total_criteria": 271,
    "primary_question": "Do you have any other diseases?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "CMB_2473",
        "nct_id": "NCT06170840",
        "raw_text": "Patients with psychoneuro-related diseases or history (such as depression, epilepsy), which affect medication compliance or the researcher's clinical judgment of suicide risk.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psychoneuro-related diseases",
          "depression",
          "epilepsy"
        ],
        "CONDITION_PATTERN": [
          "history",
          "current"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "affect medication compliance",
          "affect clinical judgment of suicide risk"
        ]
      },
      {
        "id": "CMB_2472",
        "nct_id": "NCT06170840",
        "raw_text": "Known malignant tumors or history of malignant tumors (excluding clinically cured skin basal cell carcinoma, skin squamous cell carcinoma, cervical carcinoma in situ).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignant tumors",
          "skin basal cell carcinoma",
          "skin squamous cell carcinoma",
          "cervical carcinoma in situ"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "SEVERITY": "clinically cured (excluded)",
        "ANATOMICAL_LOCATION": [
          "skin",
          "cervix"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion if malignant tumor present or history except specified cured types"
        ]
      },
      {
        "id": "CMB_2471",
        "nct_id": "NCT06170840",
        "raw_text": "Peripheral artery disease diagnosed by angiography with stroke (ischemic or hemorrhagic, including transient ischemic attack) should be excluded.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "peripheral artery disease",
          "stroke",
          "transient ischemic attack"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "peripheral arteries",
          "brain"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2470",
        "nct_id": "NCT06170840",
        "raw_text": "Hospitalization due to Cardiovascular (CV) events, CV disease or CV surgery.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular events",
          "cardiovascular disease",
          "cardiovascular surgery"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "hospitalization"
        ]
      },
      {
        "id": "CMB_2469",
        "nct_id": "NCT06170840",
        "raw_text": "There are severe arrhythmias that require medication or cardiac assistance, such as degree II type 2 or degree III atrioventricular block, long QT Interval, or long QT block.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arrhythmias",
          "degree II type 2 atrioventricular block",
          "degree III atrioventricular block",
          "long QT interval",
          "long QT block"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TREATMENT_REQUIREMENT": [
          "require medication",
          "require cardiac assistance"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2468",
        "nct_id": "NCT06170840",
        "raw_text": "History of unstable angina pectoris, myocardial infarction, coronary artery bypass grafting or coronary stent implantation.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "unstable angina pectoris",
          "myocardial infarction",
          "coronary artery bypass grafting",
          "coronary stent implantation"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "heart",
          "coronary arteries"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2467",
        "nct_id": "NCT06170840",
        "raw_text": "The presence of decompensated cardiac insufficiency (New York Heart Disease Association (NYHA) class III or IV) within 6 months prior to screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "decompensated cardiac insufficiency"
        ],
        "CONDITION_PATTERN": [
          "current",
          "within 6 months prior to screening"
        ],
        "SEVERITY": "NYHA class III or IV",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "screening"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2454",
        "nct_id": "NCT06170840",
        "raw_text": "The presence of other systemic autoimmune inflammatory diseases and skin lesions (such as eczema), which may affect the evaluation of treatment outcomes.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic autoimmune inflammatory diseases",
          "skin lesions",
          "eczema"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "may affect evaluation of treatment outcomes"
        ]
      },
      {
        "id": "CMB_2444",
        "nct_id": "NCT06643260",
        "raw_text": "Significant acute or chronic medical or psychiatric illness that, in the judgment of the Investigator, could compromise subject safety, limit the subject's ability to complete the study, and/or compromise the objectives of the study;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute medical illness",
          "chronic medical illness",
          "psychiatric illness"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "significant",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "compromise subject safety",
          "limit ability to complete study",
          "compromise study objectives"
        ]
      },
      {
        "id": "CMB_2442",
        "nct_id": "NCT06643260",
        "raw_text": "Any significant/uncontrolled neuropsychiatric illness judged as clinically significant by the investigator during screening or at Day 1, or any lifetime history of suicidal ideation, suicidal behavior, or suicidal attempts by medical history or by Columbia Suicide Severity Rating Scale (C-SSRS) documentation, or by answering \"yes\" to Question 4 or 5 for suicidal ideation on the C-SSRS at screening or at Day 1, or is clinically deemed to have a suicide risk by the investigator;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "neuropsychiatric illness",
          "suicidal ideation",
          "suicidal behavior",
          "suicidal attempts"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history",
          "lifetime"
        ],
        "SEVERITY": "significant",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to suicide risk",
          "clinical significance at screening or Day 1"
        ]
      },
      {
        "id": "CMB_2437",
        "nct_id": "NCT06643260",
        "raw_text": "Active gastrointestinal disease which could interfere with the absorption of oral medication;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "gastrointestinal disease"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract"
        ],
        "IMPACT": [
          "interfere with absorption of oral medication"
        ]
      },
      {
        "id": "CMB_2435",
        "nct_id": "NCT06643260",
        "raw_text": "A condition which increases proarrhythmic risk, including hypokalemia, hypomagnesemia, or congenital Long QT Syndrome;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hypokalemia",
          "hypomagnesemia",
          "congenital Long QT Syndrome"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "increase proarrhythmic risk"
        ]
      },
      {
        "id": "CMB_2410",
        "nct_id": "NCT06380153",
        "raw_text": "with a history of epileptic seizures.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "epileptic seizures"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "brain"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2393",
        "nct_id": "NCT06380153",
        "raw_text": "patients who had severe gastrointestinal diseases or had digestive system surgery within 3 months before screening, which affected drug absorption according to the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "severe gastrointestinal diseases",
          "digestive system surgery"
        ],
        "CONDITION_PATTERN": [
          "history",
          "within 3 months before screening"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract",
          "digestive system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "affect drug absorption"
        ]
      },
      {
        "id": "CMB_2392",
        "nct_id": "NCT06380153",
        "raw_text": "patients with a history of depression or suicidal tendencies.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "depression",
          "suicidal tendencies"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2391",
        "nct_id": "NCT06380153",
        "raw_text": "Any of the following occurred in the 6 months prior to study entry: Myocardial infarction, Congenital long QT syndrome, Torsades de pointes, right bundle branch block and left anterior hemiblock, Unstable angina pectoris, coronary artery/peripheral artery bypass grafting, New York Heart Association class III or IV congestive heart failure, cerebrovascular accident, transient ischemic attack, or pulmonary embolism.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "myocardial infarction",
          "congenital long QT syndrome",
          "Torsades de pointes",
          "right bundle branch block",
          "left anterior hemiblock",
          "unstable angina pectoris",
          "coronary artery bypass grafting",
          "peripheral artery bypass grafting",
          "New York Heart Association class III or IV congestive heart failure",
          "cerebrovascular accident",
          "transient ischemic attack",
          "pulmonary embolism"
        ],
        "CONDITION_PATTERN": [
          "occurred",
          "within 6 months prior to study entry"
        ],
        "ANATOMICAL_LOCATION": [
          "heart",
          "coronary arteries",
          "peripheral arteries",
          "brain",
          "lungs"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "study entry"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2390",
        "nct_id": "NCT06380153",
        "raw_text": "In addition to the disease causing renal impairment, patients with serious acute or chronic diseases of other vital organs within 1 year prior to screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal impairment",
          "serious acute diseases",
          "serious chronic diseases"
        ],
        "CONDITION_PATTERN": [
          "current",
          "within 1 year prior to screening"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "kidneys",
          "other vital organs"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "year",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2389",
        "nct_id": "NCT06380153",
        "raw_text": "Patients with obstructive urinary tract diseases (such as urinary tract obstruction caused by urinary calculi, urinary tract obstruction caused by abdominal space occupying lesions, etc.), and the investigator thought that they were not suitable.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "obstructive urinary tract diseases",
          "urinary tract obstruction caused by urinary calculi",
          "urinary tract obstruction caused by abdominal space occupying lesions"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "urinary tract",
          "abdomen"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "unsuitability for study"
        ]
      },
      {
        "id": "CMB_2388",
        "nct_id": "NCT06380153",
        "raw_text": "Patients with urinary incontinence or anuria.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "urinary incontinence",
          "anuria"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "urinary system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2387",
        "nct_id": "NCT06380153",
        "raw_text": "The subject has any of the following conditions: acute kidney failure, a history of kidney transplantation, or a need for kidney transplantation or any type of dialysis during the planned trial period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute kidney failure",
          "history of kidney transplantation",
          "need for kidney transplantation",
          "need for any type of dialysis"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history",
          "planned trial period"
        ],
        "ANATOMICAL_LOCATION": [
          "kidneys"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "planned trial period",
          "reference": "trial period"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_2360",
        "nct_id": "NCT06610890",
        "raw_text": "Mechanical operators engaged in high-altitude work, motor vehicle driving and other dangerous operations;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "high-altitude work",
          "motor vehicle driving",
          "dangerous operations"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to occupational risk"
        ]
      },
      {
        "id": "CMB_2358",
        "nct_id": "NCT06610890",
        "raw_text": "patients with a history of asthma or seizures;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "asthma",
          "seizures"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to past respiratory or neurological conditions"
        ]
      },
      {
        "id": "CMB_2351",
        "nct_id": "NCT06610890",
        "raw_text": "patients with clinically significant major diseases or major surgical procedures within 3 months before the trial;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major diseases",
          "major surgical procedures"
        ],
        "CONDITION_PATTERN": [
          "clinically significant",
          "within timeframe"
        ],
        "SEVERITY": "major",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "before the trial"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent major illness or surgery"
        ]
      },
      {
        "id": "CMB_2345",
        "nct_id": "NCT06610890",
        "raw_text": "a history of vomiting, diarrhea, or any physiological condition that could interfere with the test results within 7 days before the test;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "vomiting",
          "diarrhea",
          "physiological conditions interfering with test results"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 7,
          "unit": "days",
          "reference": "before the test"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent conditions affecting test validity"
        ]
      },
      {
        "id": "CMB_2344",
        "nct_id": "NCT06610890",
        "raw_text": "patients with any disease that increases the risk of bleeding, such as active or previous history of gastrointestinal ulcer, gastrointestinal bleeding or perforation, ulcerative colitis, or intracranial hemorrhage;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "gastrointestinal ulcer",
          "gastrointestinal bleeding",
          "perforation",
          "ulcerative colitis",
          "intracranial hemorrhage"
        ],
        "CONDITION_PATTERN": [
          "active",
          "previous history"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract",
          "brain"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to increased bleeding risk"
        ]
      },
      {
        "id": "CMB_2343",
        "nct_id": "NCT06610890",
        "raw_text": "patients with abnormal clinical manifestations that need to be excluded, including but not limited to diseases of the nervous system, cardiovascular system, blood and lymphatic system, immune system, kidney, liver, gastrointestinal system, respiratory system, metabolic system, skeletal system and other systems, especially patients with myasthenia gravis, schizophrenia and severe depression;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "diseases of nervous system",
          "cardiovascular system",
          "blood and lymphatic system",
          "immune system",
          "kidney",
          "liver",
          "gastrointestinal system",
          "respiratory system",
          "metabolic system",
          "skeletal system",
          "myasthenia gravis",
          "schizophrenia",
          "severe depression"
        ],
        "CONDITION_PATTERN": [
          "abnormal clinical manifestations"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "nervous system",
          "cardiovascular system",
          "blood and lymphatic system",
          "immune system",
          "kidney",
          "liver",
          "gastrointestinal system",
          "respiratory system",
          "metabolic system",
          "skeletal system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to abnormal clinical findings"
        ]
      },
      {
        "id": "CMB_2337",
        "nct_id": "NCT06610890",
        "raw_text": "90mmHg≤ systolic blood pressure <140mmHg, 60mmHg≤ diastolic blood pressure <90 mmHg, 60 beats/min ≤ pulse ≤100 beats/min, normal body temperature (abnormal vital signs could be retested, normal retest results were considered to meet the inclusion criteria);",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "systolic blood pressure",
          "diastolic blood pressure",
          "pulse",
          "body temperature"
        ],
        "CONDITION_PATTERN": [
          "current",
          "normal"
        ],
        "SEVERITY": "normal",
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "TREATMENT_REQUIREMENT": [
          "retest if abnormal"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "inclusion based on normal vital signs"
        ]
      },
      {
        "id": "CMB_2336",
        "nct_id": "NCT06610890",
        "raw_text": "90mmHg≤ systolic blood pressure <140mmHg, 60mmHg≤ diastolic blood pressure <90 mmHg, 60 beats/min ≤ pulse ≤100 beats/min, normal body temperature (abnormal vital signs could be retested, normal retest results were considered to meet the inclusion criteria);",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "systolic blood pressure",
          "diastolic blood pressure",
          "pulse",
          "body temperature"
        ],
        "CONDITION_PATTERN": [
          "current",
          "normal"
        ],
        "SEVERITY": "normal",
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "TREATMENT_REQUIREMENT": [
          "retest if abnormal"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "inclusion based on normal vital signs"
        ]
      },
      {
        "id": "CMB_2329",
        "nct_id": "NCT07219420",
        "raw_text": "Has cutaneous lesions that may interfere with the evaluation of the affected area and/or evaluation of the severity of PPP",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cutaneous lesions"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to interference with evaluation"
        ]
      },
      {
        "id": "CMB_2326",
        "nct_id": "NCT07219420",
        "raw_text": "Has PPP symptoms which improve significantly between the Screening Visit and Baseline Visit, defined as a reduction in the PPPASI score",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "PPP symptoms"
        ],
        "CONDITION_PATTERN": [
          "current",
          "improving"
        ],
        "SEVERITY": "significant improvement",
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "TIMEFRAME": {
          "relation": "between",
          "amount": null,
          "unit": null,
          "reference": "Screening Visit and Baseline Visit"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to symptom improvement"
        ]
      },
      {
        "id": "CMB_2306",
        "nct_id": "NCT06477237",
        "raw_text": "Previously diagnosed with serious mental illness such as anxiety, depression or suicidal tendency",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious mental illness",
          "anxiety",
          "depression",
          "suicidal tendency"
        ],
        "CONDITION_PATTERN": [
          "previously diagnosed"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "mental health"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to serious mental illness"
        ]
      },
      {
        "id": "CMB_2305",
        "nct_id": "NCT06477237",
        "raw_text": "A history of inflammatory bowel disease or other serious autoimmune disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease",
          "serious autoimmune disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "gastrointestinal system",
          "immune system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to autoimmune or inflammatory disease history"
        ]
      },
      {
        "id": "CMB_2284",
        "nct_id": "NCT06648772",
        "raw_text": "Any serious disease or medical measure, physical or mental condition that, in the opinion of the investigator, will affect the subject's participation in the trial (including the use of IMP and participation in required study visits), or that, in the opinion of the investigator, will pose a significant risk or effect to the subject.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious disease",
          "medical measure",
          "physical condition",
          "mental condition"
        ],
        "CONDITION_PATTERN": [
          "current",
          "opinion of investigator"
        ],
        "SEVERITY": "serious",
        "TREATMENT_REQUIREMENT": [
          "use of IMP",
          "participation in study visits"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to investigator's clinical judgment on risk or effect"
        ]
      },
      {
        "id": "CMB_2282",
        "nct_id": "NCT06648772",
        "raw_text": "Cancer (except for non-melanoma skin cancer, localized prostate cancer, ductal carcinoma in situ, stage I uterine cancer, cervical carcinoma in situ, or breast carcinoma in situ that have been treated with curative therapy) within 5 years before the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cancer"
        ],
        "CONDITION_PATTERN": [
          "within timeframe",
          "excluding certain types"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "before first dose"
        },
        "TREATMENT_REQUIREMENT": [
          "curative therapy for excluded cancers"
        ],
        "IMPACT": [
          "exclusion due to recent cancer history"
        ]
      },
      {
        "id": "CMB_2281",
        "nct_id": "NCT06648772",
        "raw_text": "Have undergone a major surgery within 4 weeks prior to the first dose of this study (for the definition of major surgery, refer to Level 3 and Level 4 surgeries specified in the \"Measures for the Classification of Surgical Procedures in Medical Institutions\" issued by the National Health Commission of the People's Republic of China on Dec. 6, 2022) or plan to undergo a major surgery during the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "within timeframe",
          "planned"
        ],
        "SEVERITY": "major",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to first dose"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or planned major surgery"
        ]
      },
      {
        "id": "CMB_2277",
        "nct_id": "NCT06648772",
        "raw_text": "History of major depressive disorder, suicidality, or suicidal tendency suggested by the C-SSRS at baseline or screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major depressive disorder",
          "suicidality",
          "suicidal tendency"
        ],
        "CONDITION_PATTERN": [
          "history",
          "suggested by C-SSRS at baseline or screening"
        ],
        "SEVERITY": "major",
        "ANATOMICAL_LOCATION": [
          "mental health"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "baseline or screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to mental health risk"
        ]
      },
      {
        "id": "CMB_2236",
        "nct_id": "NCT07013201",
        "raw_text": "Any clinically significant abnormal finding occurring during the screening period and/or observed at the baseline visit that may put the participant at risk due to their participation in the trial or could influence the participant's ability to complete the trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant abnormal finding"
        ],
        "CONDITION_PATTERN": [
          "during screening",
          "at baseline"
        ],
        "SEVERITY": "clinically significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "screening period and baseline visit"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to risk or inability to complete trial"
        ]
      },
      {
        "id": "CMB_2235",
        "nct_id": "NCT07013201",
        "raw_text": "Any disorder that is not stable and could: Affect the safety of the participant throughout the trial. Impede the participant's ability to complete the trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "disorder"
        ],
        "CONDITION_PATTERN": [
          "not stable"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "affect safety",
          "impede trial completion"
        ]
      },
      {
        "id": "CMB_2234",
        "nct_id": "NCT07013201",
        "raw_text": "Any documented active or suspected malignancy, or history of malignancy within 5 years prior to screening, except basal cell carcinoma of the skin, localized squamous cell carcinoma of the skin, or in situ carcinoma of the cervix appropriately treated before the baseline visit.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "active",
          "suspected",
          "history within timeframe",
          "except certain types"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "TREATMENT_REQUIREMENT": [
          "appropriate treatment for excluded types"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to malignancy history"
        ]
      },
      {
        "id": "CMB_2233",
        "nct_id": "NCT07013201",
        "raw_text": "Major surgery within 8 weeks prior to screening or planned in-patient surgery or hospitalisation during the trial period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery",
          "planned in-patient surgery",
          "hospitalisation"
        ],
        "CONDITION_PATTERN": [
          "within timeframe",
          "planned",
          "during trial period"
        ],
        "SEVERITY": "major",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 8,
          "unit": "weeks",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or planned surgery or hospitalisation"
        ]
      },
      {
        "id": "CMB_2228",
        "nct_id": "NCT07013201",
        "raw_text": "Active dermatologic condition that could confound the diagnosis of PPP or interfere with assessment of the IMP, as assessed by the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "dermatologic condition"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "confound diagnosis of PPP",
          "interfere with assessment of IMP"
        ]
      },
      {
        "id": "CMB_2209",
        "nct_id": "NCT06628206",
        "raw_text": "Subject has any clinically significant finding on 12-lead ECG at screening or admission.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant finding on 12-lead ECG"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening or admission"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2193",
        "nct_id": "NCT06628206",
        "raw_text": "Any known history of a rheumatologic, autoimmune or cutaneous disease other than RA (except secondary Sjögren's syndrome), or PSA.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "rheumatologic disease",
          "autoimmune disease",
          "cutaneous disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "joints",
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2192",
        "nct_id": "NCT06628206",
        "raw_text": "Any known history of malignancy within 5 years other than other than completely treated non-metastatic basal cell carcinomas or squamous cell carcinomas of the skin or localized carcinoma in situ of the cervix.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "completely treated non-metastatic basal cell carcinomas",
          "completely treated non-metastatic squamous cell carcinomas of the skin",
          "localized carcinoma in situ of the cervix"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2189",
        "nct_id": "NCT06628206",
        "raw_text": "History of clinically significant medical conditions or any other reason that in the opinion of the PI would interfere with subject's participation in this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant medical conditions",
          "other reasons"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "clinically significant",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with subject's participation"
        ]
      },
      {
        "id": "CMB_2166",
        "nct_id": "NCT07038720",
        "raw_text": "Subject with symptoms of uninduced diarrhea within 3 months prior to screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "diarrhea"
        ],
        "CONDITION_PATTERN": [
          "current symptoms"
        ],
        "ANATOMICAL_LOCATION": [
          "digestive tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "prior to screening"
        },
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2165",
        "nct_id": "NCT07038720",
        "raw_text": "Subject with structural abnormalities of the digestive tract, or previous history of gastrointestinal disease (such as gastrointestinal bleeding, gastrointestinal perforation, gastroesophageal reflux disease, and inflammatory bowel disease) or current clinically significant gastrointestinal disease (such as gallstones) or symptoms (such as nausea, vomiting, and diarrhea), or patients who had undergone gastrointestinal surgery;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "structural abnormalities of digestive tract",
          "gastrointestinal disease",
          "gallstones",
          "gastrointestinal symptoms"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "SEVERITY": [
          "clinically significant",
          "current clinically significant"
        ],
        "ANATOMICAL_LOCATION": [
          "digestive tract",
          "gallbladder"
        ],
        "TREATMENT_REQUIREMENT": [
          "previous gastrointestinal surgery"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2164",
        "nct_id": "NCT07038720",
        "raw_text": "History of abdominal surgery affecting the structure and function of the digestive tract;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "abdominal surgery"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "abdomen",
          "digestive tract"
        ],
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2163",
        "nct_id": "NCT07038720",
        "raw_text": "Subject with previous severe or current chronic diseases of the central nervous system, cardiovascular, liver, kidney, lung, digestive tract, metabolic, hematological, skeletal, immune and other systems of clinical significance, or any other diseases or medical conditions that may affect the study or pose an unacceptable risk to the subject in the judgment of the investigator;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "severe or chronic diseases of central nervous system",
          "severe or chronic cardiovascular disease",
          "severe or chronic liver disease",
          "severe or chronic kidney disease",
          "severe or chronic lung disease",
          "severe or chronic digestive tract disease",
          "severe or chronic metabolic disease",
          "severe or chronic hematological disease",
          "severe or chronic skeletal disease",
          "severe or chronic immune system disease",
          "other diseases or medical conditions"
        ],
        "CONDITION_PATTERN": [
          "previous severe",
          "current chronic"
        ],
        "SEVERITY": "severe or chronic",
        "ANATOMICAL_LOCATION": [
          "central nervous system",
          "cardiovascular system",
          "liver",
          "kidney",
          "lung",
          "digestive tract",
          "metabolic system",
          "hematological system",
          "skeletal system",
          "immune system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "pose unacceptable risk",
          "affect study"
        ]
      },
      {
        "id": "CMB_2162",
        "nct_id": "NCT07038720",
        "raw_text": "Has undergone any surgery in the 3 months prior to screening, or planned to undergo surgery during the study period;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "surgery"
        ],
        "CONDITION_PATTERN": [
          "history",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2154",
        "nct_id": "NCT07038720",
        "raw_text": "Has presence of a surgical site, trauma site, severe mucosal ulceration, or incomplete fracture healing, or risk of gastrointestinal bleeding/perforation (e.g., active gastroduodenal ulcer, intestinal obstruction, ulcerative colitis, esophagogastric varices, gastrointestinal perforation within 6 months prior to screening), and risk of infection as assessed by the investigator;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "surgical site",
          "trauma site",
          "severe mucosal ulceration",
          "incomplete fracture healing",
          "risk of gastrointestinal bleeding",
          "risk of gastrointestinal perforation",
          "active gastroduodenal ulcer",
          "intestinal obstruction",
          "ulcerative colitis",
          "esophagogastric varices",
          "gastrointestinal perforation",
          "risk of infection"
        ],
        "CONDITION_PATTERN": [
          "current",
          "within 6 months prior to screening"
        ],
        "SEVERITY": [
          "severe",
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "surgical site",
          "trauma site",
          "mucosa",
          "fracture site",
          "gastrointestinal tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2148",
        "nct_id": "NCT07038720",
        "raw_text": "Has received hematopoietic stem cell transplantation, or organ transplantation in the past;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hematopoietic stem cell transplantation",
          "organ transplantation"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2131",
        "nct_id": "NCT06842199",
        "raw_text": "Exclusion Criteria: 7. The investigator has determined that there are clinically significant test results and that participation in this trial would pose an unacceptable risk to patients; Or the laboratory values of the subjects in the screening period meet the criteria specified in the protocol.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant test results",
          "laboratory abnormalities"
        ],
        "CONDITION_PATTERN": [
          "current",
          "screening period"
        ],
        "SEVERITY": "clinically significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "screening period"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "pose unacceptable risk",
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2126",
        "nct_id": "NCT06842199",
        "raw_text": "Exclusion Criteria: 2. Subjects with concurrent skin diseases that the investigator believes would interfere with the study assessments.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "concurrent skin diseases"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with study assessments"
        ]
      },
      {
        "id": "CMB_2117",
        "nct_id": "NCT06672393",
        "raw_text": "Any significant laboratory or procedure abnormalities that might place the subject at unacceptable risk during this study period",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "laboratory abnormalities",
          "procedure abnormalities"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "study period"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "place subject at unacceptable risk"
        ]
      },
      {
        "id": "CMB_2113",
        "nct_id": "NCT06672393",
        "raw_text": "Evidence of other skin conditions that would interfere with the evaluation of psoriasis",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin conditions"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with evaluation of psoriasis"
        ]
      },
      {
        "id": "CMB_2112",
        "nct_id": "NCT06672393",
        "raw_text": "Any condition possibly affecting the PK process of the study drug",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "condition affecting pharmacokinetics"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "affect PK process of study drug"
        ]
      },
      {
        "id": "CMB_2111",
        "nct_id": "NCT06672393",
        "raw_text": "Any major illness or evidence of unstable condition of major organ systems including psychiatric disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major illness",
          "unstable condition of major organ systems",
          "psychiatric disease"
        ],
        "CONDITION_PATTERN": [
          "current",
          "evidence of unstable condition"
        ],
        "SEVERITY": "major",
        "ANATOMICAL_LOCATION": [
          "major organ systems"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclude subject"
        ]
      },
      {
        "id": "CMB_2095",
        "nct_id": "NCT06926582",
        "raw_text": "Any significant laboratory or procedure abnormalities that might place the subject at unacceptable risk during this study period",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "laboratory abnormalities",
          "procedure abnormalities"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "study period"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "place subject at unacceptable risk"
        ]
      },
      {
        "id": "CMB_2091",
        "nct_id": "NCT06926582",
        "raw_text": "Evidence of other skin conditions that would interfere with the evaluation of psoriasis",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin conditions"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with evaluation of psoriasis"
        ]
      },
      {
        "id": "CMB_2090",
        "nct_id": "NCT06926582",
        "raw_text": "Any condition possibly affecting the PK process of the study drug",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Any condition affecting pharmacokinetics"
        ],
        "CONDITION_PATTERN": [
          null
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "May affect drug pharmacokinetics"
        ]
      },
      {
        "id": "CMB_2089",
        "nct_id": "NCT06926582",
        "raw_text": "Any major illness or evidence of unstable condition of major organ systems including psychiatric disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Major illness",
          "Unstable condition of major organ systems",
          "Psychiatric disease"
        ],
        "CONDITION_PATTERN": [
          "evidence"
        ],
        "SEVERITY": [
          "major",
          "unstable"
        ],
        "ANATOMICAL_LOCATION": [
          "major organ systems",
          "psychiatric"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "Increased risk due to unstable major organ system conditions"
        ]
      },
      {
        "id": "CMB_2075",
        "nct_id": "NCT07078695",
        "raw_text": "History or evidence of clinically significant disorders.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Clinically significant disorders"
        ],
        "CONDITION_PATTERN": [
          "history",
          "evidence"
        ],
        "SEVERITY": [
          "clinically significant"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "Potential impact on study participation or safety"
        ]
      },
      {
        "id": "CMB_2066",
        "nct_id": "NCT06846541",
        "raw_text": "Any acute or chronic illness/condition or evidence of an unstable clinical condition that in the Investigator's judgment will substantially increase the risk to the patient if they continue to receive ESK-001 treatment in this extension study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Acute illness",
          "Chronic illness",
          "Unstable clinical condition"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": [
          "acute",
          "chronic",
          "unstable"
        ],
        "TREATMENT_REQUIREMENT": [
          "ESK-001 treatment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "Substantially increased risk to patient if continuing treatment"
        ]
      },
      {
        "id": "CMB_2051",
        "nct_id": "NCT06143371",
        "raw_text": "Clinically significant illness, medical/surgical procedure, or trauma within 4 weeks before the first dose of study drug.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Clinically significant illness",
          "Medical procedure",
          "Surgical procedure",
          "Trauma"
        ],
        "CONDITION_PATTERN": [
          "clinically significant",
          "within timeframe"
        ],
        "SEVERITY": [
          "clinically significant"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "before first dose of study drug"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "May affect safety or study outcomes"
        ]
      },
      {
        "id": "CMB_2050",
        "nct_id": "NCT06143371",
        "raw_text": "History or presence of: Any other clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject's ability to participate in the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Clinically significant disease",
          "Clinically significant disorder"
        ],
        "CONDITION_PATTERN": [
          "history",
          "presence"
        ],
        "SEVERITY": [
          "clinically significant"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "Risk to subject",
          "Influence on study results",
          "Influence on subject's ability to participate"
        ]
      },
      {
        "id": "CMB_2048",
        "nct_id": "NCT06143371",
        "raw_text": "History or presence of: Clinically significant psychiatric disorders.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Psychiatric disorders"
        ],
        "CONDITION_PATTERN": [
          "history",
          "presence"
        ],
        "SEVERITY": [
          "clinically significant"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "IMPACT": [
          "Potential impact on safety or study participation"
        ]
      },
      {
        "id": "CMB_2047",
        "nct_id": "NCT06143371",
        "raw_text": "History or presence of: Significant kidney, liver, or urologic disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Kidney disease",
          "Liver disease",
          "Urologic disease"
        ],
        "CONDITION_PATTERN": [
          "history",
          "presence"
        ],
        "SEVERITY": [
          "significant"
        ],
        "ANATOMICAL_LOCATION": [
          "kidney",
          "liver",
          "urologic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Potential impact on safety or study participation"
        ]
      },
      {
        "id": "CMB_2036",
        "nct_id": "NCT07116967",
        "raw_text": "Participants must not have evidence of active cancer or history of cancer (solid organ or hematologic malignancy including myelodysplastic syndrome) or lymphoproliferative disease within the previous 5 years (other than resected cutaneous basal cell or squamous cell carcinoma, or carcinoma of cervix in situ that has been treated with no evidence of recurrence).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Active cancer",
          "History of cancer",
          "Lymphoproliferative disease"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "solid organ",
          "hematologic",
          "cutaneous basal cell carcinoma",
          "squamous cell carcinoma",
          "carcinoma of cervix in situ"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Exclusion due to cancer history or active disease"
        ]
      },
      {
        "id": "CMB_2035",
        "nct_id": "NCT07116967",
        "raw_text": "Participants must not have unstable CVD, defined as a recent clinical cardiovascular event (eg, unstable angina, rapid atrial fibrillation), or a cardiac hospitalization (eg, pacemaker implantation, HF) within 90 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Unstable cardiovascular disease",
          "Recent clinical cardiovascular event",
          "Cardiac hospitalization"
        ],
        "CONDITION_PATTERN": [
          "unstable",
          "recent"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system",
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 90,
          "unit": "days",
          "reference": "prior to Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Increased risk due to recent cardiovascular events"
        ]
      },
      {
        "id": "CMB_2034",
        "nct_id": "NCT07116967",
        "raw_text": "Participants must not have recent history of 1 of the following cardiovascular events: MI, stroke, or coronary revascularization, or VTE within 90 days prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Myocardial infarction",
          "Stroke",
          "Coronary revascularization",
          "Venous thromboembolism"
        ],
        "CONDITION_PATTERN": [
          "recent history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 90,
          "unit": "days",
          "reference": "prior to Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Increased risk due to recent cardiovascular events"
        ]
      },
      {
        "id": "CMB_2031",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Current cigarette smoker",
          "Hypertension",
          "Hyperlipidemia",
          "Diabetes mellitus type 1",
          "Diabetes mellitus type 2",
          "History of coronary intervention",
          "History of coronary artery bypass grafting",
          "History of myocardial infarction",
          "History of cardiac arrest",
          "History of hospitalization for unstable angina",
          "History of acute coronary syndrome",
          "History of stroke",
          "History of transient ischemic attack",
          "Obesity",
          "Family history of premature coronary heart disease",
          "Family history of sudden death"
        ],
        "CONDITION_PATTERN": [
          "current",
          "diagnosis",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Presence of cardiovascular risk factors"
        ]
      },
      {
        "id": "CMB_2030",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Current cigarette smoker",
          "Hypertension",
          "Hyperlipidemia",
          "Diabetes mellitus type 1",
          "Diabetes mellitus type 2",
          "History of coronary intervention",
          "History of coronary artery bypass grafting",
          "History of myocardial infarction",
          "History of cardiac arrest",
          "History of hospitalization for unstable angina",
          "History of acute coronary syndrome",
          "History of stroke",
          "History of transient ischemic attack",
          "Obesity",
          "Family history of premature coronary heart disease",
          "Family history of sudden death"
        ],
        "CONDITION_PATTERN": [
          "current",
          "diagnosis",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Presence of cardiovascular risk factors"
        ]
      },
      {
        "id": "CMB_2029",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Current cigarette smoker",
          "Hypertension",
          "Hyperlipidemia",
          "Diabetes mellitus type 1",
          "Diabetes mellitus type 2",
          "History of coronary intervention",
          "History of coronary artery bypass grafting",
          "History of myocardial infarction",
          "History of cardiac arrest",
          "History of hospitalization for unstable angina",
          "History of acute coronary syndrome",
          "History of stroke",
          "History of transient ischemic attack",
          "Obesity",
          "Family history of premature coronary heart disease",
          "Family history of sudden death"
        ],
        "CONDITION_PATTERN": [
          "current",
          "diagnosis",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Presence of cardiovascular risk factors"
        ]
      },
      {
        "id": "CMB_2028",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Current cigarette smoker",
          "Hypertension",
          "Hyperlipidemia",
          "Diabetes mellitus type 1",
          "Diabetes mellitus type 2",
          "History of coronary intervention",
          "History of coronary artery bypass grafting",
          "History of myocardial infarction",
          "History of cardiac arrest",
          "History of hospitalization for unstable angina",
          "History of acute coronary syndrome",
          "History of stroke",
          "History of transient ischemic attack",
          "Obesity",
          "Family history of premature coronary heart disease",
          "Family history of sudden death"
        ],
        "CONDITION_PATTERN": [
          "current",
          "diagnosis",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Presence of cardiovascular risk factors"
        ]
      },
      {
        "id": "CMB_2026",
        "nct_id": "NCT07116967",
        "raw_text": "Have at least 1 of the following cardiovascular risk factors: Current cigarette smoker, Diagnosis of hypertension, Diagnosis of hyperlipidemia, Diabetes mellitus type 1 or 2, History of one or more of the following cardiovascular events: Coronary intervention (PCI) or coronary artery bypass grafting (CABG), myocardial infarction (heart attack), cardiac arrest, hospitalization for unstable angina, acute coronary syndrome, stroke, or transient ischemic attack, Obesity, Family history of premature coronary heart disease or sudden death in a first-degree male relative younger than 55 years of age or in a first-degree female relative younger than 65 years of age.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "Current cigarette smoker",
          "Hypertension",
          "Hyperlipidemia",
          "Diabetes mellitus type 1",
          "Diabetes mellitus type 2",
          "History of coronary intervention",
          "History of coronary artery bypass grafting",
          "History of myocardial infarction",
          "History of cardiac arrest",
          "History of hospitalization for unstable angina",
          "History of acute coronary syndrome",
          "History of stroke",
          "History of transient ischemic attack",
          "Obesity",
          "Family history of premature coronary heart disease",
          "Family history of sudden death"
        ],
        "CONDITION_PATTERN": [
          "current",
          "diagnosis",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Presence of cardiovascular risk factors"
        ]
      },
      {
        "id": "CMB_2009",
        "nct_id": "NCT06833307",
        "raw_text": "History of depression and/or suicidal ideation or any suicidal behavior based on an assessment with the Columbina Suicide Severity Rating Scale (C-SSRS) at screening and baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Depression",
          "Suicidal ideation",
          "Suicidal behavior"
        ],
        "CONDITION_PATTERN": [
          "history",
          "based on assessment"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": [
          "screening",
          "baseline"
        ],
        "TREATMENT_REQUIREMENT": [
          "Assessment with Columbia Suicide Severity Rating Scale (C-SSRS)"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Potential risk for safety"
        ]
      },
      {
        "id": "CMB_2007",
        "nct_id": "NCT06833307",
        "raw_text": "History of congestive heart failure (New York Heart Association [NYHA] functional classification ≥III), cerebro-cardiovascular events, or serious bleeding events at screening and / or randomization that in the judgement of the Investigator prevents the subject from participating in the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Congestive heart failure",
          "Cerebro-cardiovascular events",
          "Serious bleeding events"
        ],
        "CONDITION_PATTERN": [
          "history",
          "symptoms"
        ],
        "SEVERITY": [
          "NYHA functional classification ≥III",
          "serious"
        ],
        "ANATOMICAL_LOCATION": [
          "heart",
          "cerebro-cardiovascular system"
        ],
        "TIMEFRAME": [
          "screening",
          "randomization"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "Prevents participation in study"
        ]
      },
      {
        "id": "CMB_2006",
        "nct_id": "NCT06833307",
        "raw_text": "At screening, history or symptoms of malignancy of any organ system, treated or untreated, within the past 5 years, regardless of whether there is evidence of local recurrence or metastases.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Malignancy of any organ system"
        ],
        "CONDITION_PATTERN": [
          "history",
          "symptoms"
        ],
        "ANATOMICAL_LOCATION": [
          "any organ system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "IMPACT": [
          "Exclusion due to recent malignancy"
        ]
      },
      {
        "id": "CMB_2005",
        "nct_id": "NCT06833307",
        "raw_text": "History of inflammatory bowel disease or have other ongoing active autoimmune diseases.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Inflammatory bowel disease",
          "Active autoimmune diseases"
        ],
        "CONDITION_PATTERN": [
          "history",
          "ongoing active"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal",
          "immune system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "Potential impact on safety or study participation"
        ]
      },
      {
        "id": "CMB_2004",
        "nct_id": "NCT06833307",
        "raw_text": "Presence of other skin conditions (e.g. skin infections, seborrheic dermatitis) that in the judgement of the Investigator could interfere with assessment of psoriasis.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "skin infections",
          "seborrheic dermatitis"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with assessment of psoriasis"
        ]
      },
      {
        "id": "CMB_1994",
        "nct_id": "NCT07130604",
        "raw_text": "Have other skin lesions that affect the evaluation of treatment outcomes, such as eczema.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin lesions",
          "eczema"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "affect evaluation of treatment outcomes"
        ]
      },
      {
        "id": "CMB_1975",
        "nct_id": "NCT06641089",
        "raw_text": "Participants who have an established diagnosis of arthritis mutilans.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arthritis mutilans"
        ],
        "CONDITION_PATTERN": [
          "established diagnosis"
        ],
        "ANATOMICAL_LOCATION": [
          "joints"
        ]
      },
      {
        "id": "CMB_1974",
        "nct_id": "NCT06641089",
        "raw_text": "Participants who have experienced a period of ≥3 weeks of unexplained diarrhea in the 24 weeks before the Baseline Visit.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "unexplained diarrhea"
        ],
        "CONDITION_PATTERN": [
          "experienced"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 24,
          "unit": "weeks",
          "reference": "Baseline Visit"
        }
      },
      {
        "id": "CMB_1973",
        "nct_id": "NCT06641089",
        "raw_text": "Participants with a diagnosis of inflammatory bowel disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease"
        ],
        "CONDITION_PATTERN": [
          "diagnosis"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract"
        ]
      },
      {
        "id": "CMB_1972",
        "nct_id": "NCT06641089",
        "raw_text": "Participants who have a diagnosis of chronic inflammatory conditions other than PsO or PsA.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic inflammatory conditions other than PsO or PsA"
        ],
        "CONDITION_PATTERN": [
          "diagnosis"
        ],
        "AMBIGUITY_FLAG": true
      },
      {
        "id": "CMB_1963",
        "nct_id": "NCT06077331",
        "raw_text": "Any significant laboratory or procedure abnormalities that might place the subject at unacceptable risk during this study period",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "significant laboratory abnormalities",
          "procedure abnormalities"
        ],
        "SEVERITY": "significant",
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "study period",
          "reference": null
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "place subject at unacceptable risk"
        ]
      },
      {
        "id": "CMB_1959",
        "nct_id": "NCT06077331",
        "raw_text": "Evidence of other skin conditions that would interfere with the evaluation of psoriasis",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin conditions"
        ],
        "CONDITION_PATTERN": [
          "evidence"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "IMPACT": [
          "interfere with evaluation of psoriasis"
        ]
      },
      {
        "id": "CMB_1958",
        "nct_id": "NCT06077331",
        "raw_text": "Any condition possibly affecting the PK process of the study drug",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "condition possibly affecting PK process"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "affect pharmacokinetics of study drug"
        ]
      },
      {
        "id": "CMB_1957",
        "nct_id": "NCT06077331",
        "raw_text": "Any major illness or evidence of unstable condition of major organ systems including psychiatric disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major illness",
          "unstable condition of major organ systems",
          "psychiatric disease"
        ],
        "CONDITION_PATTERN": [
          "evidence"
        ],
        "SEVERITY": "major",
        "ANATOMICAL_LOCATION": [
          "major organ systems"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "increase risk to subject"
        ]
      },
      {
        "id": "CMB_1948",
        "nct_id": "NCT06865105",
        "raw_text": "History of fibromyalgia, any arthritis with onset prior to age 17 years, or current diagnosis of inflammatory joint disease other than psoriatic arthritis (PsA) (including but not limited to rheumatoid arthritis, gout, overlap connective tissue diseases, scleroderma, polymyositis, dermatomyositis, systemic lupus erythematosus).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "fibromyalgia",
          "arthritis with onset prior to age 17 years",
          "inflammatory joint disease other than psoriatic arthritis",
          "rheumatoid arthritis",
          "gout",
          "overlap connective tissue diseases",
          "scleroderma",
          "polymyositis",
          "dermatomyositis",
          "systemic lupus erythematosus"
        ],
        "CONDITION_PATTERN": [
          "history",
          "current diagnosis"
        ],
        "ANATOMICAL_LOCATION": [
          "joints"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1947",
        "nct_id": "NCT06865105",
        "raw_text": "Active skin disease other than psoriasis (PsO) which could interfere with the assessment of PsO.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active skin disease other than psoriasis"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "IMPACT": [
          "interfere with assessment of psoriasis"
        ]
      },
      {
        "id": "CMB_1945",
        "nct_id": "NCT06865105",
        "raw_text": "Participants who have had major surgery performed within 12 weeks prior to randomization or plan to have a major surgery during conduct of the study (e.g., aneurysm removal, stomach ligation).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "had",
          "plan to have"
        ],
        "SEVERITY": "major",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 12,
          "unit": "weeks",
          "reference": "randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "no major surgery within 12 weeks prior to randomization",
          "no major surgery planned during study"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1927",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have cancer or history of cancer (solid organ or hematologic including myelodysplastic syndrome) or lymphoproliferative disease within the previous 5 years.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cancer",
          "lymphoproliferative disease",
          "myelodysplastic syndrome"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "solid organ",
          "hematologic"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1926",
        "nct_id": "NCT06979453",
        "raw_text": "Participants must not have any major illness/condition or evidence of an unstable clinical condition (eg, renal, hepatic, hematologic, gastrointestinal, endocrine, pulmonary, psychiatric, neurologic, immunologic, or local active infection/infectious illness) that, in the investigator's judgment or after consultation with the Sponsor's Medical Monitor, will substantially increase the risk to the participant if he or she participates in the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major illness/condition",
          "unstable clinical condition",
          "renal disease",
          "hepatic disease",
          "hematologic disease",
          "gastrointestinal disease",
          "endocrine disease",
          "pulmonary disease",
          "psychiatric disease",
          "neurologic disease",
          "immunologic disease",
          "local active infection",
          "infectious illness"
        ],
        "CONDITION_PATTERN": [
          "evidence"
        ],
        "SEVERITY": "major",
        "ANATOMICAL_LOCATION": [
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "psychiatric",
          "neurologic",
          "immunologic",
          "local"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "substantially increase risk to participant"
        ]
      },
      {
        "id": "CMB_1906",
        "nct_id": "NCT07102888",
        "raw_text": "Subjects with any other persistent active autoimmune disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "persistent active autoimmune disease"
        ],
        "CONDITION_PATTERN": [
          "active"
        ]
      },
      {
        "id": "CMB_1905",
        "nct_id": "NCT07102888",
        "raw_text": "Subjects have other skin diseases or conditions that may affect the evaluation of the relevant endpoints of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin diseases or conditions"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "IMPACT": [
          "may affect evaluation of relevant endpoints"
        ]
      },
      {
        "id": "CMB_1889",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 21. Is currently being treated for a thyroid condition or have abnormalities in TSH, free T4 or T3 at Screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "thyroid condition",
          "abnormalities in TSH",
          "abnormalities in free T4",
          "abnormalities in T3"
        ],
        "CONDITION_PATTERN": [
          "currently being treated",
          "abnormalities at Screening"
        ],
        "ANATOMICAL_LOCATION": [
          "thyroid"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": 0,
          "unit": "time",
          "reference": "Screening"
        },
        "TREATMENT_REQUIREMENT": [
          "currently being treated for thyroid condition"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1886",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 18. Has had a major surgery within 8 weeks of Screening or has such surgery planned during the time participant is expected to participate in the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "had",
          "planned"
        ],
        "SEVERITY": "major",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 8,
          "unit": "weeks",
          "reference": "Screening"
        },
        "TREATMENT_REQUIREMENT": [
          "no major surgery within 8 weeks of Screening",
          "no major surgery planned during study"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1885",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 17. Has unstable suicidal ideation or suicidal behavior, or a suicide attempt (including interrupted, aborted attempts and preparatory behaviors for suicide attempt), in the last 6 months",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "unstable suicidal ideation",
          "suicidal behavior",
          "suicide attempt",
          "interrupted suicide attempt",
          "aborted suicide attempt",
          "preparatory behaviors for suicide attempt"
        ],
        "CONDITION_PATTERN": [
          "unstable",
          "in last 6 months"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "current"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1884",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 16. Has a transplanted organ (with the exception of a corneal transplant > 3 months before the first study drug administration)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "transplanted organ"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TIMEFRAME": {
          "relation": "greater than",
          "amount": 3,
          "unit": "months",
          "reference": "first study drug administration"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1883",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 15. Has a history of lymphoproliferative disease, including lymphoma, leukemia, monoclonal gammopathy, or signs/symptoms suggestive of possible lymphoproliferative disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "lymphoproliferative disease",
          "lymphoma",
          "leukemia",
          "monoclonal gammopathy"
        ],
        "CONDITION_PATTERN": [
          "history",
          "suggestive signs/symptoms"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1882",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 14. Currently has a known malignancy or has a history of malignancy within 5 years before screening with the exception of non-melanoma skin cancer curatively treated with no evidence of recurrence for at least 3 months before the first study drug administration or cervical carcinoma in situ of the cervix that has been treated with no evidence of recurrence for at least 3 years before the first study drug administration",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy",
          "non-melanoma skin cancer",
          "cervical carcinoma in situ"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "curatively treated with no evidence of recurrence for at least 3 months",
          "treated with no evidence of recurrence for at least 3 years"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1881",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 13. Has unstable cardiovascular disease, defined as a recent clinical deterioration in the last 3 months (e.g., unstable angina, atrial fibrillation) or a cardiac hospitalization within the last 3 months",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular disease",
          "unstable angina",
          "atrial fibrillation"
        ],
        "CONDITION_PATTERN": [
          "unstable",
          "recent clinical deterioration",
          "cardiac hospitalization"
        ],
        "SEVERITY": "unstable",
        "ANATOMICAL_LOCATION": [
          "cardiovascular system",
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1880",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 12. Has a current history of severe, uncontrolled or progressive systemic medical conditions including renal, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric, or metabolic disturbances",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal disease",
          "cardiac disease",
          "vascular disease",
          "pulmonary disease",
          "gastrointestinal disease",
          "endocrine disease",
          "neurologic disease",
          "hematologic disease",
          "rheumatologic disease",
          "psychiatric disease",
          "metabolic disturbances"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "severe, uncontrolled or progressive",
        "ANATOMICAL_LOCATION": [
          "renal",
          "cardiac",
          "vascular",
          "pulmonary",
          "gastrointestinal",
          "endocrine",
          "neurologic",
          "hematologic",
          "rheumatologic",
          "psychiatric",
          "metabolic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1879",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 11. Has evidence of skin conditions that could interfere with clinical assessments of psoriasis (e.g. eczema, seborrheic dermatitis, or pityriasis rosea)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "eczema",
          "seborrheic dermatitis",
          "pityriasis rosea"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "interference with clinical assessments of psoriasis",
          "exclusion"
        ]
      },
      {
        "id": "CMB_1872",
        "nct_id": "NCT06723171",
        "raw_text": "Exclusion Criteria: 4. Has confounding diagnoses including but not limited to palmoplantar pustulosis, eczematous dermatitis, contact/irritant dermatitis, acquired keratoderma",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "palmoplantar pustulosis",
          "eczematous dermatitis",
          "contact dermatitis",
          "irritant dermatitis",
          "acquired keratoderma"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "confounding diagnoses",
          "exclusion"
        ]
      },
      {
        "id": "CMB_1852",
        "nct_id": "NCT06620692",
        "raw_text": "Patients who have the medical history of malignancy of any organ system (other than cervical carcinoma in situ or successfully treated non-melanoma skin cancer) within 5 years prior to study entry.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "any organ system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to study entry"
        },
        "TREATMENT_REQUIREMENT": [
          "exceptions: cervical carcinoma in situ or successfully treated non-melanoma skin cancer"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1849",
        "nct_id": "NCT06620692",
        "raw_text": "Patients with chronic condition(s) which either is not stable or not well controlled.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic condition"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "not stable or not well controlled",
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1846",
        "nct_id": "NCT06620692",
        "raw_text": "Patients who have any concurrent skin condition that will interfere with assessment of treatment.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "skin condition"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "interference with assessment of treatment",
          "exclusion"
        ]
      },
      {
        "id": "CMB_1825",
        "nct_id": "NCT06100744",
        "raw_text": "Have any other autoimmune disease, rheumatic disease (including systemic Juvenile idiopathic arthritis [JIA], rheumatoid factor-positive or rheumatoid factor-negative polyarticular JIA, extended oligoarticular JIA, persistent oligoarticular JIA, enthesitis-related arthritis, and undifferentiated JIA).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "autoimmune disease",
          "rheumatic disease",
          "systemic Juvenile idiopathic arthritis",
          "rheumatoid factor-positive polyarticular JIA",
          "rheumatoid factor-negative polyarticular JIA",
          "extended oligoarticular JIA",
          "persistent oligoarticular JIA",
          "enthesitis-related arthritis",
          "undifferentiated JIA"
        ],
        "CONDITION_PATTERN": [
          "current",
          "any"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1821",
        "nct_id": "NCT07129382",
        "raw_text": "Any condition deemed unsuitable by the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "any condition"
        ],
        "CONDITION_PATTERN": [
          "any"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1797",
        "nct_id": "NCT07129382",
        "raw_text": "History of malignancy or lymphoproliferative disorders within 5 years (exceptions: basal cell carcinoma, localized squamous cell carcinoma, or cervical carcinoma in situ cured ≥1 year).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy",
          "lymphoproliferative disorders",
          "basal cell carcinoma",
          "localized squamous cell carcinoma",
          "cervical carcinoma in situ"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": null
        },
        "TREATMENT_REQUIREMENT": [
          "exceptions: basal cell carcinoma, localized squamous cell carcinoma, or cervical carcinoma in situ cured ≥1 year"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1796",
        "nct_id": "NCT07129382",
        "raw_text": "NYHA Class III/IV heart failure at screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "heart failure"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "NYHA Class III/IV",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1795",
        "nct_id": "NCT07129382",
        "raw_text": "Myocardial infarction, unstable angina, TIA, stroke, PCI, or CABG within 6 months before screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "myocardial infarction",
          "unstable angina",
          "transient ischemic attack",
          "stroke",
          "percutaneous coronary intervention",
          "coronary artery bypass graft"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "heart",
          "brain",
          "vascular system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1794",
        "nct_id": "NCT07129382",
        "raw_text": "Uncontrolled hypertension at screening (SBP >160 mmHg or DBP >100 mmHg).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hypertension"
        ],
        "CONDITION_PATTERN": [
          "current",
          "uncontrolled"
        ],
        "SEVERITY": "uncontrolled",
        "ANATOMICAL_LOCATION": [
          "cardiovascular system"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "SBP >160 mmHg or DBP >100 mmHg"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1792",
        "nct_id": "NCT07129382",
        "raw_text": "Major surgery within 2 months before randomization or planned during the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "recent",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "months",
          "reference": "before randomization"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1790",
        "nct_id": "NCT07129382",
        "raw_text": "Immune-mediated diseases requiring systemic therapy (e.g., inflammatory bowel disease), except NSAIDs.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "immune-mediated diseases",
          "inflammatory bowel disease"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "TREATMENT_REQUIREMENT": [
          "requiring systemic therapy",
          "except NSAIDs"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1789",
        "nct_id": "NCT07129382",
        "raw_text": "Presence of other skin conditions that in the judgement of the Investigator could interfere with study assessment.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin conditions"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "interference with study assessment",
          "exclusion"
        ]
      },
      {
        "id": "CMB_1774",
        "nct_id": "NCT06058546",
        "raw_text": "With a serious, progressive, or uncontrolled disease, including but not limited to a disease of the immune (such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease), endocrine, hematological, urinary, hepatobiliary, and respiratory, nervous, psychiatric, cardiovascular, gastrointestinal, or infectious system, a malignancy.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious disease",
          "progressive disease",
          "uncontrolled disease",
          "immune system disease",
          "rheumatoid arthritis",
          "systemic lupus erythematosus",
          "inflammatory bowel disease",
          "endocrine disease",
          "hematological disease",
          "urinary disease",
          "hepatobiliary disease",
          "respiratory disease",
          "nervous system disease",
          "psychiatric disease",
          "cardiovascular disease",
          "gastrointestinal disease",
          "infectious disease",
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "serious, progressive, or uncontrolled",
        "ANATOMICAL_LOCATION": [
          "immune system",
          "endocrine",
          "hematological",
          "urinary",
          "hepatobiliary",
          "respiratory",
          "nervous system",
          "psychiatric",
          "cardiovascular",
          "gastrointestinal",
          "infectious system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1756",
        "nct_id": "NCT06376474",
        "raw_text": "Those with a history of epileptic seizures.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "epileptic seizures"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1737",
        "nct_id": "NCT06376474",
        "raw_text": "Patients who had severe gastrointestinal diseases (except secondary gastrointestinal diseases caused by hepatitis) or had digestive system surgery within 3 months before screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "gastrointestinal diseases",
          "digestive system surgery"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract",
          "digestive system"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1736",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has a history of depression or suicidal tendencies.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "depression",
          "suicidal tendencies"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1735",
        "nct_id": "NCT06376474",
        "raw_text": "Any of the following occurred within 6 months prior to study entry: Myocardial infarction.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "myocardial infarction"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to study entry"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1734",
        "nct_id": "NCT06376474",
        "raw_text": "In addition to the disease causing liver function impairment, patients with serious acute or chronic diseases of other important organs within 1 year before screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious acute diseases",
          "serious chronic diseases"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "important organs"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "year",
          "reference": "before screening"
        },
        "LOGICAL_OPERATOR": "AND",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1733",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: complications such as hepatic encephalopathy.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hepatic encephalopathy"
        ],
        "CONDITION_PATTERN": [
          "current",
          "complication"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1732",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: biliary cirrhosis, biliary obstruction.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "biliary cirrhosis",
          "biliary obstruction"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "biliary system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1731",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: hepatorenal syndrome.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hepatorenal syndrome"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "liver",
          "kidney"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1730",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: suspected or confirmed liver cancer or other malignant tumors.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "liver cancer",
          "malignant tumors"
        ],
        "CONDITION_PATTERN": [
          "suspected",
          "confirmed",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "LOGICAL_OPERATOR": "OR",
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1729",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: severe portal hypertension or transsurgical portosystemic shunt.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "portal hypertension",
          "transsurgical portosystemic shunt"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "portal vein",
          "vascular system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1728",
        "nct_id": "NCT06376474",
        "raw_text": "The subject has any of the following conditions: previous liver transplantation.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "liver transplantation"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1725",
        "nct_id": "NCT06376474",
        "raw_text": "Chronic stable liver impairment (no clinically significant change in disease status as judged by the investigator to have occurred for at least 28 days (or up to 14 days for patients with moderate liver function) before taking the study drug) due to primary liver disease.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "liver impairment"
        ],
        "CONDITION_PATTERN": [
          "chronic stable"
        ],
        "SEVERITY": "stable",
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 28,
          "unit": "days",
          "reference": "before taking study drug"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "inclusion"
        ]
      },
      {
        "id": "CMB_1718",
        "nct_id": "NCT06807424",
        "raw_text": "Has other inflammatory diseases that might confound the evaluations of benefit of icotrokinra therapy, including but not limited to rheumatoid arthritis (RA), systemic lupus erythematosus, or Lyme disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "rheumatoid arthritis",
          "systemic lupus erythematosus",
          "Lyme disease",
          "other inflammatory diseases"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "immune system"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1717",
        "nct_id": "NCT06807424",
        "raw_text": "Has known allergies, hypersensitivity, or intolerance to icotrokinra or its excipients.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "allergies",
          "hypersensitivity",
          "intolerance"
        ],
        "CONDITION_PATTERN": [
          "known"
        ],
        "TREATMENT_REQUIREMENT": [
          "to icotrokinra or its excipients"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1716",
        "nct_id": "NCT06807424",
        "raw_text": "Currently has a malignancy or has a history of malignancy within 5 years prior to screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1715",
        "nct_id": "NCT06807424",
        "raw_text": "Has a history or current signs or symptoms of severe, progressive, or uncontrolled renal, hepatic, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic (with the exception of PsA), psychiatric, genitourinary, or metabolic disturbances.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal disturbances",
          "hepatic disturbances",
          "cardiac disturbances",
          "vascular disturbances",
          "pulmonary disturbances",
          "gastrointestinal disturbances",
          "endocrine disturbances",
          "neurologic disturbances",
          "hematologic disturbances",
          "rheumatologic disturbances",
          "psychiatric disturbances",
          "genitourinary disturbances",
          "metabolic disturbances"
        ],
        "CONDITION_PATTERN": [
          "history",
          "current",
          "signs",
          "symptoms"
        ],
        "SEVERITY": "severe, progressive, uncontrolled",
        "ANATOMICAL_LOCATION": [
          "renal",
          "hepatic",
          "cardiac",
          "vascular",
          "pulmonary",
          "gastrointestinal",
          "endocrine",
          "neurologic",
          "hematologic",
          "rheumatologic",
          "psychiatric",
          "genitourinary",
          "metabolic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1707",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has a history of psychiatric inpatient hospitalization within the past year before enrolling into the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psychiatric inpatient hospitalization"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "year",
          "reference": "before enrolling"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1706",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant diagnosed with severe depression in the past 6 months (prior to Screening) should be excluded",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "depression"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1705",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has the presence of active suicidal ideation, or positive suicide behavior",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "suicidal ideation",
          "suicide behavior"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1699",
        "nct_id": "NCT06425549",
        "raw_text": "Study participant has a history of inflammatory bowel disease (IBD) or symptoms suggestive of IBD",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease",
          "symptoms suggestive of inflammatory bowel disease"
        ],
        "CONDITION_PATTERN": [
          "history",
          "current symptoms"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1684",
        "nct_id": "NCT07029516",
        "raw_text": "Patients with conditions known to cause abnormal nail appearance, immunosuppression and signs of severe peripheral circulatory insufficiency.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "conditions known to cause abnormal nail appearance",
          "immunosuppression",
          "severe peripheral circulatory insufficiency"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "nail",
          "peripheral circulation"
        ],
        "LOGICAL_OPERATOR": "AND",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "abnormal nail appearance",
          "immunosuppression",
          "severe peripheral circulatory insufficiency"
        ]
      },
      {
        "id": "CMB_1680",
        "nct_id": "NCT06522035",
        "raw_text": "Major medical condition as detailed in the protocol.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major medical condition"
        ],
        "SEVERITY": "major",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "major medical condition"
        ]
      },
      {
        "id": "CMB_1678",
        "nct_id": "NCT06522035",
        "raw_text": "Other limb pain of unknown etiology.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "limb pain"
        ],
        "CONDITION_PATTERN": [
          "unknown etiology"
        ],
        "ANATOMICAL_LOCATION": [
          "limb"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "limb pain of unknown cause"
        ]
      },
      {
        "id": "CMB_1677",
        "nct_id": "NCT06522035",
        "raw_text": "Concomitant rheumatic, inflammatory or autoimmune disease other than PsA.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "rheumatic disease",
          "inflammatory disease",
          "autoimmune disease"
        ],
        "CONDITION_PATTERN": [
          "concomitant"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion of other rheumatic, inflammatory or autoimmune diseases except PsA"
        ]
      },
      {
        "id": "CMB_1675",
        "nct_id": "NCT06522035",
        "raw_text": "Findings of acute fractures, severe loss of bone density, chondrocalcinosis and/or severe bone or joint deformity in the target joint.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute fractures",
          "severe loss of bone density",
          "chondrocalcinosis",
          "severe bone deformity",
          "severe joint deformity"
        ],
        "CONDITION_PATTERN": [
          "findings in target joint"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "target joint",
          "bone",
          "joint"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "acute fractures",
          "severe bone/joint deformity",
          "severe loss of bone density",
          "chondrocalcinosis"
        ]
      },
      {
        "id": "CMB_1674",
        "nct_id": "NCT06522035",
        "raw_text": "Any significant injury to the target joint within the 6 months prior to treatment, or any surgery to the target joint within the 12 months prior to treatment.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "significant injury",
          "surgery"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "target joint"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to treatment"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "recent injury or surgery to target joint"
        ]
      },
      {
        "id": "CMB_1669",
        "nct_id": "NCT06522035",
        "raw_text": "Diagnosed with PsA.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "PsA"
        ],
        "CONDITION_PATTERN": [
          "diagnosed"
        ],
        "IMPACT": [
          "diagnosed PsA"
        ]
      },
      {
        "id": "CMB_1668",
        "nct_id": "NCT06506916",
        "raw_text": "Control Cohort: Study participant has any systemic disease (eg, cardiovascular, neurological, renal, liver, metabolic, gastrointestinal, hematological, coagulation disorders, immunological) considered by the investigator to be uncontrolled, unstable, or likely to progress to a clinically significant degree during the course of the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular disease",
          "neurological disease",
          "renal disease",
          "liver disease",
          "metabolic disease",
          "gastrointestinal disease",
          "hematological disorder",
          "coagulation disorder",
          "immunological disease"
        ],
        "CONDITION_PATTERN": [
          "systemic disease",
          "uncontrolled",
          "unstable",
          "likely to progress"
        ],
        "ANATOMICAL_LOCATION": [
          "systemic"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "study duration",
          "reference": "course of the study"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "uncontrolled or unstable systemic disease",
          "likely clinical progression"
        ]
      },
      {
        "id": "CMB_1663",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has any medical or psychiatric condition that, in the opinion of the investigator, could jeopardize or would compromise the study participant's ability to participate in this study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "medical condition",
          "psychiatric condition"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "jeopardize or compromise study participation"
        ]
      },
      {
        "id": "CMB_1662",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has any active malignancy or history of malignancy within 5 years prior to the Screening Visit EXCEPT treated and considered cured cutaneous squamous or basal cell carcinoma, or in situ cervical cancer",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy",
          "cutaneous squamous cell carcinoma",
          "basal cell carcinoma",
          "in situ cervical cancer"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history within 5 years",
          "treated and considered cured"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to Screening Visit"
        },
        "TREATMENT_REQUIREMENT": [
          "treated and considered cured for cutaneous squamous or basal cell carcinoma or in situ cervical cancer"
        ],
        "LOGICAL_OPERATOR": "EXCEPT",
        "IMPACT": [
          "active malignancy",
          "history of malignancy within 5 years except specified cured cancers"
        ]
      },
      {
        "id": "CMB_1661",
        "nct_id": "NCT06506916",
        "raw_text": "Study participant has a verified diagnosis of inflammatory conditions other than PSO or PsA, including but not limited to rheumatoid arthritis (RA), sarcoidosis, inflammatory bowel diseases (IBD), or systemic lupus erythematosus.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory conditions other than PSO or PsA",
          "rheumatoid arthritis",
          "sarcoidosis",
          "inflammatory bowel diseases",
          "systemic lupus erythematosus"
        ],
        "CONDITION_PATTERN": [
          "verified diagnosis"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "presence of other inflammatory conditions"
        ]
      },
      {
        "id": "CMB_1619",
        "nct_id": "NCT06640257",
        "raw_text": "Existence of any of the following medical history or comorbid diseases: drug-induced psoriasis; other active inflammatory diseases or autoimmune diseases; history of organ transplantation; history of lymphocytic proliferation; severe infections, etc.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "drug-induced psoriasis",
          "active inflammatory diseases",
          "autoimmune diseases",
          "history of organ transplantation",
          "history of lymphocytic proliferation",
          "severe infections"
        ],
        "CONDITION_PATTERN": [
          "history",
          "comorbid diseases"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "presence of listed comorbidities or history"
        ]
      },
      {
        "id": "CMB_1618",
        "nct_id": "NCT06640257",
        "raw_text": "Existence of any of the following medical history or comorbid diseases: drug-induced psoriasis; other active inflammatory diseases or autoimmune diseases; history of organ transplantation; history of lymphocytic proliferation; severe infections, etc.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "drug-induced psoriasis",
          "active inflammatory diseases",
          "autoimmune diseases",
          "history of organ transplantation",
          "history of lymphocytic proliferation",
          "severe infections"
        ],
        "CONDITION_PATTERN": [
          "history",
          "comorbid diseases"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "presence of listed comorbidities or history"
        ]
      },
      {
        "id": "CMB_1617",
        "nct_id": "NCT06640257",
        "raw_text": "Existence of any of the following medical history or comorbid diseases: drug-induced psoriasis; other active inflammatory diseases or autoimmune diseases; history of organ transplantation; history of lymphocytic proliferation; severe infections, etc.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "drug-induced psoriasis",
          "active inflammatory diseases",
          "autoimmune diseases",
          "history of organ transplantation",
          "history of lymphocytic proliferation",
          "severe infections"
        ],
        "CONDITION_PATTERN": [
          "history",
          "comorbid diseases"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "presence of listed comorbidities or history"
        ]
      },
      {
        "id": "CMB_1616",
        "nct_id": "NCT06640257",
        "raw_text": "Existence of any of the following medical history or comorbid diseases: drug-induced psoriasis; other active inflammatory diseases or autoimmune diseases; history of organ transplantation; history of lymphocytic proliferation; severe infections, etc.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "drug-induced psoriasis",
          "active inflammatory diseases",
          "autoimmune diseases",
          "history of organ transplantation",
          "history of lymphocytic proliferation",
          "severe infections"
        ],
        "CONDITION_PATTERN": [
          "history",
          "comorbid diseases"
        ],
        "SEVERITY": "severe",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "presence of listed comorbidities or history"
        ]
      },
      {
        "id": "CMB_1609",
        "nct_id": "NCT04123795",
        "raw_text": "Study participant has a history of severe major depression or suicide attempt (including an actual attempt, interrupted attempt, or aborted attempt), or has had suicidal ideation in the past 6 months as indicated by a positive response ('Yes') to either Question 4 or Question 5 of the 'Screening/Baseline' version of the Columbia Suicide Severity Rating Scale (CSSRS) at Screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major depression",
          "suicide attempt",
          "suicidal ideation"
        ],
        "CONDITION_PATTERN": [
          "history",
          "past 6 months"
        ],
        "SEVERITY": "severe",
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to Screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "severe major depression or suicide risk"
        ]
      },
      {
        "id": "CMB_1592",
        "nct_id": "NCT06562894",
        "raw_text": "Combined with active lipid-lowering drugs but poorly controlled hyperlipidemia: total cholesterol (TC)≥ 6.2mmol/L or low-density lipoprotein cholesterol (LDL-C)≥3.4mmol/L; or familial hypercholesterolemia (FH);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hyperlipidemia",
          "familial hypercholesterolemia"
        ],
        "CONDITION_PATTERN": [
          "poorly controlled",
          "combined with active lipid-lowering drugs"
        ],
        "TREATMENT_REQUIREMENT": [
          "active lipid-lowering drugs"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "poorly controlled hyperlipidemia despite treatment"
        ]
      },
      {
        "id": "CMB_1591",
        "nct_id": "NCT06562894",
        "raw_text": "Participants with a history of arterial or venous thrombosis or high risk factors for thrombosis within 6 months before the first dose of study drug;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arterial thrombosis",
          "venous thrombosis",
          "high risk factors for thrombosis"
        ],
        "CONDITION_PATTERN": [
          "history",
          "within 6 months"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to first dose"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "recent thrombosis or high risk"
        ]
      },
      {
        "id": "CMB_1590",
        "nct_id": "NCT06562894",
        "raw_text": "Having unstable cardiovascular disease defined as presence of a clinical cardiovascular event in the last 3 months or hospitalized for heart disease within the last 3 months; or NYHA≥grade 3, or abnormal ECG suggesting clinically significant and assessed by the investigator as carrying unforeseen risks;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular disease",
          "heart disease",
          "abnormal ECG"
        ],
        "CONDITION_PATTERN": [
          "unstable",
          "clinical cardiovascular event",
          "hospitalized",
          "NYHA grade ≥3",
          "clinically significant ECG abnormalities"
        ],
        "SEVERITY": "unstable",
        "ANATOMICAL_LOCATION": [
          "cardiovascular system",
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "unstable cardiovascular disease",
          "recent cardiovascular event or hospitalization",
          "high NYHA grade",
          "clinically significant ECG abnormalities"
        ]
      },
      {
        "id": "CMB_1589",
        "nct_id": "NCT06562894",
        "raw_text": "Uncontrolled hypertension, systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg after systemic treatment;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hypertension"
        ],
        "CONDITION_PATTERN": [
          "uncontrolled after systemic treatment"
        ],
        "SEVERITY": "uncontrolled",
        "ANATOMICAL_LOCATION": [
          "blood pressure"
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic treatment"
        ],
        "IMPACT": [
          "uncontrolled hypertension"
        ]
      },
      {
        "id": "CMB_1588",
        "nct_id": "NCT06562894",
        "raw_text": "History of malignancy or lymphoproliferative disease;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy",
          "lymphoproliferative disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1587",
        "nct_id": "NCT06562894",
        "raw_text": "Symptoms or signs of progressive or uncontrolled kidney, liver, blood, gastrointestinal, endocrine, lung, heart, neurological, psychiatric, or brain disease, or with other chronic diseases that the investigator has determined are not suitable for participation in this clinical trial;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "kidney disease",
          "liver disease",
          "blood disease",
          "gastrointestinal disease",
          "endocrine disease",
          "lung disease",
          "heart disease",
          "neurological disease",
          "psychiatric disease",
          "brain disease",
          "other chronic diseases"
        ],
        "CONDITION_PATTERN": [
          "progressive",
          "uncontrolled",
          "active"
        ],
        "SEVERITY": "progressive or uncontrolled",
        "ANATOMICAL_LOCATION": [
          "kidney",
          "liver",
          "blood",
          "gastrointestinal",
          "endocrine",
          "lung",
          "heart",
          "neurological",
          "psychiatric",
          "brain"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1586",
        "nct_id": "NCT06562894",
        "raw_text": "Organ transplantation (except corneal transplantation more than 3 months before the initiation of the investigational drug);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "organ transplantation"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "more than",
          "amount": 3,
          "unit": "months",
          "reference": "initiation of investigational drug"
        },
        "TREATMENT_REQUIREMENT": [
          "except corneal transplantation"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1585",
        "nct_id": "NCT06562894",
        "raw_text": "Major surgery within 8 weeks prior to first dose of the study drug or planned surgery during the study;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "recent",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 8,
          "unit": "weeks",
          "reference": "prior to first dose of study drug"
        },
        "TREATMENT_REQUIREMENT": [
          "no planned surgery during study"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1572",
        "nct_id": "NCT06562894",
        "raw_text": "Other active scalp or systemic diseases that may cause severe alopecia or affect the clinical evaluation of alopecia areata;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active scalp diseases",
          "active systemic diseases"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "scalp",
          "systemic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "may affect clinical evaluation of alopecia areata"
        ]
      },
      {
        "id": "CMB_1571",
        "nct_id": "NCT06562894",
        "raw_text": "Alopecia caused by other reasons;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "alopecia caused by other reasons"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1568",
        "nct_id": "NCT06562894",
        "raw_text": "The current episode of hair loss was less than 10 years ago, and there was no evidence of spontaneous hair regrowth within 6 months before screening (the overall duration of alopecia areata more than 10 years could be included);",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "hair loss"
        ],
        "CONDITION_PATTERN": [
          "current episode"
        ],
        "TIMEFRAME": {
          "relation": "less than",
          "amount": 10,
          "unit": "years",
          "reference": "current episode"
        },
        "TREATMENT_REQUIREMENT": [
          "no evidence of spontaneous hair regrowth within 6 months before screening"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "inclusion criteria"
        ]
      },
      {
        "id": "CMB_1567",
        "nct_id": "NCT06562894",
        "raw_text": "Clinical diagnosis of alopecia areata,with at least 50% scalp hair loss，as defined by a SALT score ≥50 at screening and baseline visit;",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "alopecia areata"
        ],
        "CONDITION_PATTERN": [
          "clinical diagnosis",
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "scalp"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening and baseline visit"
        },
        "TREATMENT_REQUIREMENT": [
          "at least 50% scalp hair loss defined by SALT score ≥50"
        ],
        "IMPACT": [
          "inclusion criteria"
        ]
      },
      {
        "id": "CMB_1562",
        "nct_id": "NCT06878404",
        "raw_text": "Has other inflammatory diseases that might confound the evaluations of benefit of icotrokinra therapy, including but not limited to rheumatoid arthritis (RA), systemic lupus erythematosus, or lyme disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory diseases",
          "rheumatoid arthritis",
          "systemic lupus erythematosus",
          "lyme disease"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "may confound evaluation of icotrokinra therapy benefit"
        ]
      },
      {
        "id": "CMB_1561",
        "nct_id": "NCT06878404",
        "raw_text": "Has known allergies, hypersensitivity, or intolerance to icotrokinra or its excipients",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "allergies",
          "hypersensitivity",
          "intolerance to icotrokinra or its excipients"
        ],
        "CONDITION_PATTERN": [
          "known"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1560",
        "nct_id": "NCT06878404",
        "raw_text": "Has a history or current signs or symptoms of severe, progressive, or uncontrolled renal, hepatic, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic (with the exception of PsA), psychiatric, genitourinary, or metabolic disturbances",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal disturbances",
          "hepatic disturbances",
          "cardiac disturbances",
          "vascular disturbances",
          "pulmonary disturbances",
          "gastrointestinal disturbances",
          "endocrine disturbances",
          "neurologic disturbances",
          "hematologic disturbances",
          "rheumatologic disturbances",
          "psychiatric disturbances",
          "genitourinary disturbances",
          "metabolic disturbances"
        ],
        "CONDITION_PATTERN": [
          "history",
          "current signs or symptoms"
        ],
        "SEVERITY": "severe, progressive, or uncontrolled",
        "ANATOMICAL_LOCATION": [
          "renal",
          "hepatic",
          "cardiac",
          "vascular",
          "pulmonary",
          "gastrointestinal",
          "endocrine",
          "neurologic",
          "hematologic",
          "rheumatologic (except PsA)",
          "psychiatric",
          "genitourinary",
          "metabolic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1547",
        "nct_id": "NCT06231381",
        "raw_text": "Patients with documented active or suspected malignancy or a history of malignancy within 5 years prior to screening;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "active",
          "suspected",
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1546",
        "nct_id": "NCT06231381",
        "raw_text": "Patients who have had a serious trauma or undergone a major surgery within 1 month prior to the first dose of the study drug, or plan to undergo any elective surgery during the study period;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious trauma",
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "recent",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "month",
          "reference": "prior to first dose of study drug"
        },
        "TREATMENT_REQUIREMENT": [
          "no planned elective surgery during study period"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1542",
        "nct_id": "NCT06231381",
        "raw_text": "Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome (SAPHO);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome (SAPHO)"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1541",
        "nct_id": "NCT06231381",
        "raw_text": "Drug-triggered acute generalized exanthematous pustulosis (AGEP);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute generalized exanthematous pustulosis (AGEP)"
        ],
        "CONDITION_PATTERN": [
          "drug-triggered",
          "acute"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1534",
        "nct_id": "NCT06943950",
        "raw_text": "History of malignancy.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1533",
        "nct_id": "NCT06943950",
        "raw_text": "With progressive or uncontrolled systemic disease, or with chronic disease identified by the investigator as inappropriate for participation in the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic disease",
          "chronic disease"
        ],
        "CONDITION_PATTERN": [
          "progressive",
          "uncontrolled",
          "chronic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1531",
        "nct_id": "NCT06943950",
        "raw_text": "Other active skin conditions that may affect the clinical evaluation of psoriasis.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active skin conditions"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "may affect clinical evaluation of psoriasis"
        ]
      },
      {
        "id": "CMB_1530",
        "nct_id": "NCT06943950",
        "raw_text": "Previous or current autoimmune disease that may affect the clinical evaluation of psoriasis.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "autoimmune disease"
        ],
        "CONDITION_PATTERN": [
          "previous",
          "current"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "may affect clinical evaluation of psoriasis"
        ]
      },
      {
        "id": "CMB_1517",
        "nct_id": "NCT06592274",
        "raw_text": "Previously diagnosed with serious mental illness such as anxiety, depression or suicidal tendency",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious mental illness",
          "anxiety",
          "depression",
          "suicidal tendency"
        ],
        "CONDITION_PATTERN": [
          "previously diagnosed"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "mental health"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion"
        ]
      },
      {
        "id": "CMB_1516",
        "nct_id": "NCT06592274",
        "raw_text": "A history of inflammatory bowel disease or other serious autoimmune disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease",
          "serious autoimmune disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "serious",
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1501",
        "nct_id": "NCT06299982",
        "raw_text": "Active autoimmune diseases.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "autoimmune diseases"
        ],
        "CONDITION_PATTERN": [
          "active"
        ]
      },
      {
        "id": "CMB_1500",
        "nct_id": "NCT06299982",
        "raw_text": "Other inflammatory diseases.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory diseases"
        ],
        "CONDITION_PATTERN": [
          "other"
        ],
        "AMBIGUITY_FLAG": true
      },
      {
        "id": "CMB_1486",
        "nct_id": "NCT06542614",
        "raw_text": "Those who have undergone surgical surgery within 4 weeks prior to randomization, or who plan to undergo surgical procedures during the study;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "surgical surgery",
          "surgical procedures"
        ],
        "CONDITION_PATTERN": [
          "recent",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to randomization"
        },
        "TREATMENT_REQUIREMENT": [
          "undergone surgery",
          "plan to undergo surgery"
        ],
        "LOGICAL_OPERATOR": "OR",
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "may affect participation"
        ]
      },
      {
        "id": "CMB_1482",
        "nct_id": "NCT06542614",
        "raw_text": "History of malignant tumors (including carcinoma in situ) and lymphoproliferative disorders within 5 years prior to randomization;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignant tumors",
          "carcinoma in situ",
          "lymphoproliferative disorders"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to randomization"
        },
        "LOGICAL_OPERATOR": "AND"
      },
      {
        "id": "CMB_1480",
        "nct_id": "NCT06542614",
        "raw_text": "Has any significant illness or unstable clinical condition (such as renal, hepatic, hematologic, gastrointestinal, endocrine, pulmonary, psychiatric, neurological, immune, or locally active infectious/infectious disease) that is judged by the investigator to be unsuitable for participation in this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal illness",
          "hepatic illness",
          "hematologic illness",
          "gastrointestinal illness",
          "endocrine illness",
          "pulmonary illness",
          "psychiatric illness",
          "neurological illness",
          "immune illness",
          "locally active infectious disease",
          "infectious disease"
        ],
        "CONDITION_PATTERN": [
          "significant",
          "unstable"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "psychiatric",
          "neurological",
          "immune",
          "local"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "unsuitable for participation"
        ]
      },
      {
        "id": "CMB_1474",
        "nct_id": "NCT06542614",
        "raw_text": "Presence of serovirological abnormalities during the screening period:",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serovirological abnormalities"
        ],
        "CONDITION_PATTERN": [
          "presence during screening"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "screening period"
        }
      },
      {
        "id": "CMB_1457",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has any other significant laboratory abnormalities that, in the opinion of the investigator, might place the participant at unacceptable risk for participation in this trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "significant laboratory abnormalities"
        ],
        "CONDITION_PATTERN": [
          "any"
        ],
        "SEVERITY": "significant",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "unacceptable risk for participation"
        ]
      },
      {
        "id": "CMB_1426",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has significant/uncontrolled psychiatric illness, in the opinion of the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psychiatric illness"
        ],
        "CONDITION_PATTERN": [
          "significant",
          "uncontrolled"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with participation"
        ]
      },
      {
        "id": "CMB_1425",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has ECG abnormalities that are considered clinically significant and would pose an unacceptable risk to the participant if he or she participated in the trial, in the opinion of the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "ECG abnormalities"
        ],
        "CONDITION_PATTERN": [
          "clinically significant"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "cardiac"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "pose unacceptable risk"
        ]
      },
      {
        "id": "CMB_1424",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has any history of cerebrovascular event, myocardial infarction, coronary stenting, or aorto-coronary bypass surgery.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cerebrovascular event",
          "myocardial infarction",
          "coronary stenting",
          "aorto-coronary bypass surgery"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cerebrovascular",
          "cardiac",
          "coronary"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1423",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has any of the following cardiovascular disease history: A new diagnosis of atrial fibrillation or an episode of atrial fibrillation with rapid ventricular response or other dysrhythmia, nonacute cardiac hospitalization (for example, pacemaker implantation), pulmonary embolism, or deep venous thrombosis within the past 6 months prior to screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "atrial fibrillation",
          "dysrhythmia",
          "nonacute cardiac hospitalization",
          "pulmonary embolism",
          "deep venous thrombosis"
        ],
        "CONDITION_PATTERN": [
          "new diagnosis",
          "episode",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiac",
          "pulmonary",
          "venous"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1422",
        "nct_id": "NCT06973291",
        "raw_text": "For participants with asthma, chronic obstructive pulmonary disease, or other pulmonary illnesses, participant has been hospitalized in the past 3 months, has ever required intubation for treatment, currently requires oral corticosteroids, or has required more than 1 course of oral corticosteroids within 6 months prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "asthma",
          "chronic obstructive pulmonary disease",
          "pulmonary illnesses"
        ],
        "CONDITION_PATTERN": [
          "history",
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "pulmonary"
        ],
        "TREATMENT_REQUIREMENT": [
          "hospitalized in past 3 months",
          "ever required intubation",
          "currently requires oral corticosteroids",
          "required more than 1 course of oral corticosteroids within 6 months prior to Day 1"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1421",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of cancer or lymphoproliferative disease, with the exception of successfully treated nonmetastatic cutaneous squamous cell or basal cell carcinoma and/or localized carcinoma in situ of the cervix.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cancer",
          "lymphoproliferative disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TREATMENT_REQUIREMENT": [
          "exception for successfully treated nonmetastatic cutaneous squamous cell carcinoma",
          "exception for basal cell carcinoma",
          "exception for localized carcinoma in situ of the cervix"
        ]
      },
      {
        "id": "CMB_1420",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has a history of Class III or IV congestive heart failure as defined by New York Heart Association criteria.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "congestive heart failure"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "Class III or IV",
        "ANATOMICAL_LOCATION": [
          "cardiac"
        ]
      },
      {
        "id": "CMB_1419",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has unstable, poorly controlled, or severe hypertension at screening, confirmed by 2 repeat assessments.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hypertension"
        ],
        "CONDITION_PATTERN": [
          "unstable",
          "poorly controlled",
          "severe"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "cardiac"
        ],
        "TIMEFRAME": {
          "relation": "at",
          "amount": null,
          "unit": null,
          "reference": "screening"
        },
        "TREATMENT_REQUIREMENT": [
          "confirmed by 2 repeat assessments"
        ]
      },
      {
        "id": "CMB_1418",
        "nct_id": "NCT06973291",
        "raw_text": "Participant had a major surgery within 60 days prior to Day 1 or has a major surgery planned during the trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "recent",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "prior to Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "had major surgery",
          "has major surgery planned"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1416",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has any clinically significant medical condition, evidence of an unstable clinical condition (for example, cardiovascular, renal, hepatic, hematologic, gastrointestinal, endocrine, pulmonary, or immunologic), or vital signs/physical/laboratory/Electrocardiogram (ECG) abnormality that would, in the opinion of the investigator, put the participant at undue risk or interfere with interpretation of trial results.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant medical condition",
          "unstable clinical condition",
          "vital signs abnormality",
          "physical abnormality",
          "laboratory abnormality",
          "ECG abnormality"
        ],
        "CONDITION_PATTERN": [
          "any",
          "evidence of unstable"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "cardiovascular",
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "immunologic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "put participant at undue risk",
          "interfere with interpretation of trial results"
        ]
      },
      {
        "id": "CMB_1399",
        "nct_id": "NCT06973291",
        "raw_text": "Participant has concomitant comorbid skin condition that, in the opinion of the investigator, would interfere with the trial assessments.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "comorbid skin condition"
        ],
        "CONDITION_PATTERN": [
          "concomitant"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interfere with trial assessments"
        ]
      },
      {
        "id": "CMB_1388",
        "nct_id": "NCT07090330",
        "raw_text": "History of malignancy, except for non-melanoma skin cancer or cancer curatively treated ≥ 5 years, without evidence of recurrence",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TREATMENT_REQUIREMENT": [
          "except non-melanoma skin cancer",
          "except cancer curatively treated ≥ 5 years without evidence of recurrence"
        ]
      },
      {
        "id": "CMB_1387",
        "nct_id": "NCT07090330",
        "raw_text": "Significant history or clinical manifestation of any metabolic, other dermatological, hepatic, renal, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, respiratory, endocrine, or psychiatric disorder, or any infectious disease",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "metabolic disorder",
          "dermatological disorder",
          "hepatic disorder",
          "renal disorder",
          "hematologic disorder",
          "pulmonary disorder",
          "cardiovascular disorder",
          "gastrointestinal disorder",
          "neurologic disorder",
          "respiratory disorder",
          "endocrine disorder",
          "psychiatric disorder",
          "infectious disease"
        ],
        "CONDITION_PATTERN": [
          "history",
          "clinical manifestation"
        ],
        "SEVERITY": "significant",
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to significant history or clinical manifestation"
        ]
      },
      {
        "id": "CMB_1369",
        "nct_id": "NCT06671483",
        "raw_text": "The participant has a concomitant comorbid skin condition that, in the opinion of the investigator, would interfere with the study assessments, such as evidence of non-plaque PsO (erythrodermic, pustular, predominately guttate PsO, inverse, or drug-induced PsO).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "comorbid skin condition",
          "non-plaque Psoriasis (erythrodermic, pustular, predominately guttate, inverse, drug-induced)"
        ],
        "CONDITION_PATTERN": [
          "concomitant"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interference with study assessments"
        ]
      },
      {
        "id": "CMB_1357",
        "nct_id": "NCT06176508",
        "raw_text": "Active fibromyalgia syndrome.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "fibromyalgia syndrome"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "IMPACT": [
          "exclusion due to active disease"
        ]
      },
      {
        "id": "CMB_1356",
        "nct_id": "NCT06176508",
        "raw_text": "Other autoimmune or autoinflammatory condition ( ie, rheumatoid arthritis, systemic lupus erythematous, gout), with the exception of inflammatory bowel disease and/or autoimmune uveitis being inactive at least 12 months before the screening, as assessed by the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "autoimmune condition",
          "autoinflammatory condition",
          "rheumatoid arthritis",
          "systemic lupus erythematous",
          "gout",
          "inflammatory bowel disease",
          "autoimmune uveitis"
        ],
        "CONDITION_PATTERN": [
          "active",
          "inactive"
        ],
        "TIMEFRAME": {
          "relation": "at least",
          "amount": 12,
          "unit": "months",
          "reference": "before screening"
        },
        "TREATMENT_REQUIREMENT": [
          "inactive inflammatory bowel disease and/or autoimmune uveitis"
        ],
        "LOGICAL_OPERATOR": "AND",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion if autoimmune/autoinflammatory condition active except specified inactive conditions"
        ]
      },
      {
        "id": "CMB_1343",
        "nct_id": "NCT07150988",
        "raw_text": "History of gastrointestinal surgery or diseases that may have impact on the study;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "gastrointestinal surgery",
          "gastrointestinal diseases"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "potential impact on study"
        ]
      },
      {
        "id": "CMB_1342",
        "nct_id": "NCT07150988",
        "raw_text": "History of malignant tumors;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignant tumors"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "IMPACT": [
          "exclusion due to history of malignancy"
        ]
      },
      {
        "id": "CMB_1341",
        "nct_id": "NCT07150988",
        "raw_text": "History of suicide attempts or major psychiatric disorders;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "suicide attempts",
          "major psychiatric disorders"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to psychiatric history"
        ]
      },
      {
        "id": "CMB_1340",
        "nct_id": "NCT07150988",
        "raw_text": "History of cardiovascular or cerebrovascular diseases;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular diseases",
          "cerebrovascular diseases"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular",
          "cerebrovascular"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to cardiovascular or cerebrovascular history"
        ]
      },
      {
        "id": "CMB_1339",
        "nct_id": "NCT07150988",
        "raw_text": "Has undergone or plans to undergo major surgery;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "past",
          "planned"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to surgery status"
        ]
      },
      {
        "id": "CMB_1337",
        "nct_id": "NCT07150988",
        "raw_text": "Presence of other dermatological or autoimmune diseases;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "dermatological diseases",
          "autoimmune diseases"
        ],
        "CONDITION_PATTERN": [
          "presence"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to presence of other diseases"
        ]
      },
      {
        "id": "CMB_1326",
        "nct_id": "NCT07024602",
        "raw_text": "History or presence of any clinically relevant acute or chronic medical or psychiatric condition that could interfere with the subject's safety during the clinical study or expose the subject to undue risk as judged by the Investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute medical condition",
          "chronic medical condition",
          "psychiatric condition"
        ],
        "CONDITION_PATTERN": [
          "history",
          "presence"
        ],
        "SEVERITY": "clinically relevant",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interference with subject safety",
          "exposure to undue risk"
        ]
      },
      {
        "id": "CMB_1315",
        "nct_id": "NCT06918743",
        "raw_text": "At the time of screening, laboratory tests and/or 12-lead electrocardiogram showed the following: 12-lead electrocardiogram examination indicates clinically significant abnormalities that may affect the safety of the subject, including but not limited to acute myocardial ischemia, myocardial infarction, severe arrhythmia, or significant QTc prolongation (QTc>500 ms).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "acute myocardial ischemia",
          "myocardial infarction",
          "severe arrhythmia",
          "significant QTc prolongation"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TIMEFRAME": {
          "relation": "at time of",
          "amount": 0,
          "unit": "screening",
          "reference": "screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "safety risk due to ECG abnormalities"
        ]
      },
      {
        "id": "CMB_1306",
        "nct_id": "NCT06918743",
        "raw_text": "any serious, progressive, uncontrolled cardiovascular or cerebrovascular, respiratory, liver, kidney, gastrointestinal, blood, neurological, or psychiatric disorders, or medical measures, medical conditions, etc. that may affect study participation, or may place subjects at undue risk, as determined by the investigator;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular disorder",
          "cerebrovascular disorder",
          "respiratory disorder",
          "liver disorder",
          "kidney disorder",
          "gastrointestinal disorder",
          "blood disorder",
          "neurological disorder",
          "psychiatric disorder",
          "medical measures",
          "medical conditions"
        ],
        "CONDITION_PATTERN": [
          "serious",
          "progressive",
          "uncontrolled"
        ],
        "SEVERITY": "serious, progressive, uncontrolled",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "may affect study participation",
          "may place subjects at undue risk"
        ]
      },
      {
        "id": "CMB_1304",
        "nct_id": "NCT06918743",
        "raw_text": "had any surgery within 1 month prior to screening, or had not recovered as determined by the investigator, or planned any surgery during the study period;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "surgery"
        ],
        "CONDITION_PATTERN": [
          "past",
          "planned",
          "not recovered"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "month",
          "reference": "prior to screening"
        },
        "TREATMENT_REQUIREMENT": [
          "recovered from surgery"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to recent or planned surgery or incomplete recovery"
        ]
      },
      {
        "id": "CMB_1302",
        "nct_id": "NCT06918743",
        "raw_text": "Participants with a history of depression and/or who were clinically deemed to be at risk of suicide during the screening and baseline periods;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "depression",
          "risk of suicide"
        ],
        "CONDITION_PATTERN": [
          "history",
          "clinical risk"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "screening and baseline periods",
          "reference": "screening and baseline periods"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to depression or suicide risk"
        ]
      },
      {
        "id": "CMB_1301",
        "nct_id": "NCT06918743",
        "raw_text": "There are the following important medical history or underlying diseases that affect safe: The subject has a history of any active malignancy or malignancy in the 5 years prior to the screening visit, except skin squamous cell carcinoma or basal cell carcinoma or cervical cancer in situ that has been cured after treatment;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active malignancy",
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "TREATMENT_REQUIREMENT": [
          "except cured skin squamous cell carcinoma",
          "except cured basal cell carcinoma",
          "except cured cervical cancer in situ"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to active or recent malignancy"
        ]
      },
      {
        "id": "CMB_1300",
        "nct_id": "NCT06918743",
        "raw_text": "Present with any of the following medical history or concomitant diseases: any other persistent active autoimmune disease, Including but not limited to rheumatoid arthritis, systemic lupus erythematosus, scleroderma or polymyositis, multiple sclerosis or other central demyelinating diseases, primary Sjogren's syndrome, immune deficiency syndromes (such as Felty's syndrome);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "persistent active autoimmune disease",
          "rheumatoid arthritis",
          "systemic lupus erythematosus",
          "scleroderma",
          "polymyositis",
          "multiple sclerosis",
          "central demyelinating diseases",
          "primary Sjogren's syndrome",
          "immune deficiency syndromes",
          "Felty's syndrome"
        ],
        "CONDITION_PATTERN": [
          "persistent active",
          "history",
          "concomitant"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to persistent active autoimmune disease"
        ]
      },
      {
        "id": "CMB_1299",
        "nct_id": "NCT06918743",
        "raw_text": "Present with any of the following medical history or concomitant diseases: the subject has other skin diseases or conditions that the investigator determines may affect the evaluation of the relevant endpoint of this study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "other skin diseases or conditions"
        ],
        "CONDITION_PATTERN": [
          "history",
          "concomitant"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "may affect evaluation of study endpoint"
        ]
      },
      {
        "id": "CMB_1280",
        "nct_id": "NCT06844799",
        "raw_text": "Other skin lesions, chronic inflammatory diseases or autoimmune diseases, including but not limited to systemic lupus erythematosus, Sjogren's syndrome, skin sclerosis, etc., assessed by the investigator and other factors that may affect the efficacy evaluation or assessed by other researchers before randomization;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "skin lesions",
          "chronic inflammatory diseases",
          "autoimmune diseases",
          "systemic lupus erythematosus",
          "Sjogren's syndrome",
          "skin sclerosis"
        ],
        "CONDITION_PATTERN": [
          "other",
          "chronic",
          "autoimmune"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "TIMEFRAME": {
          "relation": "before",
          "amount": null,
          "unit": "randomization",
          "reference": "randomization"
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "may affect efficacy evaluation"
        ]
      },
      {
        "id": "CMB_1268",
        "nct_id": "NCT06380907",
        "raw_text": "Patients who have a history of malignancy unless deemed cured by adequate treatment with no evidence of recurrence for ≥ 3 years before the initiation of study treatment.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignancy"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "≥",
          "amount": 3,
          "unit": "years",
          "reference": "before initiation of study treatment"
        },
        "TREATMENT_REQUIREMENT": [
          "deemed cured by adequate treatment",
          "no evidence of recurrence"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion unless malignancy cured with no recurrence for ≥3 years"
        ]
      },
      {
        "id": "CMB_1266",
        "nct_id": "NCT06380907",
        "raw_text": "History of and/or concurrent condition of inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease), or signs/symptoms of IBD at screening that, in the opinion of the Investigator, pose an unacceptable risk to the patient if participating in the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease",
          "ulcerative colitis",
          "Crohn's disease",
          "signs/symptoms of IBD"
        ],
        "CONDITION_PATTERN": [
          "history",
          "concurrent",
          "active at screening"
        ],
        "ANATOMICAL_LOCATION": [
          "bowel",
          "intestinal tract"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "unacceptable risk to patient"
        ]
      },
      {
        "id": "CMB_1261",
        "nct_id": "NCT06380907",
        "raw_text": "History of severe depression or suicidal ideation or behavior within 2 years prior to screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "severe depression",
          "suicidal ideation",
          "suicidal behavior"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "years",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1260",
        "nct_id": "NCT06380907",
        "raw_text": "Known or suspected: Severe renal insufficiency or hepatic insufficiency.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal insufficiency",
          "hepatic insufficiency"
        ],
        "CONDITION_PATTERN": [
          "known",
          "suspected"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "kidney",
          "liver"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1259",
        "nct_id": "NCT06380907",
        "raw_text": "Known or suspected: Severe renal insufficiency or hepatic insufficiency.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal insufficiency",
          "hepatic insufficiency"
        ],
        "CONDITION_PATTERN": [
          "known",
          "suspected"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "kidney",
          "liver"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1258",
        "nct_id": "NCT06380907",
        "raw_text": "Patients with any serious medical/psychiatric condition or clinically significant laboratory abnormality that would prevent study participation or place the patient at significant risk, as determined by the Investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious medical condition",
          "psychiatric condition",
          "clinically significant laboratory abnormality"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "serious",
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "prevent study participation",
          "significant risk to patient"
        ]
      },
      {
        "id": "CMB_1246",
        "nct_id": "NCT04991116",
        "raw_text": "Any condition that in the opinion of the Investigator represents an obstacle for study conduct and/or represents a potential unacceptable risk for the subject.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "any condition representing obstacle for study conduct",
          "any condition representing potential unacceptable risk"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "obstacle for study conduct",
          "unacceptable risk for subject"
        ]
      },
      {
        "id": "CMB_1236",
        "nct_id": "NCT06641076",
        "raw_text": "Participants who have an established diagnosis of arthritis mutilans.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arthritis mutilans"
        ],
        "CONDITION_PATTERN": [
          "established diagnosis"
        ],
        "ANATOMICAL_LOCATION": [
          "joints"
        ]
      },
      {
        "id": "CMB_1235",
        "nct_id": "NCT06641076",
        "raw_text": "Participants who have experienced a period of ≥3 weeks of unexplained diarrhea in the 24 weeks before the Baseline Visit.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "unexplained diarrhea"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 24,
          "unit": "weeks",
          "reference": "before Baseline Visit"
        }
      },
      {
        "id": "CMB_1234",
        "nct_id": "NCT06641076",
        "raw_text": "Participants with a diagnosis of inflammatory bowel disease.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory bowel disease"
        ],
        "CONDITION_PATTERN": [
          "diagnosis"
        ],
        "ANATOMICAL_LOCATION": [
          "bowel",
          "intestinal tract"
        ]
      },
      {
        "id": "CMB_1233",
        "nct_id": "NCT06641076",
        "raw_text": "Participants who have a diagnosis of chronic inflammatory conditions other than PsO or PsA.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "chronic inflammatory conditions other than PsO or PsA"
        ],
        "CONDITION_PATTERN": [
          "diagnosis"
        ]
      },
      {
        "id": "CMB_1224",
        "nct_id": "NCT06888193",
        "raw_text": "Study participant plans a surgical intervention during the Screening Period and Sampling Period or anticipates having surgery while participating in the Sampling Period (does not apply to tubal ligation).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "planned surgical intervention"
        ],
        "CONDITION_PATTERN": [
          "planned during Screening Period",
          "planned during Sampling Period",
          "anticipated during Sampling Period"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": "Screening Period and Sampling Period",
          "reference": "study participation"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion from study"
        ]
      },
      {
        "id": "CMB_1223",
        "nct_id": "NCT06888193",
        "raw_text": "Study participant has history of breast implants, breast augmentation, or breast reduction surgery.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "history of breast implants",
          "breast augmentation",
          "breast reduction surgery"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "breast"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1220",
        "nct_id": "NCT06888193",
        "raw_text": "Study participant has any medical, obstetrical, or psychiatric condition that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "medical condition",
          "obstetrical condition",
          "psychiatric condition"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "jeopardize ability to participate",
          "compromise ability to participate"
        ]
      },
      {
        "id": "CMB_1211",
        "nct_id": "NCT05642182",
        "raw_text": "Neuropathy of grade ≥2.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "neuropathy"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "nervous system"
        ]
      },
      {
        "id": "CMB_1210",
        "nct_id": "NCT05642182",
        "raw_text": "Abdominal fistula, GI perforation, or intra-abdominal abscess within the past 6 months.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "abdominal fistula",
          "gastrointestinal perforation",
          "intra-abdominal abscess"
        ],
        "CONDITION_PATTERN": [
          "within past 6 months"
        ],
        "ANATOMICAL_LOCATION": [
          "abdomen",
          "gastrointestinal tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1209",
        "nct_id": "NCT05642182",
        "raw_text": "Serious or non-healing wound, skin ulcer, or bone fracture.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "serious wound",
          "non-healing wound",
          "skin ulcer",
          "bone fracture"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "serious",
        "ANATOMICAL_LOCATION": [
          "skin",
          "bone"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1206",
        "nct_id": "NCT05642182",
        "raw_text": "Diabetes of any type, except Non-Insulin Dependent Diabetes Mellitus (NIDDM) that is controlled and with hemoglobin A1c 8%.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "diabetes"
        ],
        "CONDITION_PATTERN": [
          "any type"
        ],
        "ANATOMICAL_LOCATION": [
          "endocrine system"
        ],
        "TREATMENT_REQUIREMENT": [
          "except controlled Non-Insulin Dependent Diabetes Mellitus (NIDDM) with hemoglobin A1c ≤ 8%"
        ]
      },
      {
        "id": "CMB_1204",
        "nct_id": "NCT05642182",
        "raw_text": "Any active uncontrolled bleeding, a bleeding diathesis (e.g., active peptic ulcer disease), or a history of bleeding (e.g., hemoptysis, upper or lower gastrointestinal [GI] bleeding) within the past 6 months.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "active uncontrolled bleeding",
          "bleeding diathesis",
          "history of bleeding",
          "active peptic ulcer disease",
          "hemoptysis",
          "upper gastrointestinal bleeding",
          "lower gastrointestinal bleeding"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "gastrointestinal tract",
          "respiratory tract"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1203",
        "nct_id": "NCT05642182",
        "raw_text": "Known to have active central nervous system (CNS), epidural tumor or metastasis, or brain metastasis.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "central nervous system tumor",
          "epidural tumor",
          "brain metastasis"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "central nervous system"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1202",
        "nct_id": "NCT05642182",
        "raw_text": "Known to have uncontrolled hypertension (systolic blood pressure >160 mm Hg or diastolic blood pressure >90 mm Hg), or peripheral vascular disease ≥grade 2.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "uncontrolled hypertension",
          "peripheral vascular disease"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "ANATOMICAL_LOCATION": [
          "vascular system"
        ],
        "TREATMENT_REQUIREMENT": [
          "systolic blood pressure >160 mm Hg",
          "diastolic blood pressure >90 mm Hg",
          "peripheral vascular disease grade ≥2"
        ],
        "LOGICAL_OPERATOR": "OR"
      },
      {
        "id": "CMB_1201",
        "nct_id": "NCT05642182",
        "raw_text": "Known to have arterial thrombotic event, stroke, or transient ischemia attack within the past 12 months.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arterial thrombotic event",
          "stroke",
          "transient ischemia attack"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "arterial",
          "brain"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 12,
          "unit": "months",
          "reference": "past"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent thrombotic or ischemic events"
        ]
      },
      {
        "id": "CMB_1200",
        "nct_id": "NCT05642182",
        "raw_text": "Known to have a history of risk factors for torsade de pointes (e.g., clinically significant heart failure, hypokalemia, family history of Long QT Syndrome).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "torsade de pointes risk factors",
          "heart failure",
          "hypokalemia",
          "Long QT Syndrome"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "heart",
          "electrolyte system",
          "genetic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to risk of torsade de pointes arrhythmia"
        ]
      },
      {
        "id": "CMB_1196",
        "nct_id": "NCT05642182",
        "raw_text": "Presence of other form of inflammatory skin diseases (such as atopic dermatitis) or infectious diseases (such as cellulitis, warts, fungal cutaneous diseases, etc.)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory skin diseases",
          "infectious diseases"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "potential interference with study assessments"
        ]
      },
      {
        "id": "CMB_1186",
        "nct_id": "NCT06863493",
        "raw_text": "History of active ongoing inflammatory skin diseases other than PsO and psoriatic arthritis that could interfere with the assessment of PsO (e.g., hyperkeratotic eczema).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "inflammatory skin diseases"
        ],
        "CONDITION_PATTERN": [
          "history",
          "active ongoing"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "interference with assessment of Psoriasis (PsO)"
        ]
      },
      {
        "id": "CMB_1153",
        "nct_id": "NCT06005532",
        "raw_text": "14. Hepatic and/or renal insufficiency.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hepatic insufficiency",
          "renal insufficiency"
        ],
        "ANATOMICAL_LOCATION": [
          "liver",
          "kidney"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "organ insufficiency affecting eligibility"
        ]
      },
      {
        "id": "CMB_1149",
        "nct_id": "NCT06005532",
        "raw_text": "10. Any other malignant neoplasms currently or in anamnesis within the last 5 years, with the exception of completely removed and/or cured.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignant neoplasms"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "last"
        },
        "TREATMENT_REQUIREMENT": [
          "completely removed and/or cured"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or current malignancy"
        ]
      },
      {
        "id": "CMB_1148",
        "nct_id": "NCT06005532",
        "raw_text": "9. Lymphoproliferative diseases, lymphoma, leukemia, myeloproliferative diseases or a history of multiple myeloma.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "lymphoproliferative diseases",
          "lymphoma",
          "leukemia",
          "myeloproliferative diseases",
          "multiple myeloma"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to hematologic malignancies"
        ]
      },
      {
        "id": "CMB_1146",
        "nct_id": "NCT06005532",
        "raw_text": "7. Extensive surgical intervention performed less than 30 days before the screening period, or planned extensive surgical intervention during the study period.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "extensive surgical intervention"
        ],
        "CONDITION_PATTERN": [
          "past",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "less than",
          "amount": 30,
          "unit": "days",
          "reference": "before screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or planned surgery"
        ]
      },
      {
        "id": "CMB_1121",
        "nct_id": "NCT06846710",
        "raw_text": "Normal results or abnormal results but without clinical significance in comprehensive examinations, including general physical examination, vital signs, laboratory tests, 12-lead ECG, abdominal color Doppler ultrasound, and chest X-ray from the frontal and lateral position ;",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "general physical examination",
          "vital signs",
          "laboratory tests",
          "12-lead ECG",
          "abdominal color Doppler ultrasound",
          "chest X-ray"
        ],
        "CONDITION_PATTERN": [
          "normal",
          "abnormal without clinical significance"
        ],
        "ANATOMICAL_LOCATION": [
          "abdomen",
          "chest"
        ],
        "IMPACT": [
          "no exclusion if abnormalities lack clinical significance"
        ]
      },
      {
        "id": "CMB_1117",
        "nct_id": "NCT07148414",
        "raw_text": "Other autoimmune, rheumatologic, inflammatory diseases or pain-amplification syndromes that might confound the evaluations of efficacy of SPY072.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "autoimmune diseases",
          "rheumatologic diseases",
          "inflammatory diseases",
          "pain-amplification syndromes"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "potential confounding of efficacy evaluations"
        ]
      },
      {
        "id": "CMB_1097",
        "nct_id": "NCT07158268",
        "raw_text": "A history of malignant tumor before screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "malignant tumor"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "before",
          "amount": 0,
          "unit": "",
          "reference": "screening"
        },
        "IMPACT": [
          "exclusion due to past malignancy"
        ]
      },
      {
        "id": "CMB_1095",
        "nct_id": "NCT07158268",
        "raw_text": "Current diagnosis, signs, or symptoms of severe, progressive, or uncontrolled disease involving the renal, hepatic, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric, or metabolic systems",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "renal disease",
          "hepatic disease",
          "cardiac disease",
          "vascular disease",
          "pulmonary disease",
          "gastrointestinal disease",
          "endocrine disease",
          "neurologic disease",
          "hematologic disease",
          "rheumatologic disease",
          "psychiatric disease",
          "metabolic disease"
        ],
        "CONDITION_PATTERN": [
          "current",
          "severe",
          "progressive",
          "uncontrolled"
        ],
        "SEVERITY": "severe",
        "ANATOMICAL_LOCATION": [
          "kidney",
          "liver",
          "heart",
          "vascular system",
          "lungs",
          "gastrointestinal tract",
          "endocrine system",
          "nervous system",
          "blood",
          "musculoskeletal",
          "psychiatric",
          "metabolic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to severe uncontrolled systemic diseases"
        ]
      },
      {
        "id": "CMB_1086",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has developed a concomitant comorbid skin condition that, in the opinion of the investigator, would interfere with the study assessments.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "comorbid skin condition"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "ANATOMICAL_LOCATION": [
          "skin"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "interference with study assessments"
        ]
      },
      {
        "id": "CMB_1073",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has any lifetime history of suicidal ideation, suicidal behavior, or suicidal attempts by 1) medical history; or 2) by Columbia-Suicide Severity Rating Scale (C-SSRS) documentation at screening or by answering \"yes\" to Question 5 for suicidal ideation on the C-SSRS at screening; or 3) is clinically deemed to have a suicide risk by the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "suicidal ideation",
          "suicidal behavior",
          "suicidal attempts"
        ],
        "CONDITION_PATTERN": [
          "lifetime history",
          "screening"
        ],
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TREATMENT_REQUIREMENT": [
          "Columbia-Suicide Severity Rating Scale (C-SSRS) documentation"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to suicide risk"
        ]
      },
      {
        "id": "CMB_1072",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has significant/uncontrolled psychiatric illness, in the opinion of the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psychiatric illness"
        ],
        "CONDITION_PATTERN": [
          "current",
          "significant",
          "uncontrolled"
        ],
        "SEVERITY": "significant",
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to psychiatric illness"
        ]
      },
      {
        "id": "CMB_1071",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has ECG abnormalities that are considered clinically significant and would pose an unacceptable risk to the participant if he or she participated in the study, in the opinion of the investigator.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "ECG abnormalities"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to cardiac risk"
        ]
      },
      {
        "id": "CMB_1070",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has any of the following cardiovascular disease history: A new diagnosis of atrial fibrillation or an episode of atrial fibrillation with rapid ventricular response or other dysrhythmia, non-acute cardiac hospitalization (e.g., pacemaker implantation), pulmonary embolism, or deep venous thrombosis within the past 6 months prior to screening. Any history of cerebrovascular event, myocardial infarction, coronary stenting, or aortocoronary bypass surgery. If, however, the investigator determines there are no suitable treatment alternatives available for the participant and it has been at least 6 months since the occurrence of any such event, the participant may enroll.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "atrial fibrillation",
          "dysrhythmia",
          "non-acute cardiac hospitalization",
          "pulmonary embolism",
          "deep venous thrombosis",
          "cerebrovascular event",
          "myocardial infarction",
          "coronary stenting",
          "aortocoronary bypass surgery"
        ],
        "CONDITION_PATTERN": [
          "new diagnosis",
          "episode",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "heart",
          "vascular system",
          "brain"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 6,
          "unit": "months",
          "reference": "prior to screening"
        },
        "TREATMENT_REQUIREMENT": [
          "investigator determination of no suitable treatment alternatives",
          "at least 6 months since event"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion due to recent cardiovascular events unless criteria met"
        ]
      },
      {
        "id": "CMB_1069",
        "nct_id": "NCT06550076",
        "raw_text": "For participants with asthma, chronic obstructive pulmonary disease, or other pulmonary illnesses, participant has been hospitalized in the past 3 months, has ever required intubation for treatment, currently requires oral corticosteroids, or has required more than 1 course of oral corticosteroids within 6 months prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "asthma",
          "chronic obstructive pulmonary disease",
          "pulmonary illnesses"
        ],
        "CONDITION_PATTERN": [
          "current",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "lungs"
        ],
        "TIMEFRAME": {
          "relation": "past",
          "amount": 3,
          "unit": "months",
          "reference": "hospitalization"
        },
        "TREATMENT_REQUIREMENT": [
          "oral corticosteroids use",
          "intubation history"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent hospitalization or corticosteroid use"
        ]
      },
      {
        "id": "CMB_1068",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has a history of cancer or lymphoproliferative disease, with the exception of successfully treated nonmetastatic cutaneous squamous cell or basal cell carcinoma and/or localized carcinoma in situ of the cervix.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cancer",
          "lymphoproliferative disease"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TREATMENT_REQUIREMENT": [
          "successfully treated nonmetastatic cutaneous squamous cell carcinoma",
          "basal cell carcinoma",
          "localized carcinoma in situ of the cervix"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to history of cancer except certain treated types"
        ]
      },
      {
        "id": "CMB_1067",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has a history of Class III or IV congestive heart failure as defined by New York Heart Association criteria.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "congestive heart failure"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "SEVERITY": "Class III or IV",
        "ANATOMICAL_LOCATION": [
          "heart"
        ],
        "TREATMENT_REQUIREMENT": [
          "New York Heart Association criteria"
        ],
        "IMPACT": [
          "exclusion due to severe heart failure"
        ]
      },
      {
        "id": "CMB_1066",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has unstable, poorly controlled, or severe hypertension at screening, confirmed by 2 repeat assessments.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "hypertension"
        ],
        "CONDITION_PATTERN": [
          "active",
          "current"
        ],
        "SEVERITY": "unstable, poorly controlled, or severe",
        "ANATOMICAL_LOCATION": [
          "cardiovascular"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "risk to participant",
          "interference with study results"
        ]
      },
      {
        "id": "CMB_1065",
        "nct_id": "NCT06550076",
        "raw_text": "Participant had a major surgery within 60 days prior to Day 1 or has a major surgery planned during the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "history",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 60,
          "unit": "days",
          "reference": "Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1063",
        "nct_id": "NCT06550076",
        "raw_text": "Participant has any clinically significant medical condition, evidence of an unstable clinical condition (e.g., cardiovascular, renal, hepatic, hematologic, gastrointestinal, endocrine, pulmonary, or immunologic), or vital signs/physical/laboratory/ECG abnormality that would, in the opinion of the investigator, put the participant at undue risk or interfere with interpretation of study results.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "clinically significant medical condition",
          "unstable clinical condition",
          "cardiovascular",
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "immunologic",
          "vital signs abnormality",
          "physical abnormality",
          "laboratory abnormality",
          "ECG abnormality"
        ],
        "CONDITION_PATTERN": [
          "active",
          "unstable"
        ],
        "SEVERITY": "clinically significant, unstable",
        "ANATOMICAL_LOCATION": [
          "cardiovascular",
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "immunologic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "risk to participant",
          "interference with study results"
        ]
      },
      {
        "id": "CMB_1050",
        "nct_id": "NCT07204639",
        "raw_text": "Electrocardiogram abnormalities that are considered clinically significant and would pose an unacceptable risk to the patient if participating in the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "electrocardiogram abnormalities"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "cardiovascular"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "unacceptable risk to patient"
        ]
      },
      {
        "id": "CMB_1031",
        "nct_id": "NCT07204639",
        "raw_text": "Any uncontrolled psychiatric illness (such as untreated depression, or bipolar disorder) judged as clinically significant by the investigator during screening or at Day 1 OR any lifetime history of suicidal ideation, suicidal behavior, or suicidal attempts by medical history or by electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) documentation, or by answering \"yes\" to Question 4 or 5 for suicidal ideation on the eC-SSRS at screening or at Day 1, or is clinically deemed to have a suicide risk by the investigator",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psychiatric illness",
          "depression",
          "bipolar disorder",
          "suicidal ideation",
          "suicidal behavior",
          "suicidal attempts"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history",
          "lifetime"
        ],
        "SEVERITY": "clinically significant",
        "ANATOMICAL_LOCATION": [
          "psychiatric"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": 1,
          "unit": "screening or Day 1",
          "reference": null
        },
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1030",
        "nct_id": "NCT07204639",
        "raw_text": "Has cancer or history of cancer (solid organ or hematologic including myelodysplastic syndrome) or lymphoproliferative disease within the previous 5 years (other than resected cutaneous basal cell or squamous cell carcinoma, or carcinoma of cervix in situ that has been treated with no evidence of recurrence)",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cancer",
          "solid organ cancer",
          "hematologic cancer",
          "myelodysplastic syndrome",
          "lymphoproliferative disease",
          "cutaneous basal cell carcinoma",
          "squamous cell carcinoma",
          "carcinoma of cervix in situ"
        ],
        "CONDITION_PATTERN": [
          "active",
          "history"
        ],
        "ANATOMICAL_LOCATION": [
          "various"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 5,
          "unit": "years",
          "reference": "prior to screening"
        },
        "TREATMENT_REQUIREMENT": [
          "resected and treated with no evidence of recurrence"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1029",
        "nct_id": "NCT07204639",
        "raw_text": "Class III or IV congestive heart failure by New York Heart Association Criteria",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "congestive heart failure"
        ],
        "CONDITION_PATTERN": [
          "active"
        ],
        "SEVERITY": "Class III or IV",
        "ANATOMICAL_LOCATION": [
          "cardiovascular"
        ],
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1028",
        "nct_id": "NCT07204639",
        "raw_text": "Has uncontrolled arterial hypertension characterized by a systolic blood pressure (BP) >160 mm Hg or diastolic BP >100 mm Hg",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "arterial hypertension"
        ],
        "CONDITION_PATTERN": [
          "active",
          "uncontrolled"
        ],
        "ANATOMICAL_LOCATION": [
          "cardiovascular"
        ],
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1027",
        "nct_id": "NCT07204639",
        "raw_text": "Unstable cardiovascular disease, defined as a recent clinical cardiovascular event (eg, unstable angina, myocardial infarction, stroke, rapid atrial fibrillation) in the last 3 months prior to screening, or a cardiac hospitalization (eg, revascularization procedure, pacemaker implantation) within 3 months prior to screening",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cardiovascular disease",
          "unstable angina",
          "myocardial infarction",
          "stroke",
          "rapid atrial fibrillation",
          "cardiac hospitalization",
          "revascularization procedure",
          "pacemaker implantation"
        ],
        "CONDITION_PATTERN": [
          "active",
          "recent"
        ],
        "SEVERITY": "unstable",
        "ANATOMICAL_LOCATION": [
          "cardiovascular"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 3,
          "unit": "months",
          "reference": "prior to screening"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "risk to participant"
        ]
      },
      {
        "id": "CMB_1026",
        "nct_id": "NCT07204639",
        "raw_text": "Any major illness/condition or evidence of an unstable clinical condition (eg, renal, hepatic, hematologic, gastrointestinal, endocrine, pulmonary, psychiatric, neurologic, immunologic, or local active infection/infectious illness) that, in the investigator's judgment or after consultation with the medical monitor, will substantially increase the risk to the patient if he or she participates in the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major illness",
          "unstable clinical condition",
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "psychiatric",
          "neurologic",
          "immunologic",
          "local active infection",
          "infectious illness"
        ],
        "CONDITION_PATTERN": [
          "active",
          "unstable"
        ],
        "SEVERITY": "major, unstable",
        "ANATOMICAL_LOCATION": [
          "renal",
          "hepatic",
          "hematologic",
          "gastrointestinal",
          "endocrine",
          "pulmonary",
          "psychiatric",
          "neurologic",
          "immunologic"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "substantially increased risk to patient"
        ]
      },
      {
        "id": "CMB_1022",
        "nct_id": "NCT07204639",
        "raw_text": "Any major surgery within 8 weeks prior to Day 1, or any planned surgery for the first 52 weeks of the study",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "major surgery"
        ],
        "CONDITION_PATTERN": [
          "history",
          "planned"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 8,
          "unit": "weeks",
          "reference": "prior to Day 1"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "risk to participant"
        ]
      }
    ]
  },
  "CLUSTER_BIO": {
    "cluster_name": "Biomarkers",
    "cluster_code": "BIO",
    "total_criteria": 4,
    "primary_question": "Do you have biomarker test results?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "BIO_1968",
        "nct_id": "NCT06641089",
        "raw_text": "Participants test negative for both rheumatoid factor and anti-cyclic citrullinated peptide at the Screening Visit.",
        "BIOMARKER_NAME": [
          "rheumatoid factor",
          "anti-CCP"
        ],
        "BIOMARKER_STATUS": "negative",
        "TEST_STATUS": "negative_test",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BIO_1231",
        "nct_id": "NCT06641076",
        "raw_text": "Participants test negative for both rheumatoid factor and anti-cyclic citrullinated peptide at the Screening Visit.",
        "BIOMARKER_NAME": [
          "rheumatoid factor",
          "anti-CCP"
        ],
        "BIOMARKER_STATUS": "negative",
        "TEST_STATUS": "negative_test",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BIO_1101",
        "nct_id": "NCT07148414",
        "raw_text": "Documentation of ≥1 of the following: Positive test results for rheumatoid factor or anti-citrullinated peptide antibodies at Screening, OR Previous radiographs with bony erosions in hands or feet consistent with RA.",
        "BIOMARKER_NAME": [],
        "BIOMARKER_STATUS": "positive",
        "TEST_STATUS": "positive_test",
        "EXCLUSION_STRENGTH": "inclusion"
      },
      {
        "id": "BIO_1100",
        "nct_id": "NCT07148414",
        "raw_text": "Documentation of ≥1 of the following: Positive test results for rheumatoid factor or anti-citrullinated peptide antibodies at Screening, OR Previous radiographs with bony erosions in hands or feet consistent with RA.",
        "BIOMARKER_NAME": [
          "rheumatoid factor"
        ],
        "BIOMARKER_STATUS": "positive",
        "TEST_STATUS": "positive_test",
        "EXCLUSION_STRENGTH": "inclusion"
      }
    ]
  },
  "CLUSTER_FLR": {
    "cluster_name": "Flare History",
    "cluster_code": "FLR",
    "total_criteria": 52,
    "primary_question": "Have you experienced disease flares?",
    "answer_type": "autocomplete",
    "criteria": [
      {
        "id": "FLR_2462",
        "nct_id": "NCT06170840",
        "raw_text": "Use of a suppressant of CYP3A liver metabolic enzyme, or use of any medication, including prescription, over-the-counter, and herbal oral or topical drugs, other than vitamins and/or Paracetamol, within 2 weeks prior to initial administration.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of suppressant of CYP3A liver metabolic enzyme",
          "use of any medication excluding vitamins and/or Paracetamol"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to initial administration"
        },
        "TREATMENT_REQUIREMENT": [
          "no use of suppressant of CYP3A liver metabolic enzyme",
          "no use of any medication except vitamins and/or Paracetamol"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to medication use affecting metabolism"
        ]
      },
      {
        "id": "FLR_2459",
        "nct_id": "NCT06170840",
        "raw_text": "Receive contraindicated drugs, supplements, and other treatments prescribed in this trial that may affect the course of psoriasis within the specified time period prior to initial dosing or planned for the duration of the trial.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of contraindicated drugs, supplements, and other treatments affecting psoriasis course"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "planned use"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriasis"
        ],
        "TIMEFRAME": {
          "relation": "prior to or during",
          "amount": null,
          "unit": null,
          "reference": "prior to initial dosing or planned for duration of trial"
        },
        "TREATMENT_REQUIREMENT": [
          "no receipt of contraindicated drugs, supplements, or treatments"
        ],
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to interference with psoriasis treatment"
        ]
      },
      {
        "id": "FLR_2457",
        "nct_id": "NCT06170840",
        "raw_text": "Patients who have failed or are intolerant to previous treatment with Phosphodiesterase-4 (PDE4) inhibitors.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "failure or intolerance to Phosphodiesterase-4 (PDE4) inhibitors"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TREATMENT_REQUIREMENT": [
          "previous treatment with PDE4 inhibitors failed or intolerant"
        ],
        "IMPACT": [
          "exclusion due to prior treatment failure or intolerance"
        ]
      },
      {
        "id": "FLR_2456",
        "nct_id": "NCT06170840",
        "raw_text": "Taking drugs that can aggravate psoriasis (such as lithium, antimalarial drugs, etc.).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of drugs that can aggravate psoriasis (e.g., lithium, antimalarial drugs)"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriasis"
        ],
        "TREATMENT_REQUIREMENT": [
          "no use of drugs that aggravate psoriasis"
        ],
        "IMPACT": [
          "exclusion due to potential psoriasis aggravation"
        ]
      },
      {
        "id": "FLR_2440",
        "nct_id": "NCT06643260",
        "raw_text": "Concomitant use of strong cytochrome P450 inducers, e.g., rifampin, phenobarbital, phenytoin, carbamazepine;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of strong cytochrome P450 inducers (e.g., rifampin, phenobarbital, phenytoin, carbamazepine)"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "TREATMENT_REQUIREMENT": [
          "no concomitant use of strong cytochrome P450 inducers"
        ],
        "IMPACT": [
          "exclusion due to drug interaction risk"
        ]
      },
      {
        "id": "FLR_2431",
        "nct_id": "NCT06643260",
        "raw_text": "Treatment with lithium, hydroxychloroquine or chloroquine within 2 weeks of the Baseline visit, or anticipated need for such drugs during the study period, unless dose has been stable for 3 months prior to the Screening visit and will remain stable throughout the trial;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "treatment with lithium",
          "treatment with hydroxychloroquine",
          "treatment with chloroquine"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "planned use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "Baseline visit"
        },
        "TREATMENT_REQUIREMENT": [
          "no treatment within 2 weeks of Baseline visit unless dose stable for 3 months prior to Screening and remains stable"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion or monitoring due to recent or planned treatment"
        ]
      },
      {
        "id": "FLR_2430",
        "nct_id": "NCT06643260",
        "raw_text": "Ultraviolet or Dead Sea therapy within 4 weeks of the Baseline visit, or anticipated need for either of these therapies during the study period;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "Ultraviolet therapy",
          "Dead Sea therapy"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "planned use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "Baseline visit"
        },
        "TREATMENT_REQUIREMENT": [
          "no therapy within 4 weeks of Baseline visit or planned during study"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or planned phototherapy"
        ]
      },
      {
        "id": "FLR_2429",
        "nct_id": "NCT06643260",
        "raw_text": "Treatment with Vitamin D analogs, keratolytics, coal tar (other than on the scalp, palms, groin, and/or soles), any topical corticosteroid, calcineurin inhibitors, vitamin A analogs, retinoids, anthralin, calcipotriene, tazarotene, methoxsalen, trimethyl-psoralens, fumarate, PDE4 inhibitors, or aryl hydrocarbon receptor-modulating agents within 2 weeks of the Baseline visit;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "treatment with Vitamin D analogs",
          "keratolytics",
          "coal tar (except scalp, palms, groin, soles)",
          "topical corticosteroids",
          "calcineurin inhibitors",
          "vitamin A analogs",
          "retinoids",
          "anthralin",
          "calcipotriene",
          "tazarotene",
          "methoxsalen",
          "trimethyl-psoralens",
          "fumarate",
          "PDE4 inhibitors",
          "aryl hydrocarbon receptor-modulating agents"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "scalp",
          "palms",
          "groin",
          "soles"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "Baseline visit"
        },
        "TREATMENT_REQUIREMENT": [
          "no treatment with listed agents within 2 weeks of Baseline visit"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent topical or systemic treatments"
        ]
      },
      {
        "id": "FLR_2428",
        "nct_id": "NCT06643260",
        "raw_text": "Treatment with a monoclonal antibody or other biologic agent for psoriasis within 8 weeks for etanercept, adalimumab, or infliximab, or within 12 weeks for all other agents, prior to the Baseline visit;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "treatment with monoclonal antibody or biologic agent for psoriasis"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 8,
            "unit": "weeks",
            "reference": "prior to Baseline visit for etanercept, adalimumab, infliximab"
          },
          {
            "relation": "within",
            "amount": 12,
            "unit": "weeks",
            "reference": "prior to Baseline visit for all other agents"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "no treatment with specified biologics within defined washout periods"
        ],
        "IMPACT": [
          "exclusion due to recent biologic therapy"
        ]
      },
      {
        "id": "FLR_2427",
        "nct_id": "NCT06643260",
        "raw_text": "Treatment with systemic retinoids, systemic corticosteroids, tofacitinib, apremilast, immunosuppressive agents (e.g., methotrexate, cyclosporine), or any other approved drugs for the indication of plaque psoriasis (e.g., deucravacitinib) within 4 weeks of the Baseline visit;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "treatment with systemic retinoids",
          "systemic corticosteroids",
          "tofacitinib",
          "apremilast",
          "immunosuppressive agents (e.g., methotrexate, cyclosporine)",
          "other approved drugs for plaque psoriasis (e.g., deucravacitinib)"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "Baseline visit"
        },
        "TREATMENT_REQUIREMENT": [
          "no treatment with listed systemic agents within 4 weeks of Baseline visit"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent systemic therapy"
        ]
      },
      {
        "id": "FLR_2406",
        "nct_id": "NCT06380153",
        "raw_text": "who had used prescription drugs, over-the-counter drugs, health supplements, herbal products or vaccines other than those used to treat renal impairment and other concomitant diseases within 2 weeks before screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of prescription drugs",
          "use of over-the-counter drugs",
          "use of health supplements",
          "use of herbal products",
          "use of vaccines"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "before screening"
        },
        "TREATMENT_REQUIREMENT": [
          "no use except for treatment of renal impairment and other concomitant diseases"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion due to recent medication or supplement use"
        ]
      },
      {
        "id": "FLR_2405",
        "nct_id": "NCT06380153",
        "raw_text": "use of any drugs (e.g., inductors-barbiturates, pioglitazone, carbamazepine, phenytoin, glucocorticoids) that induce or inhibit hepatic drug-metabolizing enzymes within 30 days before screening.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of drugs inducing or inhibiting hepatic drug-metabolizing enzymes (e.g., barbiturates, pioglitazone, carbamazepine, phenytoin, glucocorticoids)"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 30,
          "unit": "days",
          "reference": "before screening"
        },
        "TREATMENT_REQUIREMENT": [
          "no use of enzyme inducers or inhibitors within 30 days before screening"
        ],
        "IMPACT": [
          "exclusion due to drug interaction risk"
        ]
      },
      {
        "id": "FLR_2385",
        "nct_id": "NCT06380153",
        "raw_text": "no new concomitant medications in the 2 weeks before screening, no adjustment in the treatment regimen (including the type, dose, or frequency of medications) for underlying diseases in the 4 weeks before screening.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "use of new concomitant medications",
          "adjustment in treatment regimen for underlying diseases"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "treatment adjustment"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 2,
            "unit": "weeks",
            "reference": "before screening"
          },
          {
            "relation": "within",
            "amount": 4,
            "unit": "weeks",
            "reference": "before screening"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "no new concomitant medications within 2 weeks before screening",
          "no adjustment in treatment regimen within 4 weeks before screening"
        ],
        "LOGICAL_OPERATOR": "AND",
        "IMPACT": [
          "exclusion due to medication changes"
        ]
      },
      {
        "id": "FLR_2374",
        "nct_id": "NCT03997786",
        "raw_text": "Subject who is expected to require topical therapy, phototherapy, or additional systemic therapy for psoriasis during the trial",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "requirement for topical therapy",
          "requirement for phototherapy",
          "requirement for additional systemic therapy for psoriasis"
        ],
        "CONDITION_PATTERN": [
          "planned use"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriasis"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": null,
          "unit": null,
          "reference": "during the trial"
        },
        "TREATMENT_REQUIREMENT": [
          "expected requirement for topical, phototherapy, or systemic therapy during trial"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "exclusion or monitoring due to anticipated additional therapy"
        ]
      },
      {
        "id": "FLR_2359",
        "nct_id": "NCT06610890",
        "raw_text": "who used any prescription medication, over-the-counter medication, nutrine, herbal medicine product or received a vaccination within 14 days before the trial; Or plan to take non-trial drugs or supplements during the trial; Or use of a drug for less than 5 half-lives before taking the study drug, whichever is longer;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of prescription medication",
          "use of over-the-counter medication",
          "use of nutrine",
          "use of herbal medicine product",
          "vaccination"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "planned use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 14,
          "unit": "days",
          "reference": "before trial"
        },
        "TREATMENT_REQUIREMENT": [
          "no use within 14 days before trial",
          "no planned use during trial",
          "no use of drug less than 5 half-lives before study drug"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or planned medication or vaccination"
        ]
      },
      {
        "id": "FLR_2356",
        "nct_id": "NCT06610890",
        "raw_text": "use of any drugs (e.g., inducers - barbiturates, carbamazepine, phenytoin, glucocorticoids) that inhibit or induce hepatic drug-metabolizing enzymes within 30 days before the test; Inhibitors (SSRI antidepressants, cimetidine, sedative-hypnotics, verapamil, fluoroquinolones, antihistamines);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of drugs inhibiting or inducing hepatic drug-metabolizing enzymes (e.g., barbiturates, carbamazepine, phenytoin, glucocorticoids)",
          "use of inhibitors (SSRI antidepressants, cimetidine, sedative-hypnotics, verapamil, fluoroquinolones, antihistamines)"
        ],
        "CONDITION_PATTERN": [
          "current use"
        ],
        "ANATOMICAL_LOCATION": [
          "liver"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 30,
          "unit": "days",
          "reference": "before test"
        },
        "TREATMENT_REQUIREMENT": [
          "no use of listed enzyme inhibitors or inducers within 30 days before test"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to drug interaction risk"
        ]
      },
      {
        "id": "FLR_2304",
        "nct_id": "NCT06477237",
        "raw_text": "Have concurrent or recent use of any biologic agent within the following washout periods: etanercept <28 days; infliximab and adalimumab <60 days; golimumab < 90 days; anti-IL-12/anti-IL-23 or anti-IL-23p19 antibody drugs <6 months; or other anti-psoriatic therapy not listed herein within its 5 half-lives prior to randomization",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of biologic agents (etanercept, infliximab, adalimumab, golimumab, anti-IL-12/anti-IL-23 or anti-IL-23p19 antibody drugs)",
          "use of other anti-psoriatic therapy"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "recent use"
        ],
        "ANATOMICAL_LOCATION": [
          "psoriasis"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 28,
            "unit": "days",
            "reference": "prior to randomization for etanercept"
          },
          {
            "relation": "within",
            "amount": 60,
            "unit": "days",
            "reference": "prior to randomization for infliximab and adalimumab"
          },
          {
            "relation": "within",
            "amount": 90,
            "unit": "days",
            "reference": "prior to randomization for golimumab"
          },
          {
            "relation": "within",
            "amount": 6,
            "unit": "months",
            "reference": "prior to randomization for anti-IL-12/anti-IL-23 or anti-IL-23p19 antibody drugs"
          },
          {
            "relation": "within",
            "amount": null,
            "unit": "half-lives",
            "reference": "prior to randomization for other anti-psoriatic therapy"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "no use within specified washout periods"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent biologic or anti-psoriatic therapy"
        ]
      },
      {
        "id": "FLR_2303",
        "nct_id": "NCT06477237",
        "raw_text": "Have previously received any drug that directly targets IL-17 or IL-17 receptor",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "prior use of any drug targeting IL-17 or IL-17 receptor"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TREATMENT_REQUIREMENT": [
          "no prior use of IL-17 or IL-17 receptor targeting drugs"
        ],
        "IMPACT": [
          "exclusion due to prior targeted therapy"
        ]
      },
      {
        "id": "FLR_2292",
        "nct_id": "NCT06477536",
        "raw_text": "Patients who are experiencing GPP flare",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "experiencing GPP flare"
        ],
        "CONDITION_PATTERN": [
          "current"
        ],
        "IMPACT": [
          "exclusion due to active disease flare"
        ]
      },
      {
        "id": "FLR_2271",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of lithium-containing agents or antimalarials within 4 weeks (or 5 half-lives, whichever is longer) prior to the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "prior use of lithium-containing agents",
          "prior use of antimalarials"
        ],
        "CONDITION_PATTERN": [
          "history"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to first dose"
        },
        "TREATMENT_REQUIREMENT": [
          "no prior use within 4 weeks or 5 half-lives, whichever is longer"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent prior treatment"
        ]
      },
      {
        "id": "FLR_2270",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of antihistamines, potent cytochrome P (CYP) 450 enzyme inhibitors (such as indinavir, nelfinavir, ritonavir, clarithromycin, itraconazole, ketoconazole, nefazodone, saquinavir and telithromycin) or inducers (such as efavirenz, barbiturates, phenytoin sodium, and rifampicin) within 2 weeks before the first dose of this study or these drugs cannot be discontinued during the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of antihistamines",
          "use of potent cytochrome P450 enzyme inhibitors",
          "use of cytochrome P450 enzyme inducers"
        ],
        "CONDITION_PATTERN": [
          "prior use",
          "current use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "before the first dose of this study"
        },
        "TREATMENT_REQUIREMENT": [
          "discontinuation of these drugs during the study not allowed"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or ongoing use of interacting drugs"
        ]
      },
      {
        "id": "FLR_2269",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of ZORYVE® cream or foam; prior use of oral roflumilast or other phosphodiesterase-4 (PDE4) inhibitors (apremilast, etc.) within 4 weeks prior to the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of ZORYVE cream or foam",
          "use of oral roflumilast",
          "use of other phosphodiesterase-4 inhibitors"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to the first dose of this study"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent use of specified psoriasis treatments"
        ]
      },
      {
        "id": "FLR_2268",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of psoralen plus ultraviolet A (PUVA) or ultraviolet B (UVB) phototherapy within 4 weeks before the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of psoralen plus ultraviolet A (PUVA) phototherapy",
          "use of ultraviolet B (UVB) phototherapy"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "before the first dose of this study"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent phototherapy"
        ]
      },
      {
        "id": "FLR_2267",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of topical agents for psoriasis treatment or any other agents which may impact efficacy assessment of psoriasis, including but not limited to topical glucocorticoids, vitamin D analogues, benvitimod and prescription emollients or emollients containing additives (e.g., ceramides, hyaluronic acid, urea, or filamentous proteolytic products) or antipruritic ingredients (e.g., menthol, polyhydroxyethanol, pramoxine, lidocaine, prilocaine, capsaicin, naltrexone, N-palmitoylethanolamine, etc.) or a class of drugs (including Chinese herbal formulas, herbs, proprietary Chinese medicines, etc.) containing Chinese medicinal ingredients for topical use (Note: for the treatment of diseases other than psoriasis, except in cases where the use of such medicines is deemed necessary in the medical judgment of the investigator and/or the specialist and would not interfere with the assessment of the study), etc. within 2 weeks.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of topical agents for psoriasis treatment",
          "use of topical glucocorticoids",
          "use of vitamin D analogues",
          "use of benvitimod",
          "use of prescription emollients or emollients containing additives",
          "use of antipruritic ingredients",
          "use of Chinese herbal formulas or proprietary Chinese medicines for topical use"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to first dose"
        },
        "TREATMENT_REQUIREMENT": [
          "discontinuation of these agents unless deemed necessary by investigator and not interfering with study assessment"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "potential interference with efficacy assessment of psoriasis"
        ]
      },
      {
        "id": "FLR_2266",
        "nct_id": "NCT06648772",
        "raw_text": "Prior use of systemic drugs for psoriasis treatment or any other agents which may impact efficacy assessment of psoriasis, including but not limited to oral or intravenous glucocorticoids, retinoic acids, methotrexate, cyclosporine, and other systemic immunosuppressive agents or a class of drugs (including Chinese herbal formulas, herbs, proprietary Chinese medicines, etc.) containing Chinese medicinal ingredients within 4 weeks of the first dose of this study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of systemic drugs for psoriasis treatment",
          "use of oral or intravenous glucocorticoids",
          "use of retinoic acids",
          "use of methotrexate",
          "use of cyclosporine",
          "use of systemic immunosuppressive agents",
          "use of Chinese herbal formulas or proprietary Chinese medicines containing Chinese medicinal ingredients"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to first dose"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent systemic psoriasis treatments"
        ]
      },
      {
        "id": "FLR_2246",
        "nct_id": "NCT07013201",
        "raw_text": "Other transdermal or cutaneously applied therapy on the palms or soles (except for the use of the participant's own non-medicated emollients) within 1 week prior to baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of transdermal or cutaneously applied therapy"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "week",
          "reference": "prior to baseline"
        },
        "TREATMENT_REQUIREMENT": [
          "except participant's own non-medicated emollients"
        ],
        "IMPACT": [
          "exclusion due to recent topical therapy on palms or soles"
        ]
      },
      {
        "id": "FLR_2245",
        "nct_id": "NCT07013201",
        "raw_text": "Use of systemic antibiotics or cutaneously applied antibiotics on the palms or soles within 2 weeks prior to baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of systemic antibiotics",
          "use of cutaneously applied antibiotics"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to baseline"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent antibiotic use on palms or soles"
        ]
      },
      {
        "id": "FLR_2244",
        "nct_id": "NCT07013201",
        "raw_text": "Cutaneously applied treatment with immunomodulators (e.g., phosphodiesterase-4 [PDE-4] inhibitors, pimecrolimus, tacrolimus, tapinarof, vitamin D3 derivatives) or TCS on the palms or soles within 2 weeks prior to baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "cutaneous treatment with immunomodulators",
          "use of topical corticosteroids (TCS)"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to baseline"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent immunomodulator or TCS use on palms or soles"
        ]
      },
      {
        "id": "FLR_2243",
        "nct_id": "NCT07013201",
        "raw_text": "Use of systemic or topical janus kinase inhibitors (including delgocitinib/LEO 124249) within 4 weeks prior to baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of systemic janus kinase inhibitors",
          "use of topical janus kinase inhibitors"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to baseline"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent use of janus kinase inhibitors"
        ]
      },
      {
        "id": "FLR_2242",
        "nct_id": "NCT07013201",
        "raw_text": "Use of tanning beds or phototherapy (e.g., ultraviolet B [UVB], ultraviolet A1 [UVA1], psoralen ultraviolet A [PUVA]) on the palms or soles within 4 weeks prior to baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of tanning beds",
          "use of phototherapy (UVB, UVA1, PUVA)"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to baseline"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent tanning or phototherapy on palms or soles"
        ]
      },
      {
        "id": "FLR_2241",
        "nct_id": "NCT07013201",
        "raw_text": "Systemic treatment within 4 weeks prior to baseline with immunosuppressive drugs (e.g., methotrexate, cyclosporine, azathioprine), immunomodulating drugs, retinoids (e.g., acitretin), tyrosine kinase inhibitors, phosphodiesterase-4 inhibitors, or corticosteroids (steroid eye drops and inhaled or intranasal steroids in the doses recommended in the product prescribing information for the treatment of allergic conjunctivitis, asthma, or rhinitis are allowed).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of systemic immunosuppressive drugs",
          "use of immunomodulating drugs",
          "use of retinoids",
          "use of tyrosine kinase inhibitors",
          "use of phosphodiesterase-4 inhibitors",
          "use of corticosteroids"
        ],
        "CONDITION_PATTERN": [
          "prior use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to baseline"
        },
        "TREATMENT_REQUIREMENT": [
          "allowed steroid eye drops and inhaled or intranasal steroids at recommended doses for allergic conjunctivitis, asthma, or rhinitis"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent systemic immunosuppressive or related drug use"
        ]
      },
      {
        "id": "FLR_2226",
        "nct_id": "NCT07013201",
        "raw_text": "Presence or known history of drug-induced PPP (e.g., a new onset of PPP or an exacerbation of PPP from beta blockers, calcium channel blockers, lithium, or biologic therapy including infliximab, adalimumab, or etanercept).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "drug-induced palmoplantar pustulosis (PPP)"
        ],
        "CONDITION_PATTERN": [
          "presence",
          "known history"
        ],
        "ANATOMICAL_LOCATION": [
          "palms",
          "soles"
        ],
        "IMPACT": [
          "exclusion due to drug-induced PPP presence or history"
        ]
      },
      {
        "id": "FLR_2224",
        "nct_id": "NCT07013201",
        "raw_text": "Participants with prior experiences of inadequate response with topical corticosteroid(s) (TCS) or for whom TCS are inadvisable, as judged by the investigators.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "inadequate response to topical corticosteroids (TCS)",
          "TCS inadvisable"
        ],
        "CONDITION_PATTERN": [
          "prior experience"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "exclusion based on investigator judgment of TCS response or advisability"
        ]
      },
      {
        "id": "FLR_2201",
        "nct_id": "NCT06628206",
        "raw_text": "No high potency opioid analgesics 2 weeks prior to baseline and during study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of high potency opioid analgesics"
        ],
        "CONDITION_PATTERN": [
          "no use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to baseline and during study"
        },
        "IMPACT": [
          "exclusion due to recent or ongoing use of high potency opioid analgesics"
        ]
      },
      {
        "id": "FLR_2200",
        "nct_id": "NCT06628206",
        "raw_text": "Use of psoriasis treatments: Oral or topical retinoids 2 weeks prior to Day 1 and throughout the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of oral retinoids",
          "use of topical retinoids"
        ],
        "CONDITION_PATTERN": [
          "prior use",
          "current use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 2,
          "unit": "weeks",
          "reference": "prior to Day 1 and throughout the study"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent or ongoing use of retinoids"
        ]
      },
      {
        "id": "FLR_2199",
        "nct_id": "NCT06628206",
        "raw_text": "If on prednisone, subject must be on stable dose, not to exceed equivalent of 10mg of prednisone per day (RA and PsA), and dose must be stable for ≥ 4 weeks prior to Day 1.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of prednisone"
        ],
        "CONDITION_PATTERN": [
          "current use",
          "stable dose"
        ],
        "SEVERITY": "dose not to exceed equivalent of 10mg prednisone per day",
        "TIMEFRAME": {
          "relation": "stable for",
          "amount": 4,
          "unit": "weeks",
          "reference": "prior to Day 1"
        },
        "TREATMENT_REQUIREMENT": [
          "dose must be stable"
        ],
        "IMPACT": [
          "eligibility dependent on stable and limited prednisone dose"
        ]
      },
      {
        "id": "FLR_2198",
        "nct_id": "NCT06628206",
        "raw_text": "Lack of response to > 1 therapeutic agent targeting tumor necrosis factor.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "therapeutic agents targeting tumor necrosis factor"
        ],
        "CONDITION_PATTERN": [
          "lack of response"
        ],
        "TREATMENT_REQUIREMENT": [
          "lack of response to more than one agent"
        ],
        "IMPACT": [
          "exclusion due to lack of response to TNF-targeting therapies"
        ]
      },
      {
        "id": "FLR_2181",
        "nct_id": "NCT06628206",
        "raw_text": "Participants received conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy for ≥ 3 months and on a stable dose for ≥ 4 weeks prior to the first dose of study drug.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy"
        ],
        "CONDITION_PATTERN": [
          "prior use",
          "stable dose"
        ],
        "TIMEFRAME": {
          "relation": "for",
          "amount": 3,
          "unit": "months",
          "reference": "prior to first dose"
        },
        "TREATMENT_REQUIREMENT": [
          "stable dose for at least 4 weeks prior to first dose"
        ],
        "IMPACT": [
          "eligibility requires stable csDMARD therapy"
        ]
      },
      {
        "id": "FLR_2171",
        "nct_id": "NCT07038720",
        "raw_text": "Has received any drugs that inhibit or induce hepatic drug-metabolizing enzymes within 7 days before screening; Ingestion of foods or beverages that induce or inhibit liver metabolism enzymes (e.g., grapefruit, etc.) within 48 hours before administration; Inability to comply with the prohibition of ingestion of any foods or beverages containing or metabolically producing caffeine or xanthine (e.g., coffee, tea, chocolate) within 48 hours before the first administration until the completion of the last PK blood sample;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of drugs that inhibit or induce hepatic drug-metabolizing enzymes",
          "ingestion of foods or beverages that induce or inhibit liver metabolism enzymes",
          "ingestion of foods or beverages containing or metabolically producing caffeine or xanthine"
        ],
        "CONDITION_PATTERN": [
          "prior use",
          "prohibition of ingestion"
        ],
        "TIMEFRAME": [
          {
            "relation": "within",
            "amount": 7,
            "unit": "days",
            "reference": "before screening"
          },
          {
            "relation": "within",
            "amount": 48,
            "unit": "hours",
            "reference": "before administration"
          },
          {
            "relation": "from 48 hours before first administration until completion of last PK blood sample"
          }
        ],
        "TREATMENT_REQUIREMENT": [
          "prohibition of ingestion of caffeine or xanthine containing foods/beverages during specified period"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "exclusion due to recent use of enzyme affecting drugs or prohibited ingestion affecting metabolism"
        ]
      },
      {
        "id": "FLR_2146",
        "nct_id": "NCT07038720",
        "raw_text": "Has received IL-17 small molecule inhibitors in the past;",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "use of IL-17 small molecule inhibitors"
        ],
        "CONDITION_PATTERN": [
          "past use"
        ],
        "IMPACT": [
          "exclusion due to prior use of IL-17 inhibitors"
        ]
      },
      {
        "id": "FLR_2121",
        "nct_id": "NCT06842199",
        "raw_text": "Eligible subjects must meet all of the following criteria: 4. Subjects need to receive systemic therapy and/or phototherapy.",
        "EXCLUSION_STRENGTH": "inclusion",
        "CONDITION_TYPE": [
          "psoriasis"
        ],
        "TREATMENT_REQUIREMENT": [
          "systemic therapy",
          "phototherapy"
        ],
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "eligibility requirement"
        ]
      },
      {
        "id": "FLR_2115",
        "nct_id": "NCT06672393",
        "raw_text": "Prior exposure to TYK2 inhibitors",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "exposure to TYK2 inhibitors"
        ],
        "CONDITION_PATTERN": [
          "prior exposure"
        ],
        "IMPACT": [
          "exclusion or inclusion based on prior treatment"
        ]
      },
      {
        "id": "FLR_2102",
        "nct_id": "NCT05442190",
        "raw_text": "Received phototherapy (including laser) or photodynamic (light activated drug) therapy within 4 weeks prior to the beginning of the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "phototherapy",
          "photodynamic therapy"
        ],
        "CONDITION_PATTERN": [
          "received"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "beginning of the study"
        },
        "LOGICAL_OPERATOR": "OR",
        "IMPACT": [
          "eligibility based on recent treatment"
        ]
      },
      {
        "id": "FLR_2101",
        "nct_id": "NCT05442190",
        "raw_text": "Received systemic psoriasis therapy within 4 weeks prior to the beginning of the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic psoriasis therapy"
        ],
        "CONDITION_PATTERN": [
          "received"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 4,
          "unit": "weeks",
          "reference": "beginning of the study"
        },
        "IMPACT": [
          "eligibility based on recent treatment"
        ]
      },
      {
        "id": "FLR_2100",
        "nct_id": "NCT05442190",
        "raw_text": "Received systemic biologic therapy to treat psoriasis within 12 weeks prior to the beginning of the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "systemic biologic therapy for psoriasis"
        ],
        "CONDITION_PATTERN": [
          "received"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 12,
          "unit": "weeks",
          "reference": "beginning of the study"
        },
        "IMPACT": [
          "eligibility based on recent treatment"
        ]
      },
      {
        "id": "FLR_2099",
        "nct_id": "NCT05442190",
        "raw_text": "Use of topical anti psoriatic therapy within one week prior to the beginning of the study and willing to not use other psoriasis treatments for 4 weeks following completion of the treatment portion of the study.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "topical anti-psoriatic therapy"
        ],
        "CONDITION_PATTERN": [
          "use"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 1,
          "unit": "week",
          "reference": "prior to beginning of the study"
        },
        "TREATMENT_REQUIREMENT": [
          "willingness to not use other psoriasis treatments for 4 weeks following completion of treatment portion of study"
        ],
        "IMPACT": [
          "eligibility based on recent and post-study treatment"
        ]
      },
      {
        "id": "FLR_2093",
        "nct_id": "NCT06926582",
        "raw_text": "Prior exposure to TYK2 inhibitors",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "exposure to TYK2 inhibitors"
        ],
        "CONDITION_PATTERN": [
          "prior exposure"
        ],
        "IMPACT": [
          "exclusion or inclusion based on prior treatment"
        ]
      },
      {
        "id": "FLR_2059",
        "nct_id": "NCT06143371",
        "raw_text": "2 weeks for immunizations or drugs known to possibly worsen psoriasis, unless on a stable dose for >12 weeks.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "immunizations",
          "drugs that may worsen psoriasis"
        ],
        "TIMEFRAME": {
          "relation": "2 weeks",
          "amount": 2,
          "unit": "weeks",
          "reference": ""
        },
        "TREATMENT_REQUIREMENT": [
          "stable dose for >12 weeks"
        ],
        "LOGICAL_OPERATOR": "OR",
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "AMBIGUITY_FLAG": true,
        "IMPACT": [
          "eligibility related to immunization or drug use"
        ]
      },
      {
        "id": "FLR_2003",
        "nct_id": "NCT06833307",
        "raw_text": "Had a clinically significant flare of psoriasis during the 12 weeks prior to baseline (Week 0).",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psoriasis flare"
        ],
        "CONDITION_PATTERN": [
          "clinically significant flare"
        ],
        "TIMEFRAME": {
          "relation": "during",
          "amount": 12,
          "unit": "weeks",
          "reference": "prior to baseline (Week 0)"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "eligibility based on recent disease activity"
        ]
      },
      {
        "id": "FLR_1986",
        "nct_id": "NCT05669833",
        "raw_text": "Use of moderate to high dose glucocorticoids (>10 mg);",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "glucocorticoid use"
        ],
        "CONDITION_PATTERN": [
          "use"
        ],
        "SEVERITY": "moderate to high dose (>10 mg)",
        "IMPACT": [
          "eligibility based on medication dose"
        ]
      },
      {
        "id": "FLR_1976",
        "nct_id": "NCT06641089",
        "raw_text": "Previous exposure to sonelokimab.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "exposure to sonelokimab"
        ],
        "CONDITION_PATTERN": [
          "previous exposure"
        ],
        "IMPACT": [
          "exclusion or inclusion based on prior treatment"
        ]
      },
      {
        "id": "FLR_1197",
        "nct_id": "NCT05642182",
        "raw_text": "A clinically significant flare of psoriasis within 12 weeks before baseline.",
        "EXCLUSION_STRENGTH": "mandatory_exclude",
        "CONDITION_TYPE": [
          "psoriasis flare"
        ],
        "CONDITION_PATTERN": [
          "clinically significant flare"
        ],
        "TIMEFRAME": {
          "relation": "within",
          "amount": 12,
          "unit": "weeks",
          "reference": "before baseline"
        },
        "REQUIRES_CLINICAL_JUDGMENT": true,
        "IMPACT": [
          "eligibility based on recent disease activity"
        ]
      }
    ]
  }
}